<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-17315753</id><updated>2011-12-11T23:51:10.146-06:00</updated><title type='text'>ICU room Pearls</title><subtitle type='html'>Archive of www.icuroom.net</subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://icuroom-pearls.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><link rel='next' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default?start-index=101&amp;max-results=100'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>297</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-17315753.post-116657321363310150</id><published>2006-12-19T18:05:00.000-06:00</published><updated>2006-12-19T18:06:53.660-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Tuesday December 19, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Something to share !&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;Today we will take a little break to share this important  statement:&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#003300;"&gt;"As you learn to become a doctor, there is a frequent sense of surprise, a feeling that you are not entitled to the kind of intrusion you are allowed into patients' lives. Without arguing, they permit you to examine them; it is impossible to imagine, when you do your very first physical exam, that someday you will walk in calmly and tell a man your grandfather's age to undress, and then examine him without thinking about it twice. You get used to it all, but every so often you find yourself marveling at the access you are allowed, at the way you are learning from their bodies, the stories, the lives and deaths of perfect strangers. They give up their privacy in exchange for some hope - sometimes strong, sometimes faint - of the alleviation of pain, the curing of disease. And gradually, with medical training, that feeling of amazement, that feeling that you are not entitled, scars over. You begin to identify more thoroughly with the medical profession - of course you are entitled to see everything and know everything; you're a doctor, aren't you? And as you accept this as your right, you move further from your patients, even as you penetrate more meticulously and more confidently into their lives."&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;- Perri Klass, M.D.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;/strong&gt;&lt;span style="color:#000000;"&gt;Read more about Dr. Klass &lt;/span&gt;&lt;a href="http://www.nlm.nih.gov/changingthefaceofmedicine/physicians/biography_186.html" target="_blank"&gt;&lt;span style="color:#660000;"&gt;here&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt; - source nih.gov&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-116657321363310150?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/116657321363310150'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/116657321363310150'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/12/tuesday-december-19-2006-something-to.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115617198395464366</id><published>2006-08-21T08:48:00.000-06:00</published><updated>2006-11-14T21:23:03.566-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Monday August 21, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;THAM&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Introduction;&lt;/span&gt;&lt;span style="color:#000000;"&gt; In patients with acute respiratory distress syndrome (ARDS), permissive hypercapnia is a strategy to decrease airway pressures to prevent ventilator-induced lung damage by lowering tidal volumes and tolerating higher arterial carbon dioxide tension. A pure respiratory acidosis generally does not require alkali therapy. Alkali therapy is indicated for either a metabolic acidosis or a mixed acidosis. The choice of buffer is based on type of acidosis, cardiorespiratory status, and lung mechanics.&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#660000;"&gt;&lt;br /&gt;Problem with NaHCO3:&lt;/span&gt; &lt;span style="color:#000000;"&gt;Slow infusions of NaHCO3 can be used to treat non-anion gap metabolic acidosis and some forms of increased anion gap acidosis. But using NaHCO3 to treat type A (hypoxia-related) lactic acidosis can be hazardous, particularly under conditions of hypoxemia, inadequate circulation, and limited alveolar ventilation.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;THAM:&lt;/span&gt; &lt;span style="color:#000000;"&gt;Under above circumstances, THAM is the preferable buffer because it does not increase PaCO2 and is excreted by the kidneys. Tromethamine (THAM) is a sodium-free alkalinizing agent that acts as a hydrogen ion (proton) acceptor. It is a weak base that combines with hydrogen ions from carbonic acid to form bicarbonate and cationic buffer. Administration of tromethamine decreases hydrogen ion concentration, which results in a decrease in carbon dioxide concentrations and an increase in bicarbonate concentrations. The administration of Tham also increases urine output through osmotic diuresis. Excretion of electrolytes and CO2 is also increased. Urine pH is raised along with the excretion of electrolytes.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;span style="color:#003333;"&gt;Usual Dose:&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;em&gt;Dose in ml's of 0.3M THAM = (1.1) (Wt. in Kg) (normal HCO3 – Pt’s HCO3)&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;OR&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Dose in ml’s of 0.3M THAM = body wt in kg X base deficit in MEq/L x 1.1&lt;br /&gt;Total dose should be administered over a period not less than 1 hour via central line.&lt;/em&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;.3M THAM solution is available as premix and is contra-indicated in renal failure, anuria and hyperkalemia. It may cause transient hypoglycemia and respiratory depression.&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115617198395464366?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115617198395464366'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115617198395464366'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/08/monday-august-21-2006-tham.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115521382028612849</id><published>2006-08-10T06:42:00.000-06:00</published><updated>2006-08-10T06:44:19.113-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Thursday August 10, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Level of central line tip may predispose to thrombosis&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;Interesting retrospective review of 428 central lines (inserted into 334 patients) was done in UK to look into the level central line tip's relation to thrombosis 1. The median follow-up was 72 days.&lt;br /&gt;&lt;br /&gt;*&lt;/span&gt;&lt;span style="font-size:85%;color:#000000;"&gt; The chest radiograph obtained post-catheter insertion, as well as follow-up radiographs, linograms, venograms and Doppler ultrasounds (US), were reviewed.&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;They found that: &lt;span style="color:#000066;"&gt;"There was a significant difference in thrombosis rate between lines sited with the tip in a distal third of the superior vena cava (2.6%) compared with a proximal third of the superior vena cava (41.7%) -&lt;em&gt; CVC with tips in a proximal position were 16 times more likely to thrombose than those in a distal position&lt;/em&gt;".&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Related previous pearls:&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/08/tip-of-central-line.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;CXR reading for optimum tip of central line&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;and&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/07/sc-cvc-in-ij.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;What if SC central line ends up in IJ vein?&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference:&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;list_uids=15041454&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;To clot or not to clot? That is the question in central venous catheters &lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;- Clinical Radiology, Volume 59, Issue 4, April 2004, Pages 349-355&lt;/span&gt; &lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115521382028612849?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115521382028612849'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115521382028612849'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/08/thursday-august-10-2006-level-of.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115513741764865368</id><published>2006-08-09T09:27:00.000-06:00</published><updated>2006-08-09T09:32:39.700-06:00</updated><title type='text'>tip of central line</title><content type='html'>&lt;a href="http://photos1.blogger.com/blogger/6288/1666/1600/cxr3.jpg"&gt;&lt;img style="FLOAT: left; MARGIN: 0px 10px 10px 0px; CURSOR: hand" alt="" src="http://photos1.blogger.com/blogger/6288/1666/320/cxr3.jpg" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Saturday July 22, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Do you need to pull back the central line? &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#990000;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;Ideally, tip of central venous catheter should not lie in cardiac structures and the desirable position is mid superior vena cava.&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;&lt;br /&gt;&lt;/em&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;&lt;/em&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;&lt;/em&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;Simple tip:&lt;/em&gt;&lt;/span&gt; If the tip of central venous catheter is above the superior margin of Right mainstem bronchus, it is unlikely to be in atrium.&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115513741764865368?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115513741764865368'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115513741764865368'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/08/tip-of-central-line.html' title='tip of central line'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115354358182865228</id><published>2006-07-21T22:42:00.000-06:00</published><updated>2006-07-21T22:46:21.853-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Friday July 21, 2006&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt; Prohibiting cell phones in ICUs - Are we over-reacting !&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;Truely speaking, there have been no studies to determine  the harm or benefit of mobile/cell phones in ICUs. Generally, cell phones are prohibited in hospitals, particularly in ICUs and telemetry floors due to concern of EMI* with pacemakers, ventilators, infusion pumps and other electronic units. It became pretty standard with a report published about 12 years ago&lt;/span&gt;&lt;/strong&gt;&lt;span style="color:#000000;"&gt; &lt;span style="font-size:78%;"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;.&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="font-size:85%;"&gt;* EMI = electromagnetic interference&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;At the 2003 meeting of the ASA (American Society of Anesthesiologists), 7878 five-questions survey, regarding modes of communication in the ORs/ICUs, were distributed.  4018 responses were received&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;2.&lt;/span&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;65% of surveyed reported using pagers as their primary mode of communications, &lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;17.5% of surveyed reported using cell-phones as their primary mode of communications and &lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;17.5% used overhead paging (or did not respond to this question)&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;And&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Among the 2607 respondents using pagers, 1179 (45%) reported experiencing significant delays in communication and 407 indicated that these delays led to medical error or patient injury. &lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;31% of cell-phone users reported delays in  communications. &lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Only 2.4% of the respondents indicated that they had ever experienced interference between a cell phone and a medical device.&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;It has been suggested that through proper policy controls, hospitals can provide a more safe environment taking advantage of this 2-way communication technology, with a reduction in the risk of medical error or injury resulting from  delay !!.&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;It has been recommended that as far as cell phones be kept at least &lt;em&gt;1 meter away&lt;/em&gt; from medical equipment, they seems safe&lt;/strong&gt; &lt;span style="font-size:85%;"&gt;3.&lt;/span&gt;&lt;br /&gt;&lt;/p&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Similar theme was echoed in an editorial in BMJ about 3 years ago: &lt;/strong&gt;&lt;/span&gt;&lt;a href="http://bmj.bmjjournals.com/cgi/content/full/326/7387/460" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Mobile phones in hospitals&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt; (BMJ 2003;326:460-461 - 1 March)&lt;/strong&gt;&lt;/span&gt;&lt;a name="art"&gt;&lt;/a&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;Related previous pearl: &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/01/saturday-january-21-2006-noise-level.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Noise level in ICUs&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;br /&gt;&lt;/strong&gt;&lt;span style="font-size:78%;"&gt;References: click to get abstract/article&lt;br /&gt;1. &lt;/span&gt;&lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&amp;amp;amp;db=pubmed&amp;amp;amp;list_uids=8198505&amp;amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#000000;"&gt;Mobile telephones interfere with medical electrical equipment &lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#000000;"&gt;- Australas Phys Eng Sci Med.1994 Mar;17(1):23-7.&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://www.anesthesia-analgesia.org/cgi/content/abstract/102/2/535" target="_blank"&gt;&lt;span style="font-size:78%;color:#000000;"&gt;Communication in Critical Care Environments: Mobile Telephones Improve Patient Care&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#000000;"&gt;  - Anesth Analg 2006;102:535-541&lt;br /&gt;3. &lt;/span&gt;&lt;a href="http://www.anesthesia-analgesia.org/cgi/content/abstract/101/5/1393" target="_blank"&gt;&lt;span style="font-size:78%;color:#000000;"&gt;Modern Wireless Telecommunication Technologies and Their Electromagnetic Compatibility with Life-Supporting Equipment&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt;&lt;span style="font-size:78%;"&gt; - Anesth Analg 2005;101:1393-1400&lt;br /&gt;&lt;/span&gt;&lt;strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000066;"&gt;Thursday July 20, 2006&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Q:&lt;/span&gt; &lt;em&gt;&lt;span style="color:#003300;"&gt;what is "cryo reduced  plasma"?&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A;&lt;/span&gt; Yesterday we learned that: one unit of cryoprecipitate is derived from one unit of fresh frozen plasma (FFP). Left over FFP, after removal of cryoprecipitate is called supernatant plasma or CRYO-REDUCED PLASMA.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#003300;"&gt;&lt;br /&gt;Clinical Significance:&lt;/span&gt;&lt;/em&gt; Cryo-reduced plasma is used as a treatment in  plasmapheresis for TTP, not responding to regular plasma exchange with FFP. Some physicians even use it as first line for plasmapheresis/Therapeutic Plasma Exchange (TPE) for a patient with Thrombotic Thrombocytopenic Purpura (TTP).&lt;br /&gt;&lt;/strong&gt; &lt;/span&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115354358182865228?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115354358182865228'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115354358182865228'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/07/friday-july-21-2006-prohibiting-cell.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115336423682638199</id><published>2006-07-19T20:53:00.001-06:00</published><updated>2006-07-20T11:45:14.280-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000099;"&gt;Wednesday July 19, 2006&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Q:&lt;/span&gt; &lt;em&gt;&lt;span style="color:#003333;"&gt;Why we call it cryoprecipitate?&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A:&lt;/span&gt; &lt;span style="color:#000000;"&gt;The name explains everthing. cryoprecipitate means "cold precipitate". When FFP is thawed slowly at 4 degree C, a white precipitate forms at the bottom of the bag, which can then be separated from the supernatant plasma. This precipitate is rich in fibrinogen, factor VIII, von Willebrand factor, factor XIII, and fibronectin - and call crayoprecipitate. One unit of cryoprecipitate is derived from fresh frozen plasma (FFP) prepared from a unit of whole blood and as it is only a little precipitate at the bottom of the bag, 1 unit of cryoprecipitate comprised only a volume of 10-20 mL.&lt;br /&gt;&lt;br /&gt;Contents:&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;80-100 units of factor VIII, which consists of both the procoagulant activity and the von Willebrand factor, &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;150-250 mg of fibrinogen, &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;50-100 units of factor XIII, and &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;50-60 mg of fibronectin.&lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Half life is about one year if stored at -18 degree C. When ordered (generally given as 6 units at a time), cryoprecipitate is thawed back to 37 degree C. Once thawed it must be kept at room temperature and has an expiration time of 4 to 6 hours.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Previous related pearls: &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/03/howmuchffp.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;How much FFP?&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; and &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/03/ffp.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Some facts about FFP&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115336423682638199?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115336423682638199'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115336423682638199'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/07/wednesday-july-19-2006-q-why-we-call_19.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115319902720588267</id><published>2006-07-17T23:01:00.000-06:00</published><updated>2006-07-17T23:05:07.416-06:00</updated><title type='text'></title><content type='html'>&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Tuesday July 18, 2006&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Q:&lt;/span&gt; &lt;em&gt;&lt;span style="color:#003300;"&gt;H&lt;/span&gt;&lt;span style="color:#003300;"&gt;ow IV (intravenous) DDAVP (desmopressin) should be given?&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A:&lt;/span&gt; DDAVP, short name of 1-deamino-8-D-arginine vasopressin and also known as desmopressin is use for varity of reasons in ICUs including uremic bleeding diasthesis, some platelet disorders, to boost the plasma level of factor VIII and von Willebrand factor (VWF) and in diabetes insipidus. It may be given as nasal spray or subcutaneous injection but in ICUs mostly get administrated via IV route.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#000066;"&gt;DDAVP should be diluted in 100 ml of normal saline and given by slow intravenous infusion over 30 minutes.&lt;/span&gt;&lt;/em&gt; The usual dose is 0.3 mcg/kg. Rapid infusion may result in tachycardia, flushing, tremor and abdominal discomfort. Also thrombosis and even myocardial infarction after an infusion of DDAVP has been reported and should be used with caution in patients with signs of arterial disease.&lt;/strong&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115319902720588267?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115319902720588267'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115319902720588267'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/07/tuesday-july-18-2006-q-how-iv.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115312073107420597</id><published>2006-07-17T01:16:00.000-06:00</published><updated>2006-07-17T01:20:01.786-06:00</updated><title type='text'></title><content type='html'>&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Monday July 17, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Intensivists' compensation&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;We looked into recent surveys' from different sources and found the following:&lt;br /&gt;&lt;/strong&gt;&lt;span style="font-size:85%;"&gt;&lt;br /&gt;* All compensations in US dollar annually&lt;br /&gt;* K = 1000&lt;/span&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Average base salary&lt;/span&gt; compensation for intensivist has been ranged from annual 195K (new graduate) to 240K (3/5 years experienced). Highly experienced intensivist (15-20 years) should have compensation around 255K - 263K annual.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Latest market:&lt;/span&gt; all these surveys were published atleast a year ago and in last 12 months advertisements for intensivists' opportunities continue to show rising trend of salaries even upto 225-250K for new graduates.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Academic factor:&lt;/span&gt; Intensivist at a university setting make less but have better life style due to house staff availability and protected time for research (average 168 K), while critical care staff physicians employed by a non-university-affiliated hospital gets higher compensation (avaerage 240K) but more burn out.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Total clinical time&lt;/span&gt; in university setting is around 26-34 weeks per year but in private groups it all depends on local needs with 40-47 weeks (with 4 weeks vacation and one week for CME). Many groups prefer to work in block scheduling (like '7 days on 7 days off' to wear off burn out).&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;VA factor:&lt;/span&gt; VA system intensivits have good benefits and life style (like their university based colleagues) but salary remained low around 130-140K 3. Recently, there are strong indications that salaries would go up.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;eICU factor:&lt;/span&gt; Recently eICU physicians have been offered higher than average compensation with heavy investments in this sector from major health systems but still very few intensivists have been found to take it as a full time employment.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Subspeciality factor:&lt;/span&gt; Overall critical care anesthesiologists and critical care non-trauma surgeons were under-compensated per one survey 1. Out of all PEDIATRIC intensivists found to be in highest demand due to lowest supply.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Geographical:&lt;/span&gt; Region wise east coast (particularly north east) has about 5-10% less compensation in all fields as compared to other regions.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Benefits:&lt;/span&gt; Benefits and bonuses upto 15% on top of base salary is a norm. In benfits - continuing medical education (CME) allowance range from 1000 - 5000 per year with average of 3000 US annual. 401 K (retirement), ADD, life insurance are usually part of the package but 3 essential benefits should include&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;ol&gt;&lt;li&gt;Malpractice with tail coverage&lt;/li&gt;&lt;li&gt;Health/dental benefits for self and family&lt;/li&gt;&lt;li&gt;CME&lt;/li&gt;&lt;/ol&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Mal-practice coverage:&lt;/span&gt; As a standard, malpractice with tail should be covered. New graduates often fail to ask for tail coverage and later found themselves in hot water with a condition call &lt;span style="color:#003300;"&gt;&lt;em&gt;'locked by the tail'&lt;/em&gt;&lt;/span&gt;. If candidate fail to negotiate but in later years want to relocate or leave the group, tail buying costs around 30K to 80K, depending on region. Tail buying is 200% of annual malpractice premiums.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Non-compete clause:&lt;/span&gt; Ideally, there should not be any non-compete or restrictive covenant clause as intensivists are unlikely to carry their own patient base but when private group is contracted or busy in one ICU its natural to have restrictive covenant and should be accepted as standard business practice.&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003300;"&gt;References:&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://www.sccm.org/SCCM/Publications/Critical+Connections/Archives/June+2005/CompensationJune05.htm" target="_blank"&gt;&lt;span style="font-size:78%;color:#003300;"&gt;Compensation for Physicians in Critical Care&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003300;"&gt; - Compensation of Critical Care Professionals 2005 - Society of Critical Care Medicine&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://www.cejkasearch.com/compensation/amga_physician_compensation_survey.htm" target="_blank"&gt;&lt;span style="font-size:78%;color:#003300;"&gt;The 2005 AMGA (American Medical Group Association) Medical Group Compensation and Financial Survey &lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003300;"&gt;- cejkasearch.com&lt;br /&gt;3. &lt;/span&gt;&lt;a href="http://veterans.house.gov/hearings/schedule108/oct03/10-21-03/srosenthal.html" target="_blank"&gt;&lt;span style="font-size:78%;color:#003300;"&gt;Testimony of Dr. Stephen P. Rosenthal President National Association of VA Physicians and Dentists &lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003300;"&gt;4. &lt;/span&gt;&lt;a href="http://www.ccmjournal.com/pt/re/ccm/abstract.00003246-200603001-00004.htm;jsessionid=G4sfmh2RsJQhRvTSghLql6w8h1CTRcyJqwF6zmLCJCQjnTJnz9NZ!-1734750035!-949856144!8091!-1" target="_blank"&gt;&lt;span style="font-size:78%;color:#003300;"&gt;Intensive care unit physician staffing: Financial modeling of the Leapfrog standard&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003300;"&gt; - Critical Care Medicine. Interface of Public Policy and Critical Care Medicine. 34(3) Suppl:S18-S24, March 2006.&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115312073107420597?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115312073107420597'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115312073107420597'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/07/monday-july-17-2006-intensivists.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115304720145247762</id><published>2006-07-16T04:50:00.000-06:00</published><updated>2006-07-16T08:22:20.390-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Sunday July 16, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Optimum patients' load for intensivist&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;ICUs in united stated range anywhere from 6 to 24 beds or may be more. At this point, it is not clear at what point intensivist's efficiency plateau out and effects the overall outcome.&lt;br /&gt;&lt;br /&gt;Drs. Saqib Dara, MD and Bekele Afessa, MD from Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, MN looked into the issue with regression analyses of about 25,00 patients. They divided intensivits' patients load into 4 groups:&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt;1:7.5,&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;1:9.5, &lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;1:12, and &lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;1:15 &lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;strong&gt;They found that the ICU period with one intensivist for 15 beds had a longer adjusted ICU LOS (length of stay). Although the ICU period with an intensivist-to-bed ratio of 1:7.5 had the shortest ICU LOS ratio, the difference was not statistically significant compared to the periods with intensivist-to-ICU bed ratios of 1:9.5 or 1:12.&lt;br /&gt;&lt;br /&gt;This is the only study of its kind from single institution but it appears that optimum number of patients, &lt;/strong&gt;&lt;strong&gt;&lt;em&gt;&lt;span style="color:#660000;"&gt;intensivist should carry to produce maximum outcome is around 12 or less.&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;It is all good work of intensivists' that observed ICU mortality did not differ significantly in any group despite progressive increase of load of work.&lt;br /&gt;&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:78%;color:#003300;"&gt;&lt;br /&gt;Reference: click to get article/abstract&lt;br /&gt;&lt;/span&gt;&lt;a href="http://www.chestjournal.org/cgi/content/abstract/128/2/567" target="_blank"&gt;&lt;span style="font-size:78%;color:#003300;"&gt;Intensivist-to-Bed Ratio - Association With Outcomes in the Medical ICU&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003300;"&gt; - chest. 2005;128:567-572.&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115304720145247762?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115304720145247762'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115304720145247762'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/07/sunday-july-16-2006-optimum-patients.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115296467474265912</id><published>2006-07-15T05:56:00.000-06:00</published><updated>2006-07-15T08:19:19.270-06:00</updated><title type='text'></title><content type='html'>&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Saturday July 15, 2006&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Case:&lt;/span&gt; &lt;em&gt;&lt;span style="color:#003333;"&gt;32 year old male with history of HIV presented to ED with complaint of upper quadrant pain. Initial lab shows elevated LFT and severe acidosis with bicarb of 8 in initial chemistry. You quickly start working through your mnemonic of increased anion gap acidosis - "CAT MUD PILES" !! *. Lactic acid level reported 9.4 mg/dl. CT scan of abdomen done to rule out ischemic colitis but showed only hepatic steatosis. Patient clinically does not appears toxic or septic though you started him on IV fluid and prophylactic antibiotics. Pt. is ruled out for DKA and other causes of acidosis also. What is the probable source of his severe lactic acidosis ?&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Answer:&lt;/span&gt; Cause is patient's HIV medicines &lt;span style="font-size:85%;"&gt;(HAART - Highly Active Anti-Retroviral Therapy)&lt;/span&gt;, mostly likely the nucleoside reverse-transcriptase inhibitors (NRTIs), - stavudine. NRTIs can cause hyperlactatemia by disrupting the function of the mitochondria. This is known as mitochondrial toxicity. NRTIs also cause fatty liver (hepatic steatosis), may be acute liver failure, and inefficient liver cannot metabolize lactic acid quickly resulting in severe hyperlactatemia.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;This week The New England Journal of Medicine has posted a free article &lt;/strong&gt;&lt;/span&gt;&lt;a href="http://content.nejm.org/cgi/content/full/355/2/173" target="_blank"&gt;&lt;span style="color:#660000;"&gt;&lt;strong&gt;Intensive Care of Patients with HIV Infection&lt;/strong&gt;&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;span style="font-size:85%;"&gt;(N Engl J Med 2006; 355:173-181, Jul 13, 2006).&lt;br /&gt;&lt;/span&gt;&lt;strong&gt;&lt;br /&gt;&lt;br /&gt;* The mnemonic &lt;span style="color:#990000;"&gt;"CAT MUD PILES"&lt;/span&gt; is a easy way to remember the differential for an increased anion gap acidosis &lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;br /&gt;Carbon monoxide, Cyanide, &lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Alcoholic ketoacidosis, &lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Toluene, &lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;br /&gt;Methanol,&lt;br /&gt;Uremia,&lt;br /&gt;Diabetic ketoacidosis,&lt;br /&gt;&lt;br /&gt;Paraldehyde, Phenformin,&lt;br /&gt;Iron, Isoniazid,&lt;br /&gt;Lactic acidosis,&lt;br /&gt;Ethylene glycol,&lt;br /&gt;Salicylates.&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115296467474265912?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115296467474265912'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115296467474265912'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/07/saturday-july-15-2006-case-32-year-old.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115288510551912784</id><published>2006-07-14T07:49:00.000-06:00</published><updated>2006-08-09T13:56:11.683-06:00</updated><title type='text'>SC CVC in IJ</title><content type='html'>&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Friday July 14, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;If SC central line ends up in IJ vein ?&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;It is always a possibility that central venous catheter placed in subclavian (SC) vein may take path upward and travel in internal jugular (IJ) vein. Incidence is about 5.4% and does not vary with side of insertion or with the head position during the procedure&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;1&lt;/span&gt;&lt;strong&gt;.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;First 2 preventive measures,&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;1)&lt;/span&gt; One study clearly showed that if you direct 'tip of J-wire' caudally, the relative risk for cannulating the ipsilateral internal jugular vein is low 2.&lt;br /&gt;&lt;br /&gt;OR&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;2)&lt;/span&gt; After cannulating subclavian vein, apply little pressure at ipsilateral IJ vein while passing wire. If wire stop threading or resistance felt, it means you need to pull back wire for few centimeters (making sure you don't loose vein cannulation) and thread again.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000066;"&gt;Alternatively,&lt;/span&gt; after you place subclavian catheter, before applying sutures there are 2 ways to make sure you are not in IJ vein.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;1)&lt;/span&gt; Hook central line to central venous pressure (CVP) measurement. Apply firm pressure over the ipsilateral IJ vein in the supraclavicular region for approximately 10 seconds. Quick change in transducer pressure and waveform, like CVP increased by 5 mm Hg (fictitious rise in CVP) or flattening of waveforms indicates jugular misplacement of the catheter tip. Its called&lt;em&gt; Internal Jugular Vein Occlusion Test&lt;/em&gt;&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;3.&lt;br /&gt;&lt;/span&gt;&lt;strong&gt;&lt;br /&gt;OR&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;2)&lt;/span&gt; Flush about 3 -5 cc of saline and put your sthethoscope or even finger on ipsilateral IJ vein to hear or feel the bruit/flow.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;In case, you don't do above maneuvers while inserting SC central line and CXR shows IJ placement, pull central venous cather back upto 4-5 cm from punture point and try above maneuvers. Another trick you can apply in case you have to pull back catheter and pass over J-wire again - thread J-wire only partially till you are sure you are in vein, pull back catheter completely (preferably use new catheter to avoid risk of infection) , slightly curve the tip of catheter downwards (like S tip PA-catheters) and pass with little twist.&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: Click to get abstract/article&lt;br /&gt;&lt;br /&gt;1. Misplacement of subclavian venous Catheters: Importance of head position and choice of puncture site. BJA1990; 64: 632-33&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://www.thoracic.org/sections/clinical-information/critical-care/evidence-based-critical-care/structured-abstracts-from-critical-care-literature/direction-of-the-j-tip.html" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Direction of the J-tip of the guidewire, in Seldinger technique, is a significant factor in misplacement of Subclavian vein catheter: A randomized, controlled study&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Anesth Analg 2005;100:21-24&lt;br /&gt;3. &lt;/span&gt;&lt;a href="http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ija/vol9n1/cvc.xml" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Internal Jugular Vein Occlusion Test For Rapid Detection Of Misplaced Subclavian Vein Catheter&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - The Internet Journal of Anesthesiology. 2005. Volume 9 Number 1&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115288510551912784?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115288510551912784'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115288510551912784'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/07/sc-cvc-in-ij.html' title='SC CVC in IJ'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115279530880824613</id><published>2006-07-13T06:53:00.000-06:00</published><updated>2006-07-13T06:55:08.833-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt; &lt;span style="color:#000066;"&gt;Thursday July 13, 2006&lt;/span&gt;&lt;br /&gt; &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Case:&lt;/span&gt;  &lt;em&gt;&lt;span style="color:#003333;"&gt;54 year old male with history of alcoholic cirrhosis,  brought to ED after fall and found to have intracranial bleed. INR noted to be 1.5. Neurology service wrote for FFP (fresh frozen plasma) and IV Vitamin K. Patient admitted to ICU after neurosurgery decided to go conservative route. At admission patient mental status seems appropriate but 2 hours after admission you have been called as patient noted to have seizures by bedside staff. On arrival you noticed patient having generalized muscular contractions but he respond appropriately to your questions.&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Probable etiology is:&lt;/span&gt; &lt;span style="color:#003333;"&gt;Hypocalcemia induced by citrate present in FFP&lt;/span&gt;.&lt;br /&gt;&lt;br /&gt;Citrate is usually used in blood products as anticoagulant. It binds to free calcium to form soluble calcium citrate, &lt;em&gt;thereby lowering the free (ionized) but not the total serum calcium concentration.&lt;span style="color:#000066;"&gt; It is important to check the ionized calcium  instead of total serum calcium&lt;/span&gt;&lt;/em&gt;&lt;span style="color:#000066;"&gt;.&lt;/span&gt; The slower infusion rate has shown significantly less reduction in ionized calcium than did the higher infusion rates.&lt;br /&gt;&lt;br /&gt;Prophylactic calcium infusion is not recommended with each blood product transfusion unless clinically indicated. Citrate is normally rapidly excreted by the liver and transient hypocalcemia is not necessary to treat. However, when a patient receives more than 1 unit of erythrocytes/blood product every 5 minutes or the capacity of the liver to metabolize citrate effectively is exceeded (like in our patient above with cirrhosis), the associated hypocalcemia can cause depressed ventricular contractility and decreased peripheral vascular resistance, causing arrhythmias, hypotension and neurologic symptoms of  tetany.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Remember:&lt;/span&gt; &lt;span style="color:#003333;"&gt;In addition to calcium, citrate binds to magnesium, which can result in clinically important hypomagnesemia too.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115279530880824613?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115279530880824613'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115279530880824613'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/07/thursday-july-13-2006-case-54-year-old.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115270881652343150</id><published>2006-07-12T06:49:00.000-06:00</published><updated>2006-07-12T06:53:36.553-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Wednesday July 12, 2006&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Case:&lt;/span&gt; &lt;span style="color:#003333;"&gt;&lt;em&gt;47 year old morbidly obese female with baseline history of COPD, successfully extubated post-op and admitted to ICU for overnight observation after gastric bypass surgery. Patient appears more lethargic in late evening and ABG was drawn which showed PH of 7.20, PO2 of 59 and PCO2 of 98 (pt's baseline PCO2 is around 55). You ordered nebulizer treatments and applied full face mask's noninvasive positive pressure ventilation (BiPAP) with setting of 10/5 (IPAP of 10 cm H2O and EPAP of 5 cm H20) and ordered ABG after one hour. Followup ABG is PH of 7.24, PO2 of 72 and PCO2 of 86. Patient is still lethargic.Your next step would be:&lt;br /&gt;&lt;br /&gt;A) Increase IPAP  with followup ABG in 1-2 hours&lt;br /&gt;&lt;br /&gt;B) Change to nasal mask with followup ABG in 1-2 hours&lt;br /&gt;&lt;br /&gt;C) Intubate patient&lt;br /&gt;&lt;br /&gt;D) Continue present settings with followup ABGin 1-2 hours&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Answer:  C&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#990000;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;strong&gt;Noninvasive positive pressure ventilation (BiPAP) should be use with caution in fresh gastric bypass patients and there should be a low threshold to intubate if situation arise. BiPAP  pumps air into the small gastric pouch and can lead to  complications like breakdown of suture lines, bowel  perforation and gastric distension. Though one small study of 27 patients didn't show either any complication or advantage of BiPAP in the first 24 postoperative hours of severely obese patients with comorbid illnesses who have undergone elective gastric bypass&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;1&lt;/span&gt;&lt;strong&gt; but there are case reports in literature showing potential complication and geniune concern for use of of bi-level positive airway pressure after gastric bypass surgery&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference: click to get abstract/article&lt;br /&gt;1.&lt;/span&gt;&lt;a href="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6WWS-46G484J-3&amp;amp;_user=10&amp;amp;_handle=V-WA-A-W-AD-MsSWYWW-UUA-U-AACCAVDZBB-AACWDWYVBB-EEAAVWCBA-AD-U&amp;amp;_fmt=summary&amp;amp;_coverDate=09%2F30%2F2002&amp;amp;_rdoc=3&amp;amp;_orig=browse&amp;amp;_srch=%23toc%237138%232002%23999039990%23331306!&amp;amp;_cdi=7138&amp;amp;view=c&amp;amp;_acct=C000050221&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=10&amp;amp;md5=2ecf8f7cf7e1901944c76a77273a51e8" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;The effect of bi-level positive airway pressure on postoperative pulmonary function following gastric surgery for obesity&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Respiratory Medicine Volume 96, Issue 9, September 2002, Pages 672-676&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=15018761&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;A potential complication of bi-level positive airway pressure after gastric bypass surgery &lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;- Obes Surg. 2004 Feb;14(2):282-4.&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115270881652343150?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115270881652343150'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115270881652343150'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/07/wednesday-july-12-2006-case-47-year.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115266407866581232</id><published>2006-07-11T18:24:00.000-06:00</published><updated>2006-07-11T22:09:20.636-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Tuesday July 11, 2006&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Paracentesis with seldinger technique / with central venous catheter kit&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;During paracentesis regular single, double or triple lumen central venous catheter may provide some benefits over angiocath (catheter over needle). Using regular central venous catheter kit's needle, advance till you get ascitic fluid. Now pass J-wire through needle upto appropriate length -------&gt;remove the needle ----&gt; advance your catheter over wire -----&gt; remove the wire ----&gt; if you don't see fluid, slowly pull back the catheter till you get flow. Advantages of this technique:&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;1)&lt;/span&gt; This is relatively safe as paracentesis needle in available kits are usually long and may carry risk of trauma if you keep advancing at non-ascitic area. (In commercial kits, usual length of catheter and needle is about 19 cm/ 7.5 inches).&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;2)&lt;/span&gt; While advancing catheter away from needle, it may get kinked. Catheter getting advanced over wire is unlikely to get kinked.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;3)&lt;/span&gt; Use catheter from original kit as it may provide advantage of bigger diameter but in large fluid removal you may use tripple lumen catheter and leave it lock like regular central line for 4/5 days to drain required fluid everyday.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;4)&lt;/span&gt; Multiple ports may allow you to drain in 2/3 bags/bottles simultaneously.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-size:85%;"&gt;&lt;span style="color:#660000;"&gt;Editors' note:&lt;/span&gt; &lt;span style="color:#003333;"&gt;Contributor of this peal is a practicing intensivist but request to hold his and institution's name. We often post bedside tips which are fully anecdotal and individual's idea and may not be evidence based. Use it per your discretion.&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115266407866581232?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115266407866581232'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115266407866581232'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/07/tuesday-july-11-2006-paracentesis-with.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115258626214642339</id><published>2006-07-10T20:49:00.000-06:00</published><updated>2006-07-10T20:55:41.730-06:00</updated><title type='text'></title><content type='html'>&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Monday July 10, 2006&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Q;&lt;/span&gt; &lt;span style="color:#003333;"&gt;&lt;em&gt;How much intavenous albumin should be given to patient while removing ascitic fluid via paracentesis?&lt;br /&gt;&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A;&lt;/span&gt; Per 2004 guidelines published in &lt;/strong&gt;&lt;/span&gt;&lt;a name="1143"&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Hepatology 2004 Mar;39(3):841-56, for management of adult patients with ascites due to cirrhosis by &lt;/strong&gt;&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD)&lt;/strong&gt;&lt;/span&gt;&lt;a name="1143"&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;, &lt;/strong&gt;&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;&lt;strong&gt;"Post-paracentesis albumin infusion may not be necessary for a single paracentesis of less than 4 to 5 L. For large-volume paracenteses, an albumin infusion of 8 to 10 g per liter of fluid removed can be considered".&lt;/strong&gt;&lt;/span&gt; &lt;span style="font-size:85%;"&gt;(Grade II-2 evidence - Cohort or case-control analytic studies).&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;span style="font-size:85%;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;strong&gt;Read full guidelines &lt;/strong&gt;&lt;/span&gt;&lt;a href="http://www3.interscience.wiley.com/cgi-bin/fulltext/107630502/PDFSTART" target="_blank"&gt;&lt;span style="color:#660000;"&gt;&lt;strong&gt;here&lt;/strong&gt;&lt;/span&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115258626214642339?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115258626214642339'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115258626214642339'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/07/monday-july-10-2006-q-how-much.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115245874809275611</id><published>2006-07-09T09:24:00.000-06:00</published><updated>2006-07-10T01:20:13.676-06:00</updated><title type='text'></title><content type='html'>&lt;a href="http://photos1.blogger.com/blogger/6288/1666/1600/fnnavels.0.jpg"&gt;&lt;img style="DISPLAY: block; MARGIN: 0px auto 10px; CURSOR: hand; TEXT-ALIGN: center" alt="" src="http://photos1.blogger.com/blogger/6288/1666/320/fnnavels.0.jpg" border="0" /&gt;&lt;/a&gt;&lt;strong&gt;&lt;br /&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Sunday July 9, 2006&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;NAVEL&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;“NAVEL" is a mnemonic for position of the structures at the inguinal ligament, from lateral to medial. It is always helpful to stand beside patient before attempting femoral central line and say NAVEL and try to feel femoral artery and visualize femoral vein before putting needle. Again!, at the inguinal ligament, &lt;em&gt;from lateral to medial&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;ul&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Femoral &lt;span style="color:#660000;"&gt;N&lt;/span&gt;erve &lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Femoral &lt;span style="color:#660000;"&gt;A&lt;/span&gt;rtery &lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Femoral &lt;span style="color:#660000;"&gt;V&lt;/span&gt;ein &lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;E&lt;/span&gt;mpty space &lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;L&lt;/span&gt;ymphatics&lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115245874809275611?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115245874809275611'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115245874809275611'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/07/sunday-july-9-2006-navel-navel-is_09.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115241217369317118</id><published>2006-07-08T20:27:00.000-06:00</published><updated>2006-07-08T20:29:33.716-06:00</updated><title type='text'></title><content type='html'>&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Saturday July 8, 2006&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Q:&lt;/span&gt; &lt;span style="color:#003333;"&gt;&lt;em&gt;21 year old male presented to ER with chest pain. CXR showed small spontaneous pneumothorax with less than 3 cm from apex to cupola. Saturation is 99% on room-air. Management is ?&lt;br /&gt;&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A)&lt;/span&gt; Observation&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;B)&lt;/span&gt; Observation with oxygen&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;C)&lt;/span&gt; Aspiration of the pneumothorax&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;D)&lt;/span&gt; Aspiration of the pneumothorax with application of Heimlich valve or a water seal device&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;E)&lt;/span&gt; Chest tube to suction&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;Ans. is B (or A)&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Clinically stable patient with small primary pneumothorax  with less than 3 cm from apex to cupola, should be observed. There is some evidence available that administration of oxygen may speed up resolution of the pneumothorax  (exercise caution in patients with COPD).&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Read 2 guidelines for management of spontaneous  pneumothorax:&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;br /&gt;1) &lt;/strong&gt;&lt;/span&gt;&lt;a href="http://www.chestjournal.org/cgi/content/full/119/2/590" target="_blank"&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;An American College of Chest Physicians Delphi Consensus Statement&lt;/span&gt; &lt;/strong&gt;&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Chest. 2001;119:590-602&lt;br /&gt;2) &lt;/strong&gt;&lt;/span&gt;&lt;a href="http://thorax.bmjjournals.com/cgi/content/full/58/suppl_2/ii39" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;BTS guidelines for the management of spontaneous pneumothorax&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt; Thorax 2003;58:ii39&lt;/strong&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115241217369317118?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115241217369317118'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115241217369317118'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/07/saturday-july-8-2006-q-21-year-old.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115232351345923275</id><published>2006-07-07T19:50:00.000-06:00</published><updated>2006-07-07T19:51:53.473-06:00</updated><title type='text'></title><content type='html'>&lt;span style="color:#000066;"&gt;&lt;strong&gt;Friday July 7, 2006&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Q:&lt;/span&gt; &lt;span style="color:#003333;"&gt;&lt;em&gt;Which antibiotic interferes with the measurement of serum creatinine and cause "pseudo-acute renal failure" ?&lt;br /&gt;&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Ans:&lt;/span&gt; &lt;span style="color:#990000;"&gt;Cefoxitin: &lt;/span&gt;Cefoxitin effects routine measurement of serum creatinine, resulting in falsely elevated levels of renal function. Cefoxitin is a second generation wide spectrum cephalosporin. Other medications which can interfere includes methyldopa and levodopa.&lt;/strong&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115232351345923275?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115232351345923275'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115232351345923275'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/07/friday-july-7-2006-q-which-antibiotic.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115224098351706531</id><published>2006-07-06T20:55:00.000-06:00</published><updated>2006-07-06T20:56:23.530-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Thursday, July 6, 2006&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Case:&lt;/span&gt; &lt;span style="color:#003333;"&gt;&lt;em&gt;54 year old essentially healthy female admitted to floor with abdominal pain, and found to have only constipation as all major workup reported negative. Primary care physician wrote for fleet enemas till constipation get resolved. You have been called as patient was found in bed having "seizure like symptoms"(which you later diagnosed as tetany). On arrival, you found  monitor showing arrhythmias and systolic BP in 70s. You asked for STAT labs, started IVF bolus and pressor. Lab shows phophate level of 12 mg/dl (3.87 mmol/L), magnesium of 0.8 meq/L (0.4 mmol/L) and calcium of 4.5 meq/L (2.25 mmol/L)and Cr of 2.4 mg/dl (pt. had normal kidney function on admission). Patient recovered as electrolytes were replaced and kidney function recovered with hemodynamic support.&lt;/em&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Ans:&lt;/span&gt; &lt;/span&gt;&lt;span style="color:#000000;"&gt;Enema induced hyperphosphatemia&lt;br /&gt;&lt;br /&gt;The Fleet enema contains 19 g of monobasic sodium phosphate and 7 g of dibasic sodium phosphate per 118 mL of fluid. If series of enemas given, inorganic phosphate salts can readily get absorbed from the gastrointestinal tract and can cause  hyperphosphatemia even in patients with normal kidneys. Severe hyperphosphatemia results in acute hypocalcemia and hypomagnesemia. Tetany, seizures, bradycardia prolonged QT interval, dysrhythmias, coma, and cardiac arrest are the possible consequences. Treatment is supportive and replacement of electrolytes. Dialysis may be needed if other measures fail.&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115224098351706531?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115224098351706531'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115224098351706531'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/07/thursday-july-6-2006-case-54-year-old.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115215209361072290</id><published>2006-07-05T20:11:00.001-06:00</published><updated>2006-07-05T20:14:53.613-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;Wednesday, July 5, 2006&lt;br /&gt;&lt;span style="color:#990000;"&gt;SPECT as a 'gold standard' to determine Brain Death ?&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Angiography has been considered the gold standard for diagnosis of Brain Death for decades. With arrival of new technologies, we try to move more and more towards non-invasive procedures.&lt;br /&gt;&lt;br /&gt;Dr. Munari from Italy looked into 20 clinically brain dead patients. ( 99mTc-HMPAO) SPECT and four-vessel angiography were performed in the same session, with no time delay in between. Then, the results of SPECT and angiography were interpreted separately by a specialist in nuclear medicine and a neuroradiologist, respectively; &lt;em&gt;both of them were blind to the results of the other investigation.&lt;/em&gt; Both angiography and SPECT confirmed BD in 19 of 20 patients: angiography showed the absence of filling of intracranial arteries, while SPECT showed a picture of empty skull. For one patient, angiography showed slight and late filling of vessels while SPECT showed faint traces of uptake.For this patient, the tests were repeated 48 hrs later, and both showed the arrest of intracranial circulation, thus confirming brain death.&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:85%;"&gt;SPECT = Single Photon Emission Computed Tomography&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;It was concluded by the authors that&lt;/span&gt;: SPECT is a good candidate for the gold standard of diagnosis as: &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;ul&gt;&lt;li&gt;It is noninvasive and, therefore, free from complications and can be repeated for patients who are not brain dead with no harm; &lt;/li&gt;&lt;li&gt;It shows a clear-cut picture of empty skull, an image that can be easily understood by physicians and even by patient's relatives; &lt;/li&gt;&lt;li&gt;It fully fits the definition of whole Brain death, showing the absence of whole brain perfusion, down to the foramen magnum. &lt;/li&gt;&lt;/ul&gt;&lt;p&gt;See interesting Power point presentation on &lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;a href="http://www.brown.edu/Departments/Center_for_Biomedical_Ethics/Powerpoints/Brain%20Death-Mernoff.ppt" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Brain Death: The Neurologist's Perspective&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; from Stephen T. Mernoff, MD, Clinical Assistant Professor of Neurology, Brown Medical School. Also see our neurology section for various related topics as&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;a href="http://neuro-oas.mgh.harvard.edu/stopstroke/brain_death.htm" target="tlx_new"&gt;&lt;span style="color:#660000;"&gt;&lt;strong&gt;Brain death determination (Source MGH stroke service)&lt;/strong&gt;&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#660000;"&gt;&lt;strong&gt;&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;a href="http://www.virginia.edu/uvaprint/HSC/pdf/010114.pdf" target="tlx_new"&gt;&lt;span style="color:#660000;"&gt;&lt;strong&gt;Pre-Apnea test checklist (sample from virginia.edu)&lt;/strong&gt;&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#660000;"&gt;&lt;strong&gt;&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;a href="http://www.virginia.edu/uvaprint/HSC/pdf/010115.pdf" target="tlx_new"&gt;&lt;span style="color:#660000;"&gt;&lt;strong&gt;Post-Apnea test checklist (sample from virginia.edu)&lt;/strong&gt;&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003300;"&gt;References: click to get abstract/article&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003300;"&gt;1. &lt;/span&gt;&lt;a href="http://www.ccmjournal.com/pt/re/ccm/abstract.00003246-200509000-00026.htm;jsessionid=GqTd1T1N651c2tqmmJnlTRxb51NwkLCnzbrmMCX2hlLwvlpVqqTp!-1243080020!-949856145!8091!-1" target="_blank"&gt;&lt;span style="font-size:78%;color:#003300;"&gt;Confirmatory tests in the diagnosis of brain death: Comparison between SPECT and contrast angiography&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003300;"&gt; - Critical Care Medicine. 33(9):2068-2073, September 2005&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115215209361072290?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115215209361072290'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115215209361072290'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/07/wednesday-july-5-2006-spect-as-gold_05.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115202703424266304</id><published>2006-07-04T09:28:00.000-06:00</published><updated>2006-07-04T09:30:34.280-06:00</updated><title type='text'></title><content type='html'>&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Happy Birthday America&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;How many attempts to intubate?&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;Its hard to give up procedure if you are failing it !!. For intubation, ASA (American Society of Anesthesiologists) recommends to&lt;em&gt;&lt;span style="color:#003333;"&gt; limit laryngoscopic attempts to three&lt;/span&gt;&lt;/em&gt;. Dr. Thomas C. Mort from Hartford Hospital, CT entered  2833 Critically-ill patients, suffering from cardiovascular, pulmonary, metabolic, neurologic, or trauma-related deterioration into an emergency intubation quality improvement database. Data confirmed that the number of laryngoscopic attempts were directly proportional with the incidence of airway and hemodynamic adverse events (more than 2 attempts).&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;ul&gt;&lt;li&gt;incidence of hypoxemia went from 11.8% to 70%,&lt;/li&gt;&lt;li&gt; incidence of regurgitation of gastric contents went from 1.9% to 22%, &lt;/li&gt;&lt;li&gt;incidence of aspiration of gastric contents went from 0.8% to 13%, &lt;/li&gt;&lt;li&gt;incidence of bradycardia went from 1.6% to 21%, and &lt;/li&gt;&lt;li&gt;incidence of cardiac arrest went from 0.7% to 11%&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Call for help !! and remember, to limit intubation attempts to 3, unless untill you are trained to deal with 'difficult intubations'.&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family:verdana;font-size:78%;color:#003333;"&gt;&lt;br /&gt;&lt;span style="font-family:arial;"&gt;References: click to get abstract/article&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;/span&gt;&lt;a href="http://www.anesthesia-analgesia.org/cgi/content/abstract/99/2/607" target="_blank"&gt;&lt;span style="font-family:arial;font-size:78%;color:#003333;"&gt;Emergency tracheal intubation: complications associated with repeated laryngoscopic attempts -&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:arial;font-size:78%;color:#003333;"&gt; Anesth Analg 2004;99:607-613&lt;/span&gt; &lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115202703424266304?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115202703424266304'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115202703424266304'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/07/happy-birthday-america-how-many.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115196061823602568</id><published>2006-07-03T15:00:00.000-06:00</published><updated>2006-07-03T15:03:38.266-06:00</updated><title type='text'></title><content type='html'>&lt;img style="FLOAT: right; MARGIN: 0px 0px 10px 10px; CURSOR: hand" alt="" src="http://photos1.blogger.com/blogger/6288/1666/320/ddimer.jpg" border="0" /&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Monday July 3, 2006&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;span style="color:#990000;"&gt;Simplify D-dimer&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;D&lt;/strong&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;-dimer has great negative predictive value in excluding pulmonary embolism (PE) or deep vein thrombosis (DVT). So far we had to send blood  for laboratory-based quantitative D-dimer.&lt;br /&gt;&lt;br /&gt;Simplify D-dimer is a new version of test which can be  performed at bedside quickly and can provide instant clue&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;1.&lt;/span&gt;&lt;strong&gt; Check &lt;/strong&gt;&lt;/span&gt;&lt;a href="http://www.agen.com.au/products/simplify.htm" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;here&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt; to see details on test, that can be performed &lt;span style="color:#000000;"&gt;with a drop of blood at bedside.&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;strong&gt;Recently in chest, Dr. Kline and coll. from Department of Emergency Medicine, Carolinas Medical Center, Charlotte, NC reported that the posttest prevalence of PE among low-risk patients with negative d-dimer results by simplify D-dimer Assay was only 0.7% &lt;span style="font-size:78%;"&gt;2&lt;/span&gt;, supplementing the previous famous study on d-dimer by Dr. Wells&lt;/strong&gt;&lt;span style="font-size:78%;"&gt; 3.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Related previous pearls:&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/06/wells-score-of-dvt.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Wells Score of DVT&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt; ,&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/05/massive-pe.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;What if even thrombolysis fails in massive PE ?&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;span style="font-size:78%;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References:  click to get abstract/article&lt;br /&gt;&lt;br /&gt;1. A new rapid bedside assay for D-dimer measurement (Simplify D-dimer) in the diagnostic work-up for deep vein thrombosis - J Thromb Haemost. 2003 Dec;1(12):2681-3.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://www.chestjournal.org/cgi/content/short/129/6/1417" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Prospective Study of the Diagnostic Accuracy of the Simplify D-dimer Assay for Pulmonary Embolism in Emergency Department Patients&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; Chest. 2006;129:1417-1423.)&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;br /&gt;3. &lt;/span&gt;&lt;a href="http://www.annals.org/cgi/content/abstract/135/2/98" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Excluding Pulmonary Embolism at the Bedside without Diagnostic Imaging: Management of Patients with Suspected Pulmonary Embolism Presenting to the Emergency Department by Using a Simple Clinical Model and D-dimer &lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;- 17 July 2001  Volume 135 Issue 2  Pages 98-107, Annals&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115196061823602568?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115196061823602568'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115196061823602568'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/07/monday-july-3-2006-simplify-d-dimer-d.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115188798124548268</id><published>2006-07-02T18:50:00.000-06:00</published><updated>2006-07-02T18:55:26.790-06:00</updated><title type='text'>BNP</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Sunday July 2, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;So what is the cut off of BNP ?&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/strong&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;When the landmark article on BNP published in The New England Journal of Medicine in July 2002&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;1&lt;/span&gt;&lt;strong&gt;, the cutoff point in establishing or excluding the diagnosis of congestive heart failure in patients with acute dyspnea was given at 100 pg per milliliter. But over time we learned that this level probably carries more negative predictive value and there may be a huge gray zone before a definite high BNP value, atleast in critical care setting. This month in Critical Care Medicine&lt;/strong&gt; &lt;span style="font-size:85%;"&gt;2&lt;/span&gt;&lt;strong&gt;, Dr. Rana and coll. from Mayo Clinic College of Medicine, Rochester, MN looked into this gray zone. Their conclusion:&lt;br /&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;"When measured early after the onset of acute pulmonary edema, a BNP level of less than 250 pg/mL supports the diagnosis of acute lung injury. The high rate of cardiac and renal dysfunction in critically ill patients limits the discriminative role of BNP. No level of BNP could completely exclude cardiac dysfunction".&lt;/em&gt;&lt;br /&gt;&lt;span style="font-size:85%;"&gt;&lt;br /&gt;The median time from the onset of pulmonary edema to BNP testing was 3 hrs.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;Other interesting findings in the study:&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;*&lt;/span&gt; The predictive value of BNP in the differentiation between ALI and cardiogenic pulmonary edema was comparable with PAOP (when measured) and superior to troponin and echocardiographic determination of ejection fraction. (Not supported by other studies - see related peal below).&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;*&lt;/span&gt;The accuracy of BNP improved if pts with renal failure were excluded.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;*&lt;/span&gt; BNP levels of more than 950 pg/dL suggest congestive heart failure and BNP levels of less than 250 suggest ALI, the values in between have no diagnostic value.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Related previous pearls: &lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;ul&gt;&lt;li&gt;&lt;/strong&gt;&lt;/span&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/03/bnp-and-pwp.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Can BNPs replace Pulmonary Wedge Pressure?&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;, &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2005/12/tuesday-december-20-2005-bnp-or-pro.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;BNP or Pro-BNP ?&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2005/12/wednesday-december-7-2005-re.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Re. Nesiritide (Netrecor)&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: click to get abstract/article&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://content.nejm.org/cgi/content/abstract/347/3/161" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - July 18, 2002,N Engl J Med 2002; 347:161-167, Jul 18, 2002&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://www.ccmjournal.com/pt/re/ccm/abstract.00003246-200607000-00012.htm;jsessionid=GmLXppFsQG7GKwvQRLp24WCVrvpvhyYWjVhBW29qjQSJyTrvRlqZ!-1734750035!-949856144!8091!-1" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;B-type natriuretic peptide in the assessment of acute lung injury and cardiogenic pulmonary edema&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Critical Care Medicine. 34(7):1941-1946, July 2006.&lt;/span&gt;&lt;/p&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115188798124548268?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115188798124548268'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115188798124548268'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/07/bnp.html' title='BNP'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115176518605872470</id><published>2006-07-01T08:44:00.000-06:00</published><updated>2006-07-01T08:46:26.076-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Elevation of the head of the bed- 30 or 45 degrees ?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Answer is probably 45 degrees.Elevation of the head of the bed is a must thing in ICU, unless some contra-indication. It is an essential part of VAP (ventilator associated pneumonia) bundle. But there is some debate about the extent of elevation need to be done. Accepted level is atleast 30 degrees but many guidelines wrote for 45 degrees. IHI recommends elevation anywhere from 30 to 45 degrees&lt;/strong&gt;&lt;span style="font-size:78%;"&gt; 3.&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Study from The Netherlands &lt;/strong&gt;&lt;span style="font-size:78%;"&gt;1&lt;/span&gt;&lt;strong&gt; compared 109 patients in the supine group to 112 in the semirecumbent group. Target for semirecumbent group was 45 degrees but the targeted backrest elevation of 45° for semirecumbent positioning was not reached, so supine position (10°) was compared with achieved semirecumbent positioning (28°). Elevation of head of bed to 28° did not prevent the development of VAP.&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;7 years back Drakulovic and coll. published their landmark study in lancet showing 83% decrease of bacteriologically confirmed VAP in a group of patients treated in a semirecumbent position of 45°&lt;/strong&gt; &lt;span style="font-size:85%;"&gt;2&lt;/span&gt;&lt;strong&gt;.&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;So the answer is probably 45 degrees or to be diplomatically right - atleast more than 30 degrees.&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;But is it easy to do and keep head of bed elevated to 45 degrees in practical world ?. The study group found that despite the presence of dedicated research nurses to control and maintain patient positioning, the semirecumbent treatment position with an aimed backrest elevation of 45° is not feasible for mechanically ventilated patients.&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Another interesting question raised in discussion of first study: Is semirecumbent positioning itself a risk for VAP ? !!!, as pooling of colonized oropharyngeal fluids above the inflated cuff of the endotracheal tube is common in mechanically ventilated patients and it is possible that the semirecumbent position (and all movements to keep it) stimulates leakage of oropharyngeal fluid by means of gravity. Whether ETT with continuous aspiration of subglottic secretions (CASS) will be more effective than semirecumbent positioning?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: Click to get article/abstract&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;1. &lt;/span&gt;&lt;a href="http://www.ccmjournal.com/pt/re/ccm/abstract.00003246-200602000-00017.htm;jsessionid=GlRZGdWMmyqJpR9nyymJ1KnfGjhcXq2HtJmPRlvP5TyLSpJQ09DB!-1243080020!-949856145!8091!-1" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Feasibility and effects of the semirecumbent position to prevent ventilator-associated pneumonia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;: A randomized study - Critical Care Medicine. 34(2):396-402, February 2006.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;2. &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;amp;list_uids=10584721&amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Lancet.1999 Nov 27;354(9193):1851-8.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;3. &lt;/span&gt;&lt;a href="http://www.ihi.org/IHI/Topics/CriticalCare/IntensiveCare/Changes/IndividualChanges/Elevationoftheheadofthebed.htm" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Elevation of the Head of the Bed&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Institute for Healthcare Improvement&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115176518605872470?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115176518605872470'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115176518605872470'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/07/elevation-of-head-of-bed-30-or-45.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115167595663242806</id><published>2006-06-30T07:57:00.000-06:00</published><updated>2006-06-30T08:00:42.783-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Friday June 30, 2006&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#660000;"&gt;Double the dose of mucomyst ?&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;A noteworthy study came out yesterday in The New England Journal of Medicine1 regarding protective effect of N-Acetylcysteine in Contrast-Induced Nephropathy in primary angioplasty. When the cumulative dose of N-Acetylcysteine was doubled from 3000 mg &lt;span style="font-size:85%;"&gt;(a 600mg IV bolus before angioplasty followed by 600 mg orally twice daily for the 48 hours after angioplasty)&lt;/span&gt; to 6000 mg &lt;span style="font-size:85%;"&gt;(a 1200 mg IV bolus followed by 1200 mg orally twice daily for the 48 hours after intervention), &lt;/span&gt;it showed&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;significant decrease in increase of serum creatinine concentration (15 percent vs 8 percent)&lt;br /&gt;&lt;/span&gt;&lt;/li&gt;&lt;/strong&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;overall decrease in in-hospital mortality in patients with contrast induced nephropathy (4 percent vs 3 percent).&lt;br /&gt;&lt;/span&gt;&lt;/li&gt;&lt;/strong&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;When the combined end point of death, acute renal failure requiring temporary renal replacement therapy, or the need for ventilator during the acute phase of myocardial infarction was considered, the rate was 7% in the standard dose group, and 5% in the high dose group. &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;strong&gt;&lt;span style="font-size:85%;color:#000000;"&gt;&lt;em&gt;In study there were 3 groups - placebo, standard dose and double dose.&lt;/em&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;It appears that, the benefit of high-dose N-acetylcysteine is greater in patients receiving a larger or more than regular volume of contrast.&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Conclusion:&lt;/span&gt; N-acetylcysteine reduced the severity of contrast medium induced nephropathy in patients with acute myocardial infarction treated with primary angioplasty. &lt;span style="color:#003333;"&gt;&lt;em&gt;The effect appears to be dose dependent&lt;/em&gt;&lt;/span&gt; and is accompanied by a significantly improved in-hospital outcome.&lt;br /&gt;&lt;br /&gt;Related previous pearls:&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/05/contrast-induced-nephropathy.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Contrast induced Nephropathy&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt; &lt;span style="color:#000000;"&gt;and&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2005/10/preventingcontrastinducednephropathy.html" target="_blank"&gt;&lt;span style="color:#660000;"&gt;&lt;strong&gt;Preventing contrast-Induced Nephropathy&lt;/strong&gt;&lt;br /&gt;&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference: Click to get article/abstract&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://content.nejm.org/cgi/content/short/354/26/2773" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;N-Acetylcysteine and Contrast-Induced Nephropathy in Primary Angioplasty&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Volume 354:2773-2782, Number 26, June 29 2006&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://clinicaltrials.gov/show/NCT00237614" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Contrast Nephropathy Prevention With N-Acetylcysteine in Acute Myocardial Infarction&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - clinicaltrials.gov&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115167595663242806?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115167595663242806'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115167595663242806'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/friday-june-30-2006-double-dose-of.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115162615374304785</id><published>2006-06-29T18:03:00.000-06:00</published><updated>2006-06-29T18:09:13.760-06:00</updated><title type='text'></title><content type='html'>&lt;a href="http://photos1.blogger.com/blogger/6288/1666/1600/icuindex.0.jpg"&gt;&lt;img style="DISPLAY: block; MARGIN: 0px auto 10px; CURSOR: hand; TEXT-ALIGN: center" alt="" src="http://photos1.blogger.com/blogger/6288/1666/320/icuindex.0.jpg" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Thursday June 29, 2006&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;ICU Index Spider Diagram&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;The Society of Critical Care Medicine’s (SCCM) Coalition for Critical Care Excellence (CCCE) has developed &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.sccm.org/SCCM/Publications/Critical+Connections/Archives/June+2004/ICUJune04.htm" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;The ICU Index™&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; (click to get more details) as a measurement tool that can be used at the individual ICU level to baseline a series of performance variables and then track progress. It look into 16 important measures and can either be approached in a regular bar chart form or as a spider diagram.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;Goal is to move the said measure as much as possible inside the spider to central target.&lt;/em&gt;&lt;/span&gt; Comparing spider diagrams every few months can tell improvements in ICU in just one glance. See the diagram above. You may wish to change, add, substract measures like you can track VAP rate, LOS etc as per your local ICU need.&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;If you would like more information, or would like to participate in the pilot project, please email &lt;/span&gt;&lt;/strong&gt;&lt;a href="mailto:ICUIndex@sccm.org"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;ICUIndex@sccm.org&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;.&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115162615374304785?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115162615374304785'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115162615374304785'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/thursday-june-29-2006-icu-index-spider.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115152740595027657</id><published>2006-06-28T14:40:00.000-06:00</published><updated>2006-06-28T14:44:59.443-06:00</updated><title type='text'>Diagnostic criteria of Delirium</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Wednesday June 28, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Diagnostic criteria of Delirium&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Q:&lt;/span&gt; &lt;em&gt;&lt;span style="color:#003333;"&gt;What are 4 basic criteria to label patient as having Delirium?&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;&lt;/span&gt;&lt;/em&gt;&lt;p&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A:&lt;/span&gt; &lt;span style="color:#000000;"&gt;Per American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (DSM-IV), Patient is having delirium if&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;1.&lt;/span&gt; &lt;em&gt;&lt;span style="color:#000066;"&gt;Disturbance of consciousness&lt;/span&gt;&lt;/em&gt; (eg, reduced clarity of awareness of the environment) with reduced ability to focus, sustain, or shift attention. &lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;"&gt;&lt;p&gt;&lt;span style="color:#660000;"&gt;2.&lt;/span&gt;&lt;em&gt; &lt;span style="color:#000066;"&gt;A change in cognition&lt;/span&gt;&lt;/em&gt; such as memory deficit, disorientation, language disturbance (or the development of a perceptual disturbance that is not better accounted for by a preexisting, established, or evolving dementia). &lt;/p&gt;&lt;p&gt;&lt;span style="color:#660000;"&gt;3.&lt;/span&gt; The disturbance develops over a &lt;span style="color:#000066;"&gt;&lt;em&gt;short period of time&lt;/em&gt;&lt;/span&gt; (usually hours) and tends to &lt;em&gt;&lt;span style="color:#000066;"&gt;fluctuate&lt;/span&gt;&lt;/em&gt; during the course of the day. &lt;/p&gt;&lt;p&gt;&lt;span style="color:#660000;"&gt;4.&lt;/span&gt; Disturbance &lt;em&gt;&lt;span style="color:#000066;"&gt;caused by&lt;/span&gt;&lt;/em&gt; a general medical condition or substance intoxication or medication use.&lt;br /&gt;&lt;br /&gt;Related website: &lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;a href="http://www.icudelirium.org/" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;www.icudelirium.org&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; (must see for intensivists)&lt;br /&gt;&lt;br /&gt;Related previous pearls:&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/04/ambien.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Zolpidem-Induced Delirium&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; ,&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2005/12/ss.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;SEROTONIN SYNDROME&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; ,&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/01/friday-january-27-2006-amiodarone.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Amiodarone Neurotoxicity&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;p&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: click to get abstract/article&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://neuro.psychiatryonline.org/cgi/content/full/15/2/200" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;An Empirical Study of Different Diagnostic Criteria for Delirium Among Elderly Medical Inpatients&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - J Neuropsychiatry Clin Neurosci 15:200-207, May 2003&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://focus.psychiatryonline.org/cgi/content/abstract/3/2/320" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Delirium in Elderly Patients &lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;- Focus 3:320-332 (2005)&lt;br /&gt;3. Delirium in Older Persons - N. Engl. J. Med., March 16, 2006; 354(11): 1157 - 1165&lt;br /&gt;4. &lt;/span&gt;&lt;a href="http://www.emedicine.com/med/topic3006.htm" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Delirium&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - emedicine.com&lt;br /&gt;5. &lt;/span&gt;&lt;a href="http://www.aafp.org/afp/20030301/1027.html" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Delirium&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - American Family Physician® Vol. 67/No. 5 (March 1, 2003)&lt;/span&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115152740595027657?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115152740595027657'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115152740595027657'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/diagnostic-criteria-of-delirium.html' title='Diagnostic criteria of Delirium'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115144349066733827</id><published>2006-06-27T15:22:00.000-06:00</published><updated>2006-06-27T15:24:50.683-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Tuesday June 27, 2006&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;We will need more intensivists !!&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Currently in USA, only 37% of critically ill patients are cared for by intensivists and an estimated 360,000 deaths occur each year in ICUs not managed by intensivists. In 2003, the US Senate asked Health Resources and Services Administration (HRSA) to work with the American College of Chest Physicians (ACCP) to update critical care workforce models in order to more accurately assess the adequacy of supply for critical care physicians. In the newly released US Department of Health and Human Services Report to Congress: The Critical Care Workforce: A Study of the Supply and Demand for Critical Care Physicians, it has been predicted that the demand for critical care services will increase rapidly, while the intensivist supply would not be able to care for a greater proportion of critically ill patients. The shortage is will be exacerbated by the year 2020 due to the aging population and the increased utilization of intensivists.&lt;em&gt; &lt;/em&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;/span&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;em&gt;&lt;/em&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;em&gt;By 2020,  the demand for intensivists would likely increase by 129 percent above the current supply.&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#660000;"&gt;Some Suggestions include:&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;ul&gt;&lt;li&gt;Increase role of eICU&lt;/li&gt;&lt;li&gt;Possible rationing of critical care services or regionalization of ICU services like trauma system&lt;/li&gt;&lt;li&gt;Restructuring current Medicare reimbursement system&lt;/li&gt;&lt;li&gt;Expanding National Health Services Corps and J-1 waiver program&lt;/li&gt;&lt;li&gt;Only deserving patients getting admission to ICU&lt;/li&gt;&lt;li&gt;Decreasing care for know futile outcomes by more public/physician education&lt;br /&gt; &lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Read full report: &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.chestnet.org/downloads/practice/gr/HRSAReportMay06.pdf" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;HRSA Report to Congress. The Critical Care Workforce: A Study of the Supply and Demand for Critical Care Physicians&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt; &lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115144349066733827?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115144349066733827'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115144349066733827'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/tuesday-june-27-2006-we-will-need-more.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115137547457651387</id><published>2006-06-26T20:29:00.000-06:00</published><updated>2006-06-26T20:31:14.593-06:00</updated><title type='text'></title><content type='html'>&lt;a href="http://photos1.blogger.com/blogger/6288/1666/1600/teg1.gif"&gt;&lt;img style="FLOAT: right; MARGIN: 0px 0px 10px 10px; CURSOR: hand" alt="" src="http://photos1.blogger.com/blogger/6288/1666/320/teg1.gif" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Monday June 26, 2006&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Thrombelastography - TEG&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;TEG was first introduced about 60 years ago by Hartert . TEG monitors hemostasis as a whole dynamic process and measures the viscoelastic properties of blood. The strength of a clot is graphically represented over time in a cigar shape figure. With little practice, just a glance at shape and size of cigar, it provides clue to underlying disease process. It is an underutilized tool in ICU. See picture for self explanation:&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Read review on Thromboelastography/thromboelastometry &lt;/span&gt;&lt;/strong&gt;&lt;a href="https://www.bloodmed.com/home/clharchivepdf/clh_681.pdf" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;here&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; &lt;span style="font-size:85%;"&gt;(pdf file)&lt;/span&gt; &lt;span style="font-size:85%;"&gt;(ref: Clin. Lab. Haem. 2005, 27, 81–90)&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115137547457651387?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115137547457651387'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115137547457651387'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/monday-june-26-2006-thrombelastography.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115126287154148713</id><published>2006-06-25T13:12:00.000-06:00</published><updated>2006-06-25T13:14:31.566-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Sunday June 25, 2006&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Introducing iCritical Care Podcasts&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/strong&gt;&lt;a href="http://www.sccm.org/podcast" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#cc0000;"&gt;www.sccm.org/podcast&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;iCritical Care Podcasts from Society of Critical Care Medicine is a kind of radio which you can listen on your home computer, or your portable media player (iPod and others). The iCritical Care Podcast is a novel way for you to keep up-to-date with the latest in Critical Care. Site get frequently updated with talks on recent breakthrough articles carrying interviews with authors of these articles as well as talks on non-academic but critical care related issues. So far upto 34 talks have been added including but not limited to:&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;br /&gt;&lt;/strong&gt;&lt;strong&gt;&lt;ul&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Lorazepam vs. Propofol&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Catheter-Related Bloodstream Infections&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Prophylactic Antimicrobial Use in the ICU&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Hospital Mortality Assessment&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Rationing in the ICU&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Morbid Obesity and the Surgical Critical Patient  &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Dopamine's Influence on the Outcome of Shock&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Defining and Treating Abdominal Compartment  Syndrome&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Early Indicators of Sepsis Survival&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Getting Our ICU Language Straight&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Critical Care Pharmacists&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Implementing the Surviving Sepsis Campaign&lt;/span&gt;&lt;br /&gt; &lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span style="color:#000000;"&gt;Host is &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.maimonidesmed.org/staff/rsavel.htm" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#003333;"&gt;Richard H. Savel, MD&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;, Associate Director, Surgical Intensive Care Unit at Maimonides Medical Center, Brooklyn, NY, and Assistant Professor of Medicine at Mt. Sinai School of Medicine, NY.&lt;/span&gt; &lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Again site is &lt;/strong&gt;&lt;a href="http://www.sccm.org/podcast"&gt;&lt;strong&gt;&lt;span style="color:#cc0000;"&gt;www.sccm.org/podcast&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;Related previous themes:&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/03/monday-march-13-2006-introducing.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Introducing Resident ICU Course&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt; &lt;span style="color:#000000;"&gt;and&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/05/pact.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;PACT - Critical Care distant learning course&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt; &lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115126287154148713?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115126287154148713'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115126287154148713'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/sunday-june-25-2006-introducing.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115115753008699397</id><published>2006-06-24T07:56:00.000-06:00</published><updated>2006-06-24T07:58:50.110-06:00</updated><title type='text'>fenoldopam</title><content type='html'>&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Saturday June 24, 2006&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Case:&lt;/span&gt; &lt;em&gt;&lt;span style="color:#003333;"&gt;39 year old male admitted with hypertensive emergency after he ran out of his prescriptions. "ED Doc" started patient on IV cardene (nicardipine) drip and resumed patient's home med for BP which consist of Toprol (metoprolol) XL - first dose given in ER. On review of CXR you noticed some pulmonary edema and decide to switch to Fenoldopam to get dual effect of lowering BP as well as dopaminergic effect to resolve pulmonary edema. Patient dropped his BP precipitously and coded.&lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;Probable cause:&lt;/span&gt; It is not advisable to start fenoldopam on patients with B-blocker or atleast close caution should be maintained. Concomitant use of beta-blockers in conjunction with fenoldopam  may cause life threatening hypotension from beta-blocker's inhibition of the sympathetic reflex response to fenoldopam&lt;/span&gt;&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;1&lt;/span&gt;.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#003333;"&gt;Related previous pearl:&lt;/span&gt; &lt;/strong&gt;&lt;/span&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/02/rdf.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Renal dose Fenoldopam ?&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: click to get abstract/article1. &lt;/span&gt;&lt;a href="http://www.fda.gov/medwatch/SAFETY/2004/apr_PI/Corlopam_PI.pdf" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Corlopam &lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;- fda.gov&lt;br /&gt;&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://content.nejm.org/cgi/content/short/345/21/1548" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Fenoldopam — A Selective Peripheral Dopamine-Receptor Agonist for the Treatment of Severe Hypertension&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Volume 345:1548-1557, Number 21, Nov. 22,2001&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115115753008699397?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115115753008699397'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115115753008699397'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/fenoldopam.html' title='fenoldopam'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115109863862472696</id><published>2006-06-23T15:30:00.000-06:00</published><updated>2006-06-23T15:37:18.643-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Friday June 23, 2006&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Case:&lt;/span&gt; &lt;span style="color:#003333;"&gt;&lt;em&gt;24 year old male admitted with left thigh cellulitis and abcess. I and D was performed and cefazolin (ancef) was initiated. Patient did not respond to cefazolin and antibiotic was changed to vancomycin after availability of sensitivity from micro lab. Patient showed marked improvement over next 3 days except patient complaint of new rash on his body which you attributed to "Red man syndrome" and wrote an order to infuse vancomycin slowly and with increase dilution. Next day, as you reached hospital, you were informed by outgoing intensivist that patient deteriorated overnight and required intubation. You were baffled and as you examine the patient, you find extensive dermal exfoliation along with axillary and inguinal lymphadenopathy. On lab, LDH and liver enzymes were markedly elevated and kidney funtion deteriorated from normal to anuria. CBC showed eosinophilia.&lt;/em&gt;&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Vancomycin-induced Stevens-Johnson syndrome&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Stevens-Johnson syndrome is an acute mucocutaneous process characterized by severe exfoliative dermatitis and mucosal involvement of the gastrointestinal tract and conjunctiva. Pathogenesis is unclear, but an immunological mechanism, probably cell-mediated, has been suggested. Clinical diagnosis of Stevens-Johnson syndrome is based on the presence of "target" or "iris" lesions involving the skin and erosive lesions of two or more mucosal surfaces. Associated findings include extensive dermal exfoliation, nephritis, lymphadenopathy, hepatitis, and multiple serologic abnormalities. Vancomycin, a glycopeptide antibiotic, has case reports in literature produceing immunologically mediated adverse reactions such as interstitial nephritis, linear IgA bullous dermatosis, exfoliative erythroderma, necrotizing cutaneous vasculitis and toxic epidermal necrolysis. The treatment consists of cessation of vancomycin and administration of antihistamine and/or steroid.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;See pic&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.siamhealth.net/Health/picture/sjs.jpg" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; &lt;/span&gt;&lt;span style="color:#660000;"&gt;here&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: click to get abstract/article&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;1.&lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=8934797&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Vancomycin-induced Stevens-Johnson syndrome&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; Allergy Asthma Proc. 1996 Mar-Apr;17(2):75-8.&lt;br /&gt;&lt;br /&gt;2.&lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=1482807&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Stevens-Johnson-type reaction with vancomycin treatment. &lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;- Ann Pharmacother. 1992 Dec;26(12):1520-1&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;3 &lt;/span&gt;&lt;a href="http://www.scielo.br/pdf/bjid/v6n4/v6n4a07.pdf" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Uncommon Vancomycin-Induced Side Effects - Brazilian Journal of Infectious Diseases&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - 2002;6(4):196-200&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115109863862472696?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115109863862472696'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115109863862472696'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/friday-june-23-2006-case-24-year-old.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115101550913072042</id><published>2006-06-22T16:29:00.000-06:00</published><updated>2006-06-22T16:36:19.623-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Thursday June 22, 2006 &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Imipenem and Primaxin&lt;/span&gt;&lt;/strong&gt; &lt;strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Q:&lt;/span&gt; &lt;em&gt;&lt;span style="color:#003333;"&gt;What advantage we have when we add cilastatin with Impenem ?&lt;br /&gt;&lt;br /&gt;OR in other words, What is the difference between Imipenem and Primaxin (Imipenem plus Cilastatin) ?&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A:&lt;/span&gt; &lt;span style="color:#000000;"&gt;Imipenem get metabolized in the kidneys by enzyme called dehydropeptidase I and cannot achive therapeutic level in urine. Addition of Cilastatin inhibit the enzyme in kidney's renal tubules so that when imipenem and cilastatin are given concomitantly, increased imipenem levels are achieved in the urine.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Bonus Pearl:&lt;/span&gt;&lt;span style="color:#000000;"&gt; Primaxin is hemodialyzable so dose may be unreliable in such patients or preferably should be given after hemodialysis session. Dose in dialysis dependent patient is either 250 mg q 12 hrs or 500 mg after each dialysis.&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;em&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;When Imipenem was introduced, it get reputed with nick name of "Jesus water" due to its broad coverage and to kill most bugs&lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;em&gt;&lt;span style="color:#000000;"&gt;.&lt;/span&gt;&lt;/em&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115101550913072042?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115101550913072042'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115101550913072042'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/thursday-june-22-2006-imipenem-and.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115086297484339802</id><published>2006-06-20T22:06:00.000-06:00</published><updated>2006-06-21T18:03:07.813-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Wednesday June 21, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Normosol is NOT just Normal Saline&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Being an intensivist, the most important thing to know - what is infusing in patient. There is some misconception that Normosol is just another name of Normal Saline, which is not true.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Contents of Normal Saline:&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;Na = 154 mEq/L&lt;br /&gt;Cl = 154 mEq/L&lt;br /&gt;PH = 5.4&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;Contents of Normosol:&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Na = 140 mEq/L&lt;br /&gt;Cl = 98 mEq/L&lt;br /&gt;K = 4 mEq/L&lt;br /&gt;Mg = 3 mEq/L&lt;br /&gt;Acetate = 27 mEq/LGluconate = 23 mEq/L&lt;br /&gt;PH =6.6&lt;br /&gt;&lt;br /&gt;Normosol contains added K and Mg which may be unsuitable for some patients like patients with renal failure.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Bonus Pearl:&lt;/span&gt; If it says &lt;span style="color:#660000;"&gt;R&lt;/span&gt; on IVF bag, it means manufacturer recommends bag for replacement therapy and if it says &lt;span style="color:#660000;"&gt;M&lt;/span&gt; on IVF bag , it is meant for maintenance IV. Contents may be little different. Most "M" bags contain extra dextrose.&lt;br /&gt;&lt;br /&gt;Related Previous Pearl: &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/02/dblranss.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Difference between LR and Normal Saline&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115086297484339802?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115086297484339802'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115086297484339802'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/wednesday-june-21-2006-normosol-is-not.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115084544276758841</id><published>2006-06-20T17:14:00.000-06:00</published><updated>2006-06-20T17:21:47.026-06:00</updated><title type='text'>Labetolol dose</title><content type='html'>&lt;p&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Tuesday June 20, 2006&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Labetolol dose&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;&lt;em&gt;Q:&lt;/em&gt;&lt;/span&gt; &lt;em&gt;&lt;span style="color:#003333;"&gt;What is the usual guided dose of labetalol in hypertensive emergency ?&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A;&lt;/span&gt; Loading dose of 0.25 mg/kg followed by 0.5 mg/kg every 15 minutes but total dose should remain less than 3.25 mg/kg.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;Advantage of Labetalol:&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;ul&gt;&lt;li&gt;Action within 5 minutes and &lt;/li&gt;&lt;li&gt;combined alpha and beta blocker effect&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span style="color:#003333;"&gt;Disadvantage of Labetalol:&lt;/span&gt; &lt;/p&gt;&lt;ul&gt;&lt;li&gt;It decreases both SVR (Systemic Vascular Resistance) and CO (Cardiac Output).&lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;span style="font-size:85%;"&gt;&lt;strong&gt;(From &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;a href="http://www.drvaron.yourmd.com/" target="_blank"&gt;&lt;span style="font-size:85%;color:#003333;"&gt;&lt;strong&gt;Dr. Joseph Varon's&lt;/strong&gt;&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:85%;color:#000000;"&gt;&lt;strong&gt; lecture "Hypertensive Emergencies in the Perioperative Cardiovascular Setting" at Hypertensive Crisis: Strategies To minimize End-Organ Damage With Focus On The Heart and Brain - symposium during Chest 2005)&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115084544276758841?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115084544276758841'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115084544276758841'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/labetolol-dose.html' title='Labetolol dose'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115077003797160359</id><published>2006-06-19T20:19:00.000-06:00</published><updated>2006-06-19T20:20:37.986-06:00</updated><title type='text'>Anemia in ICU</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Monday June 19, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Anemia in ICU&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Q:&lt;/span&gt; &lt;span style="color:#003333;"&gt;&lt;em&gt;If you admit a patient with Hb of 10 g/dL and draw 100 ml of blood for various lab works. How much will be the drop in Hb ?&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A;&lt;/span&gt; &lt;span style="color:#000000;"&gt;Hb will drop from 10 to 9.3 g/dL. With each 100 ml of blood draws, Hb drop by 0.7 g/dL 1. Remember ! phlebotomy (blood draws) is the major of cause anemia in ICUs.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Bonus pearl:&lt;/span&gt; In anemic patients, if blood workup is necessary, use pediatric tubes.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Related previous pearl: &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/03/anemia-score.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;ICU anemia score&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference: click to get abstract&lt;br /&gt;&lt;/span&gt;&lt;a href="http://www.ccjm.org/PDFFILES/Dec_05poem2.pdf" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Blood testing causes anemia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - J Gen Intern Med 2005; 20:520–524&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115077003797160359?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115077003797160359'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115077003797160359'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/anemia-in-icu.html' title='Anemia in ICU'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115066413970528247</id><published>2006-06-19T14:48:00.000-06:00</published><updated>2006-06-20T22:50:08.626-06:00</updated><title type='text'>pre-ICU care</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Sunday June 18, 2006&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;To decrease ICU mortality - fix pre-ICU care !!&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Team from Cooper University Hospital, Camden, NJ (Raquel Nahra, MD, Christa Schorr, RN and David R. Gerber, DO) - addressed a very important and often ignored issue at ACCP meeting of november 2005 : PRE–INTENSIVE CARE UNIT LENGTH OF STAY AND OUTCOME IN CRITICALLY ILL PATIENTS&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;1&lt;/span&gt;.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Patients were divided into 4 groups:&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;ol&gt;&lt;li&gt;Group M1 - medical patients HLOS less than / = 5 days &lt;/li&gt;&lt;li&gt;Group M2 - medical patients HLOS more than / = 6 days &lt;/li&gt;&lt;li&gt;Group S1 - surgical patients HLOS less than / =5 but more than 1 day &lt;/li&gt;&lt;li&gt;Group S2 - surgical patients HLOS more than / = 6 days &lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ol&gt;&lt;br /&gt;&lt;span style="font-size:85%;color:#000000;"&gt;&lt;strong&gt;*HLOS = hospital length of stay and data was obtained from the Project Impact database.&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Study found that: ICU admission from a general care floor after more than / = 6 days is associated with poor outcome(Group M2). Suboptimal care prior to ICU admission is the reason for poorer outcomes. Probable reasons:&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;ul&gt;&lt;li&gt;Poor organization, &lt;/li&gt;&lt;li&gt;Insufficient knowledge, &lt;/li&gt;&lt;li&gt;Failure to appreciate clinical urgency, &lt;/li&gt;&lt;li&gt;Inadequate supervision and &lt;/li&gt;&lt;li&gt;Failure to seek advice &lt;/li&gt;&lt;/ul&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Editors note:&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt; Lessons to be learned include intensivists' early involvement in care outside ICU, formation of rapid response team, close working of floor team (hospitalist) and intensivist and more inservices/training for floor staff.&lt;/span&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;br /&gt;Related previous pearl: &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/03/rapid-response-team.html" target="_blank"&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Rapid Response Team&lt;/span&gt;&lt;/strong&gt; &lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Related Sites: IHI's &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.ihi.org/NR/rdonlyres/9134B60C-BB05-4735-8DF4-D96D09CC9EAB/0/RRTHowtoGuideFINAL71505.pdf" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;RRT - getting started kit&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; and SCCM's &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://forums.sccm.org/messages.aspx?ForumID=22" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;RRT/ MET forum&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference: click to get abstract&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;a href="http://meeting.chestjournal.org/cgi/content/abstract/128/4/298S" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;PRE–INTENSIVE CARE UNIT LENGTH OF STAY AND OUTCOME IN CRITICALLY ILL PATIENTS&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Critical Care Outcomes, ACCP meeting November 2, 2005&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115066413970528247?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115066413970528247'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115066413970528247'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/pre-icu-care.html' title='pre-ICU care'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115058121750979976</id><published>2006-06-17T15:51:00.000-06:00</published><updated>2006-08-14T19:44:57.310-06:00</updated><title type='text'>EKG changes in Hyperkalemia</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Saturday June 17, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;4 EKG changes in Hyperkalemia&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;The first EKG sign of hyperkalemia is &lt;em&gt;peaked T waves &lt;/em&gt;and usually appears once K level go around 6 meq/L.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;Second sign is &lt;em&gt;prolongation of PR interval&lt;/em&gt; which can be seen with K level going around or above 7 meq/L.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;em&gt;Absent P wave with widen QRS complex&lt;/em&gt; is the third manifestation and is a very dangerous sign. It means that atrial activity is lost and stage is set for ventricular tachycardia/fibrillation. It is usually seen at level around 8-9 meq/L.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;em&gt;Ventricular tachycardia/fibrillation&lt;/em&gt; is the price you pay of ignoring above changes on monitor.&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;Above are just rough rules of thumb. Read a good review&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;a href="http://emj.bmjjournals.com/cgi/content/full/19/1/74"&gt;&lt;span style="color:#660000;"&gt;Recognising signs of danger: ECG changes resulting from an abnormal serum potassium concentration&lt;/span&gt;&lt;/a&gt; &lt;/a&gt;&lt;span style="font-size:85%;color:#000000;"&gt;(&lt;span style="color:#000000;"&gt;source: Emerg Med J 2002; 19:74-77)&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000000;"&gt; &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115058121750979976?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115058121750979976'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115058121750979976'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/ekg-changes-in-hyperkalemia.html' title='EKG changes in Hyperkalemia'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115049203256668901</id><published>2006-06-16T15:05:00.000-06:00</published><updated>2006-06-16T15:07:12.583-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Friday June 16, 2006&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Carvediol (Coreg)&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;&lt;strong&gt;Q:&lt;/strong&gt;&lt;/span&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;&lt;strong&gt; How Carvediol (Coreg) is different from other B-blockers?&lt;br /&gt;&lt;/strong&gt;&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;&lt;strong&gt;A;&lt;/strong&gt;&lt;/span&gt; &lt;strong&gt;&lt;span style="color:#000000;"&gt;Coreg is a triple blocker. It blocks beta-1, beta-2 and alpha-1 receptors. Alpha-1 blockade provides vasodilation and so protection in congestive heart failure (CHF).  U.S. Carvedilol Heart Failure Study&lt;/span&gt;&lt;/strong&gt;&lt;a name="uscarvedilol"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; &lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;with 1094 patients showed 65% lower risk of death than placebo patients 1. Dose should be started at 3.125 mg BID and titrated (as tolerated) upto 25 mg BID. Obese patients may require higher dose.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="font-size:85%;"&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Extended release Metoprolol (Toprol XL) is another B-blocker approved from FDA for use in CHF. MERIT-HF study showed 34% reduction in mortality than placebo in patients taking Toprol XL&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;2&lt;/span&gt;&lt;/span&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;.&lt;br /&gt;&lt;br /&gt;FDA approves only Toprol-XL and Coreg for CHF.&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: Click to get article/abstract&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://content.nejm.org/cgi/content/abstract/334/21/1349" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - N Engl J Med. 1996;334:1349-1355.&lt;br /&gt;&lt;br /&gt;2. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure. Lancet. 1999;353:2001-2007&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115049203256668901?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115049203256668901'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115049203256668901'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/friday-june-16-2006-carvediol-coreg-q.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115038124316454589</id><published>2006-06-15T08:19:00.000-06:00</published><updated>2006-06-15T08:20:43.183-06:00</updated><title type='text'>IV Dig</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Thursday June 15, 2006&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;IV Digoxin&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Q: &lt;em&gt;&lt;span style="color:#003333;"&gt;You wrote an order: Digoxin 0.25 mg IV x 1.  &lt;/span&gt;&lt;/em&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;      What is missing in this order?&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;A; &lt;span style="color:#660000;"&gt;Rate:&lt;/span&gt; Digoxin IV should be given over at least &lt;em&gt;5 minutes&lt;/em&gt;. Rapid infusion of Digoxin (digitalis) may cause coronary arteriolar constriction, which may induce cardiac ischemia or make it worse. Also, it is not advisable to administer digoxin simultaneously in the same intravenous line as with other drip/drug, if possible. Another important reminder - Digoxin level should be measured just before the next scheduled dose (trough) or at least 6 to 8 hours after the last dose, to allow adequate time for equilibration of digoxin between serum and tissue.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Related previous pearl: &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/04/iv-vasotec.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Why sometime IV vasotec (enalapril) does not work?&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115038124316454589?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115038124316454589'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115038124316454589'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/iv-dig.html' title='IV Dig'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115029730703316944</id><published>2006-06-14T08:58:00.000-06:00</published><updated>2006-06-14T09:01:47.363-06:00</updated><title type='text'></title><content type='html'>&lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;&lt;strong&gt;Wednesday June 14, 2006&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Swan is still very in !!&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Lately we had some constant negative studies for pulmonary artery catheter like ESCAPE trial, PAC-MAN study and recently published ARDSnet's FACTT trial&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;2&lt;/span&gt;&lt;strong&gt;.&lt;br /&gt;&lt;br /&gt;This month Critical Care Medicine published retrospective database analysis of 53,312 trauma patients&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;1&lt;/span&gt;&lt;strong&gt;. After all adjustments following groups showed benefit:&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Patients aged 61-90 yrs,&lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt; with arrival base deficit worse than -11 and &lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Injury Severity Score of 25-75.&lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;It was found that it was associated with a protective effect in patients with severe shock, regardless of age, and in older patients with moderate shock.&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;br /&gt;Also note &lt;span style="color:#003333;"&gt;negative outcome&lt;/span&gt;: Highest risk of death associated with PAC use was in younger patients who arrived at the ED without a significant base deficit. Moreover, no survival benefit was detected with PAC use in patients arriving at the ED without evidence of shock.&lt;br /&gt;&lt;/p&gt;&lt;p&gt;&lt;span style="color:#660000;"&gt;Conclusion:&lt;/span&gt; PAC insertion is associated with&lt;/p&gt;&lt;ol&gt;&lt;li&gt; improved outcome in critically injured patients with severe shock at admission, regardless of age, and &lt;/li&gt;&lt;li&gt;in elderly patients with moderate shock. &lt;/li&gt;&lt;/ol&gt;&lt;p&gt;Related previous pearls: &lt;/strong&gt;&lt;/span&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/02/pms.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;PAC-MAN study !&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt; and &lt;/strong&gt;&lt;/span&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2005/11/etstsl.html" target="_blank"&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;ESCAPE Trial&lt;/span&gt;&lt;/strong&gt; &lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference: Click to get article&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://www.ccmjournal.com/pt/re/ccm/abstract.00003246-200606000-00002.htm;jsessionid=GPvTFTh6y1Bn1c5pp1LZfVsJwTLwZbfZ9zGcq1mbWpzvNJzVyDyh!-1110070904!-949856144!8091!-1" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Pulmonary artery catheter use is associated with reduced mortality in severely injured patients: A National Trauma Data Bank analysis of 53,312 patients&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Critical Care Medicine. 34(6):1597-1601, June 2006.&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://content.nejm.org/cgi/content/abstract/354/21/2213" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Pulmonary-Artery versus Central Venous Catheter to Guide Treatment of Acute Lung Injury&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Volume 354:2213-2224, NEJM, May 25, 2006&lt;/span&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115029730703316944?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115029730703316944'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115029730703316944'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/wednesday-june-14-2006-swan-is-still.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115025104029416533</id><published>2006-06-13T20:08:00.000-06:00</published><updated>2006-06-13T20:11:32.173-06:00</updated><title type='text'>CVP via PICC</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Tuesday June 13, 2006&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;strong&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Can we measure CVP (central venous pressure) with PICCs (peripherally inserted central catheters) ?&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;YES: &lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;PICC lines can be used to measure CVP, if situation arise. CVP recorded via PICC lines are about 1 mm Hg higher than CVP from centrally inserted venous catheters. PICC lines need to be hooked to continuous infusion with heparinized saline at 3 mL/hr to overcome the resistance of longer length and narrower lumen of PICC line. Trend should be followed for better perception as first PICC measured CVP is reported higher, probably due to microthrombi which get flushed later on.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:85%;color:#000000;"&gt;Dr. Black and coll. from Pennsylvania State University College of Medicine, Hershey, PA studied 77 data pairs from 12 patients with measurements recorded at end-expiration. 19-gauge dual-lumen PICCs were used and were zeroed/levelled at right atrium. To overcome the longer length, narrower lumen an so higher inherent resistance, continuous infusion device is used with heparinized saline at 3 mL/hr (like in arterial lines)&lt;/span&gt;&lt;/strong&gt;&lt;span style="font-size:78%;"&gt; 1.&lt;/span&gt;&lt;strong&gt;&lt;br /&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference: Click to get article&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://www.ccmjournal.com/pt/re/ccm/abstract.00003246-200012000-00014.htm;jsessionid=GNtL5KvJyyDNy27X2w2Sy1fvL10nyGQLGS0JFkGR35JHK3SZHVpr!-1110070904!-949856144!8091!-1" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Central venous pressure measurements: Peripherally inserted catheters versus centrally inserted catheters&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Critical Care Medicine. 28(12):3833-3836, December 2000.&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115025104029416533?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115025104029416533'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115025104029416533'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/cvp-via-picc.html' title='CVP via PICC'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115015051781569529</id><published>2006-06-12T16:13:00.000-06:00</published><updated>2006-06-12T16:47:39.843-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Monday June 12, 2006&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;While you are carrying 'code beeper' as an intensivist, you heard 'code blue in cafeteria'. On arrival you found 36 year old female who was in cafeteria after visiting allergy clinic, where according to daughter she received her 'expensive asthma shot'. While you were resuscitating patient from what appears to be anaphylactic shock, you keep wandering about that 'expensive asthma shot'.&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;Xolair:&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.xolair.com/" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#003333;"&gt;Omalizumab (xolair)&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; is the subcutaneous injection treatment for allergic asthma that works by blocking immunoglobulin E (IgE). Anaphylaxis is rare but the tricky part is it may cause anaphylaxis even after months of successful and uneventful treatment. There is an indication in atleast one case report that polysorbate present in omalizumab may be responsible for it&lt;/span&gt;&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;1&lt;/span&gt;&lt;strong&gt;.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;Per month cost of treatment is about 500 - 2000 US $.&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference: Click to get article&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://www.acep.org/webportal/MemberCenter/Periodicals/Medical+News/emergencytrauma/default.htm?newsid=0c023092" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Late-Onset Anaphylaxis to Omalizumab Reported&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;"&gt;&lt;span style="color:#003333;"&gt; - from acep.org site&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115015051781569529?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115015051781569529'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115015051781569529'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/monday-june-12-2006-while-you-are.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-115005671515513671</id><published>2006-06-11T14:10:00.000-06:00</published><updated>2006-06-11T19:46:48.206-06:00</updated><title type='text'>IV to PO conversion</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Sunday June 11, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;IV to PO conversion - check med list everyday !!&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;58 year old male admitted with atrial fibrillation with RVR (rapid ventricular rate) and required intravenous (IV) Diltiazem (cardizem). Now patient is stable at 7 mg/hr dose. What would be the equivalent PO dose?&lt;br /&gt;&lt;/em&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2005/11/saturday-november-26-2005-is-post.html" target="_blank"&gt;&lt;/a&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Diltiazem CD 240 mg po qd&lt;/span&gt; &lt;/strong&gt;&lt;span style="font-size:78%;"&gt;1. &lt;/span&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;Usual IV to PO Cardizem is as follows:&lt;br /&gt;&lt;br /&gt;3 mg/h = Diltiazem CD 120 mg po qd&lt;br /&gt;5 mg/h = Diltiazem CD 180 mg po qd&lt;br /&gt;7 mg/h = Diltiazem CD 240 mg po qd&lt;br /&gt;11 mg/h = Diltiazem CD 300 mg po qd&lt;br /&gt;15 mg/h = Diltiazem CD 360 mg po qd&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Using this question as an excuse, the objective is to highlight the point that many times PO medications are as effective as IV &lt;span style="font-size:85%;"&gt;(See reference # 1).&lt;/span&gt; Good intensivist always remain in the quest to simplify the medication list. It always help to have a savy critical care pharmacist in the team !.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Related: Sample &lt;/strong&gt;&lt;/span&gt;&lt;a href="http://www.ashp.org/emplibrary/R-IVtoPOConvPol-4.pdf" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;INTRAVENOUS TO ORAL/ENTERAL (IV TO PO) MEDICATION SWITCH PROGRAM&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt; from &lt;/strong&gt;&lt;/span&gt;&lt;a href="http://www.ashp.org/" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#003333;"&gt;American Society of Health-System Pharmacists' site&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003300;"&gt;Reference: click to get abstract/article&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://www2.cc.nih.gov/formulary/ccfs/ivpoinfo.htm" target="_blank"&gt;&lt;span style="font-size:78%;color:#003300;"&gt;Intravenous to Oral Conversion Table&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003300;"&gt;: source nih.gov&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-115005671515513671?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115005671515513671'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/115005671515513671'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/iv-to-po-conversion.html' title='IV to PO conversion'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114993770989762300</id><published>2006-06-10T04:58:00.000-06:00</published><updated>2006-06-10T05:08:30.120-06:00</updated><title type='text'>Feeding in ventilated patients</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Saturday June 10, 2006&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Yes ! Feed Critically Ill Mechanically Ventilated Medical Patients early despite risk of VAP&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;There is some hesitancy in literature about early feeding for critically ill mechanically ventilated medical patients due to increase risk of ventilator-associated pneumonia (VAP)&lt;/span&gt;&lt;/strong&gt;&lt;span style="color:#000000;"&gt; &lt;span style="font-size:78%;"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;.&lt;br /&gt;&lt;br /&gt;Dr.  Artinian  and coll. from Division of Pulmonary and Critical Care Medicine, Henry Ford Health System, Detroit, MI recently looked into about 4000 patients requiring mechanical ventilation for more than 2 days&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;2&lt;/span&gt;&lt;strong&gt;. Those patients who received enteral feeding within 48 hours of mechanical ventilation were labeled as  the "early feeding group" otherwise as "late feeding group." Results showed that &lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;strong&gt;&lt;ul&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;The overall ICU mortality was 18.1% vs 21.4% &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;The overall hospital mortality was 28.7% vs 33.5% &lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span style="color:#000000;"&gt;In substudy, three separate models were done using APACHE II, simplified acute physiology score II, and mortality prediction model at time 0. In all models, early enteral feeding was  associated with &lt;/span&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;an approximately 20% decrease in ICU mortality &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;a 25% decrease in hospital mortality&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;The lower mortality rates in the early feeding group were most evident in the sickest group&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;The truth was found that in all adjusted analysis, early feeding was found to be independently associated with an increased risk of ventilator-associated pneumonia (VAP).&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;Study concluded that early feeding significantly reduces ICU and hospital mortality mainly in the sickest patients and should be instituted in medical patients receiving mechanical ventilation especially in patients at high risk of death, despite being associated with an increased risk of VAP developing.&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt; &lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;span style="color:#003333;"&gt;Related previous pearls: &lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/03/is-gut-working.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Where is my food dude !!&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;  and  &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2005/11/saturday-november-26-2005-is-post.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Is post pyloric feeding absolute ?&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference: click to get abstract/article&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://jpen.aspenjournals.org/cgi/content/abstract/26/3/174" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;  - Journal of Parenteral and Enteral Nutrition, Vol 26, Issue 3, 174-181&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://www.chestjournal.org/cgi/content/abstract/129/4/960" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Effects of Early Enteral Feeding on the Outcome of Critically Ill Mechanically Ventilated Medical Patients&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Chest. 2006;129:960-967&lt;/span&gt; &lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114993770989762300?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114993770989762300'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114993770989762300'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/feeding-in-ventilated-patients.html' title='Feeding in ventilated patients'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114990357303065983</id><published>2006-06-09T19:38:00.000-06:00</published><updated>2006-06-09T19:39:33.063-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Friday June 9, 2006&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Case:&lt;/span&gt; &lt;em&gt;&lt;span style="color:#003333;"&gt;76 year old female, admitted 3 days ago to your ICU with possible aspiration pneumonia. Review of report from nursing home also mention of increase diarrhea. You decide to add  metronidazole (flagyl) and start the workup. Patient responded well to treatments and appears to be back to her baseline. You decide to keep patient overnight before transferring to floor in AM. Patient complaint of epigastric abdominal pain during night and on-call physician added pancreatic enzymes for AM and lipase is noted to be 1254 (was normal on admission). You could not find any apparent reason of acute pancreatitis. As C.diff came back negative you stopped the Flagyl and pancreatitis resolved.&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;Metronidazole Induced Pancreatitis:&lt;/span&gt; Acute pancreatitis is a potentially serious adverse effect of  metronidazole. Any patient while on metronidazole develops nausea, vomitting and epigastric pain should be evaluated for acute pancreatitis. Acute pancreatitis may develop upto 5 weeks after metronidzole exposure and drug intake in previous weeks should be evaluated carefully particularly in long term care facility residents. Diagnosis can be confirmed with rechallenge with metronidazole but obviously it should be avoided. The mechanism of metronidazole-induced pancreatitis is not known but unlike many other antibiotics metronidazole penetrates well into pancreatic tissue and explains atleast part of the problem.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference: click to get abstract/article&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://www.joplink.net/prev/200411/13.html" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Metronidazole Induced Pancreatitis. A Case Report and Review of Literature&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - JOP. J Pancreas(Online) 2004; 5(6):516-519&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://www.theannals.com/cgi/content/abstract/34/10/1152" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Metronidazole-associated pancreatitis&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - The Annals of Pharmacotherapy: Vol. 34, No. 10, pp. 1152-1155&lt;br /&gt;3. &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=8569910&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Acute pancreatitis caused by metronidazole&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Ned Tijdschr Geneeskd. 1996 Jan 6;140(1):37-8.&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114990357303065983?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114990357303065983'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114990357303065983'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/friday-june-9-2006-case-76-year-old.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114973983592531387</id><published>2006-06-07T22:09:00.000-06:00</published><updated>2006-06-07T22:10:35.940-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Thursday June 8, 2006&lt;/span&gt; &lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;What if plasma exchange is not available as treatment of TTP&lt;/span&gt; &lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Q:&lt;/span&gt; &lt;span style="color:#003333;"&gt;&lt;em&gt;You just diagnosed a patient with thrombotic thrombocytopenic purpura (TTP) but you were informed by the nursing supervisor that plasma exchange with fresh frozen plasma is not available in hospital due to technical reason and it will take time before patient can be transferred to a facility where the said services are available. What would be your alternate plan to bridge that time?&lt;/em&gt;&lt;/span&gt; &lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;A;&lt;/span&gt; &lt;span style="color:#000000;"&gt;High-dose plasma infusion with rate of 25-30 mL/kg per day. When immediate plasma exchange with fresh frozen plasma is not available, simple plasma infusion can be performed until transfer to a higher care facility is available. There is always a substanial risk of fluid overload with such high plasma infusion and you have to weigh risks and benefits of the clinical decision or to watch patient closely while plasma is infusing.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference: click to get abstract/article &lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;a href="http://www.md-journal.com/pt/re/medicine/abstract.00005792-200301000-00003.htm;jsessionid=GHbJtyv78tXTn1QQsJnPpmZpCnwy2RRpTSs4xyfHnMW238G7Myq2!-818462210!-949856145!8091!-1" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Medicine. 82(1):27-38, January 2003.&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114973983592531387?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114973983592531387'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114973983592531387'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/thursday-june-8-2006-what-if-plasma.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114969403714879855</id><published>2006-06-07T09:26:00.000-06:00</published><updated>2006-06-07T09:32:00.056-06:00</updated><title type='text'>acetazolamide for metabolic alkalosis</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Wednesday June 7, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Dose of acetazolamide (diamox) for metabolic alkalosis&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#990000;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;Many times we use acetazolamide for metabolic alkalosis in mechanically ventilated patients when nothing else is making it better. What dose should we use?. Mazur and coll. from Henry Ford Health System, Detroit, MI looked into 40 mechanically ventilated patients with a metabolic alkalosis (arterial pH more/= 7.48 and serum bicarbonate concentration more/= 26 mEq/L) which were resistant to other therapies such as fluid infusion or potassium therapy.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;Study found that a single IV 500-mg dose of acetazolamide is as effective as multiple doses of IV 250 mg of acetazolamide.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference: click to get abstract/article&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;a href="http://www.ccmjournal.com/pt/re/ccm/abstract.00003246-199907000-00004.htm;jsessionid=GFRZ6GtpLQG0LLMK6DfLSQ6Yb45Z6Rw1221vLQQplVmGyjp02Rr9!1318151080!-949856144!8091!-1" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Single versus multiple doses of acetazolamide for metabolic alkalosis in critically ill medical patients: A randomized, double-blind trial. &lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Critical Care Medicine. 27(7):1257-1261, July 1999.&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114969403714879855?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114969403714879855'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114969403714879855'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/acetazolamide-for-metabolic-alkalosis.html' title='acetazolamide for metabolic alkalosis'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114962033725345558</id><published>2006-06-06T12:56:00.000-06:00</published><updated>2006-06-06T13:00:44.233-06:00</updated><title type='text'>Wells Score of DVT</title><content type='html'>&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;&lt;strong&gt;Tuesday June 6, 2006&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;&lt;span style="color:#990000;"&gt;Wells Score of DVT&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;Pulmonary embolism from deep venous thrombosis remains a leading killer. Many times intensivists are faced with the question of proceeding or not with further radiological workup. Although Wells score is not the absolute score to rule out DVT and subsequently the risk of PE (some literature argue against its validity), it still remains a strong quick tool while differential diagnosis with other conditions. It has been said that if the score of low-probability is combined with negative d-dimer, the negative predictive value is 99.5%&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;1&lt;/span&gt;&lt;strong&gt;. In other words, you can safely hold on further radiological workup.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;3 points&lt;/span&gt; if objective signs like localized tenderness, asymmetric calf swelling.&lt;br /&gt;&lt;span style="color:#660000;"&gt;1.5 points&lt;/span&gt; if Heart Rate more than 100 beats/min&lt;br /&gt;&lt;span style="color:#660000;"&gt;1.5 points&lt;/span&gt; if bedridden for more than 3 days or major surgery within 4 weeks&lt;br /&gt;&lt;span style="color:#660000;"&gt;1.5 points&lt;/span&gt; if previous 'documented' diagnosis of DVT or PE&lt;br /&gt;&lt;span style="color:#660000;"&gt;1 point&lt;/span&gt; if hemoptysis&lt;br /&gt;&lt;span style="color:#660000;"&gt;1 point&lt;/span&gt; if active cancer&lt;br /&gt;&lt;span style="color:#660000;"&gt;3 points&lt;/span&gt; if high clinical suspicion of PE (on overall clinical and lab. findings).&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;ul&gt;&lt;li&gt;0 - 2 low probability, &lt;/li&gt;&lt;li&gt;2-6 moderate probability,&lt;/li&gt;&lt;li&gt;3-6 high probability&lt;/li&gt;&lt;/ul&gt;&lt;br /&gt;Remember,&lt;br /&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;low-probability + negative d-dimer = -ve predictive value of not having DVT is 99.5%&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;Related previous pearl: &lt;/strong&gt;&lt;/span&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/05/massive-pe.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;What if even thrombolysis fails in massive PE ?&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference: click to get abstract/article&lt;br /&gt;&lt;/span&gt;&lt;a href="http://www.annals.org/cgi/content/abstract/135/2/98" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Excluding Pulmonary Embolism at the Bedside without Diagnostic Imaging: Management of Patients with Suspected Pulmonary Embolism Presenting to the Emergency Department by Using a Simple Clinical Model and D-dimer&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; Philip S. Wells and coll.,Ann Intern Med 2001;135:98-107&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114962033725345558?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114962033725345558'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114962033725345558'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/wells-score-of-dvt.html' title='Wells Score of DVT'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114951215002715294</id><published>2006-06-05T06:53:00.000-06:00</published><updated>2006-06-05T06:55:50.046-06:00</updated><title type='text'>Four generations of Quinolones</title><content type='html'>&lt;strong&gt;&lt;span style="color:#990000;"&gt;&lt;span style="color:#000066;"&gt;Monday June 5, 2006&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Four generations of Quinolones&lt;/span&gt;&lt;br /&gt; &lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;The classification of the fluoroquinolones on the basis of generations (imitating from cephalosporins) is not officially standardized, but it is now commonly use to classify them by their spectrum of action.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;1st generation&lt;/span&gt; - Gram negative coverage but not pseudomonas (example: Nalidixic acid)&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;2nd generation&lt;/span&gt; - Gram negative coverage with pseudomonas and some gram postive coverage including s.aureus but not strep pneumoniae.  (example: Ciprofloxacin, Ofloxacin, Norfloxacin)&lt;br /&gt;&lt;span style="color:#660000;"&gt;&lt;br /&gt;3rd generation&lt;/span&gt; - Gram negative coverage with pseudomonas. More gram postive coverage including penicillin sensitive and resistant s. pneumoniae. (example: Levofloxacin, Sparfloxacin, Gatifloxacin (tequin), Moxifloxacin (avalox)). Avalox has been said to be the most effective in this generation.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;4th generation&lt;/span&gt; - Same as 3rd generation but with anaerobic coverage (example: Trovafloxacin (Trovan) ).&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Read &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.aafp.org/afp/20020201/455.pdf" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;comprehensive review on Quinolones&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; &lt;span style="font-size:85%;"&gt;(Source: Am Fam Physician 2002;65:455-64, authors: CATHERINE M. OLIPHANT, PHARM.D., University of Wyoming School of Pharmacy and GARY M. GREEN, M.D., Kaiser Permanente, California)&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114951215002715294?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114951215002715294'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114951215002715294'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/four-generations-of-quinolones.html' title='Four generations of Quinolones'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114940769318362695</id><published>2006-06-04T01:52:00.000-06:00</published><updated>2006-06-04T02:31:23.850-06:00</updated><title type='text'>Quinolones in UTI</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Sunday June 4, 2006&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Quinolones in UTI&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;Q; Name atleast one quinolone which should not be used for UTI in ICU ?&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A:&lt;/span&gt; Moxifloxacin (avelox) - as it doesn't reach sufficient level in the urine. On the flip side, the advantage is that you don't need to adjust dose in renal insufficiency unlike other quinolones if use for other reasons. Similarly, Sparfloxacin (Zagam) and trovafloxacin (Trovan - almost off the market due to severe hepatic side effects) should not be used as these 3rd and 4th generation quinolones are more metabolized through liver.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Urinary tract infection (UTI) is a common and many time an isolated or accidental finding in ICU. Rememeber ! Bactrim (TMP/SMX) is still a first line, cost-effective and preferred antibiotic for uncomplicated UTIs. You should jump to quinolone only if your hospital's antibiogram shows local resistance higher than 20% or if patient is allergic to sulfas. Even in this instance nitrofurantoin is a very valid choice. If you decide to use quinolone - ciprofloxacin, ofloxacin, or norfloxacin is a better choice. Levofloxacin is also commonly prescribed but technically it is not really needed for UTI and just contribute to increase resistance in ICU by overuse.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Previous related pearls:&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2005/10/qaegr.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Quinolones and errant glycemic reaction&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;2. &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2005/12/sunday-december-4-2005-epidemic-of-new.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Epidemic of new fluoroquinolone induce strain of C. Diff.&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114940769318362695?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114940769318362695'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114940769318362695'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/quinolones-in-uti.html' title='Quinolones in UTI'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114937458696898305</id><published>2006-06-03T16:40:00.000-06:00</published><updated>2006-06-03T16:43:06.993-06:00</updated><title type='text'></title><content type='html'>&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;&lt;strong&gt;Saturday June 3, 2006&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Q; Which one electrolyte you will be worried most in patients on TPN (Total Parenteral Nutrition) ?&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;A;&lt;/span&gt; Phosphate. About 33% of patients on TPN develop hypophosphatemia despite supplemented in solution. Patients who require insulin during TPN, or have a history of alcoholism, chronic weight loss, cancer and on diuretic therapy are at increased risk of hypophosphatemia, which also may manifest as "Refeeding syndrome".  Serum phophate level below 1.5 mg/dl ( .5 mmol/L), can manifest symptoms of refeeding syndrome.&lt;br /&gt;&lt;br /&gt;Read interesting editorial, &lt;/strong&gt;&lt;/span&gt;&lt;a href="http://bmj.bmjjournals.com/cgi/content/full/328/7445/908"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Refeeding syndrome, &lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;a href="http://bmj.bmjjournals.com/cgi/content/full/328/7445/908"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Is underdiagnosed and undertreated, but treatable&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt; , from BMJ. &lt;span style="font-size:85%;"&gt;( BMJ  2004;328:908-909 )&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References:  click to get abstract/article&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://qjmed.oxfordjournals.org/cgi/content/extract/98/4/318-a" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Refeeding syndrome: life-threatening, underdiagnosed, but treatable&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;, QJM, April 1, 2005; 98(4): 318 - 319.&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114937458696898305?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114937458696898305'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114937458696898305'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/saturday-june-3-2006-q-which-one.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114930745858764134</id><published>2006-06-02T21:59:00.000-06:00</published><updated>2006-06-02T22:04:18.610-06:00</updated><title type='text'>4 Ts of HIT</title><content type='html'>&lt;p&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Friday June 2, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;4 Ts of HIT&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;Continuing our theme of Heparin-Induced Thrombocytopenia  (HIT) from yesterday, lets talk today about  "4 Ts"  of HIT.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#660000;"&gt;Thrombocytopenia&lt;/span&gt;&lt;/em&gt;   - more than 50% fall&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Timing&lt;/span&gt; of platelet count fall -  Days 5 to 10, or less than/= 1 day if heparin  exposure within past 30 days   &lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;span style="color:#000000;"&gt;&lt;p&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Thrombosis&lt;/span&gt; or other sequelae - Proven thrombosis, skin necrosis, or, after  heparin bolus, acute systemic reaction&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Other&lt;/span&gt; cause for thrombocytopenia - None &lt;/strong&gt;&lt;/p&gt;&lt;p&gt; &lt;/p&gt;&lt;p&gt;&lt;strong&gt;American Society of Hematology has developed a full HIT score which can be seen by clicking &lt;/strong&gt;&lt;/span&gt;&lt;a href="http://circ.ahajournals.org/cgi/content/full/111/20/2671/TBL2" target="_blank"&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;here&lt;/strong&gt;&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;.&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;br /&gt;References:  click to get abstract/article&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://circ.ahajournals.org/cgi/content/full/111/20/2671"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;When Heparins Promote Thrombosis - &lt;/span&gt;&lt;/a&gt;&lt;a href="http://circ.ahajournals.org/cgi/content/full/111/20/2671"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Review of Heparin-Induced Thrombocytopenia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Circulation. 2005;111:2671-2683&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114930745858764134?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114930745858764134'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114930745858764134'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/4-ts-of-hit.html' title='4 Ts of HIT'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114917121469303633</id><published>2006-06-01T08:10:00.000-06:00</published><updated>2006-06-01T08:13:35.306-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Thursday June 1, 2006&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Argatroban Therapy in Hepatic Dysfunction&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/strong&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Argatroban is a second line anti-coagulation as well as remained one of the drug of choice in patients affected with Heparin-induced thrombocytopenia (HIT). Argatroban improve outcomes in patients with HIT, by reducing new thrombosis &lt;/strong&gt;&lt;span style="font-size:78%;"&gt;1 .&lt;/span&gt;&lt;strong&gt; Also reported its safety with no increase risk of bleeding&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;2 .&lt;/span&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;Argatroban is primarily metabolized in the liver and its dosing  need to be adjusted in hepatic dysfunction. Dr. Levine and coll. from Texas has reported in this month of chest after retrospectively analysing data of 82 argatroban patients and 34 historical control therapy patients with hepatic impairments (all HIT patients)&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;5&lt;/span&gt;&lt;strong&gt;. Their results concluded following points:&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;1.&lt;/span&gt; In hepatic impairment 0.5 µg/kg/min is a reasonable, conservative initial dosage of argatroban.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;2.&lt;/span&gt; serum bilirubin level appears to be a better indicator than ALT or AST of argatroban dosing requirements and argatroban should be initiated at a dose of 0.5 µg/kg/min if a patient’s serum total bilirubin level is 1.5 mg/dL.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;3.&lt;/span&gt; Conservatic dose should be the starting point if combined hepatic/renal dysfunction is present.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;4.&lt;/span&gt; As steady-state anticoagulation will be delayed in many patients with hepatic dysfunction, check the aPTT atleast 4 to 5 h after drug initiation or dose change.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;5.&lt;/span&gt;  Argatroban should be stopped for a more extended period in hepatic dysfuntion if an invasive procedure is planned.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Related: Sample &lt;/strong&gt;&lt;/span&gt;&lt;a href="http://www.gwicu.com/Assets/Orders/Argatroban%20orders%20and%20flowsheet.pdf" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Argatroban Protocol For HIT&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;  (from The George Washington University Hospital )&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;"&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;References:  click to get abstract/article&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;/span&gt;&lt;a href="http://archinte.ama-assn.org/cgi/content/abstract/163/15/1849" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Argatroban Anticoagulation in Patients With Heparin-Induced Thrombocytopenia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Arch Intern Med. 2003;163:1849-1856&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt; 2. &lt;/span&gt;&lt;a href="http://circ.ahajournals.org/cgi/content/full/103/14/1838" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia &lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;- Circulation. 2001;103:1838&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;3. &lt;/span&gt;&lt;a href="http://www.extenza-eps.com/PPI/doi/abs/10.1592/phco.20.4.318.34881" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;The Pharmacokinetics and Pharmacodynamics of Argatroban: Effects of Age, Gender, and Hepatic or Renal Dysfunction&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Pharmacotherapy 2000;20,318-329&lt;br /&gt;4. &lt;/span&gt;&lt;a href="http://www.theannals.com/cgi/content/abstract/37/7/970" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Argatroban Dosing in Patients with Heparin-Induced Thrombocytopenia &lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;The Annals of Pharmacotherapy: Vol. 37, No. 7, pp. 970-975.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;5. &lt;/span&gt;&lt;a href="http://www.chestjournal.org/cgi/content/abstract/129/5/1167" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Argatroban Therapy in Heparin-Induced Thrombocytopenia With Hepatic Dysfunction&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;  Chest. 2006;129:1167-1175&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114917121469303633?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114917121469303633'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114917121469303633'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/06/thursday-june-1-2006-argatroban.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114911770294474861</id><published>2006-05-31T17:20:00.000-06:00</published><updated>2006-05-31T17:21:42.960-06:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Wednesday May 31, 2006&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Bedside tip !  - Tracheal Tube Tolerance&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Some intubated patients wake up and cough on the tracheal tube, but may not be ready for extubation and you may be reluctant to re-sedate them. Consider a trial of intravenous Lidocaine. Administer 1 mg/Kg slowly over about two minutes. There is a good chance that the patient will experience immediate and dramatic relief from irritation caused by the tracheal tube (some may even sleep for a while). If the patient has a good response to the bolus, you may even start an intravenous infusion of Lidocaine at 2mg/ min. This can buy you the 1 – 3 hours the patient may need to be able to extubated the patient safely.&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114911770294474861?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114911770294474861'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114911770294474861'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/wednesday-may-31-2006-bedside-tip.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114900077519547907</id><published>2006-05-30T08:51:00.000-06:00</published><updated>2006-05-30T08:52:55.210-06:00</updated><title type='text'>Capnography in CPR</title><content type='html'>&lt;span style="color:#000066;"&gt;&lt;strong&gt;Tuesday May 30, 2006&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;&lt;strong&gt;Use of Capnography in Assessment of CPR Adequacy&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Myocardial blood flow is determined by the difference between aortic diastolic and right atrial pressures. Because both aorta and atrium experience the same intrathoracic pressure change during cardiopulmonary resuscitation (CPR), myocardial blood flow is very poor during cardiac resuscitation. Even high compression forces that may generate acceptable systemic and pulmonary artery pressures yield only small coronary perfusion pressures.&lt;br /&gt;&lt;br /&gt;The arterial blood gas values during CPR manifest complex abnormalities. The reduction in cardiac output, and thus tissue perfusion, promotes anaerobic metabolism and lactic acidosis. However, arterial blood samples reflect either a normal or low PCO2 during CPR, while venous blood gases manifest both a respiratory and metabolic acidosis.&lt;br /&gt;&lt;br /&gt;When perfusion is absent in the presence of ventilation, the primary influence on arterial acid-base status is alveolar ventilation. Venous acidosis develops as tissue beds drain CO2 and lactate is produced by anaerobic metabolism. The PCO2 in pulmonary veins increases due to reduced pulmonary blood flow and a resulting decrease in CO2 excretion.&lt;br /&gt;&lt;br /&gt;With effective CPR or return of spontaneous circulation, pulmonary blood flow is improved and arterial pH decreases as more of the venous acid load (CO2 and lactate) reaches the arterial side. Aerobic and anaerobic metabolism produce carbon dioxide that is transported in venous blood to the lung and eliminated from the lung by minute ventilation. End-tidal CO2 is a measure of the partial pressure of carbon dioxide at the airway opening at the end of expiration.&lt;br /&gt;&lt;br /&gt;During cardiac arrest, the abrupt decrease in cardiac output results in reduction of carbon dioxide transport from the tissues to lung and, hence, decreased carbon dioxide. More recently, capnography has been used to determine the adequacy of cardiopulmonary resuscitation.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;There are 2 good sources to understand capnography:&lt;br /&gt;&lt;br /&gt;1.  &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.capnography.com/Homepage/HomepageM.htm" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;capnography.com&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; , educational site on subject from Bhavani-Shankar Kodali  MD, Department of Anesthesia, Brigham and Women's Hospital, Harvard Medical School, Boston, USA&lt;br /&gt;&lt;br /&gt;2. See concise &lt;/span&gt;&lt;span style="color:#660000;"&gt; &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.biotel.ws/protocolsHTML/Protocols2004/CapnographyInterpretation.asp"&gt;&lt;/a&gt;&lt;a href="http://www.biotel.ws/protocolsHTML/Protocols2004/CapnographyInterpretation.asp"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;INTERPRETATION OF CAPNOGRAPHIC WAVEFORM &lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;span style="font-size:85%;"&gt;(from biotel.ws website)&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114900077519547907?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114900077519547907'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114900077519547907'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/capnography-in-cpr.html' title='Capnography in CPR'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114893146440094873</id><published>2006-05-29T13:35:00.000-06:00</published><updated>2006-05-29T13:37:44.420-06:00</updated><title type='text'>Blumberg's sign</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Monday May 29, 2006 &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Blumberg's sign&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Q:&lt;/span&gt; &lt;span style="color:#003333;"&gt;&lt;em&gt;You received call from an old fashioned experienced ER physician to consult a patient with hypotension and positive Blumberg's sign ?&lt;/em&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;&lt;br /&gt;Do you know what is Blumberg's sign ?&lt;br /&gt;&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A;&lt;/span&gt; &lt;span style="color:#000000;"&gt;Sudden release of steadily applied pressure on a suspected area of the abdomen cause sudden stab of pain - an indication of peritonitis. Yes its another name of rebound tenderness. Ideal technique requires to watch patient's face to assess severity of pain while doing above maneuver (there is an innocent tendency to watch abdomen).&lt;br /&gt;&lt;br /&gt;Historically this maneuver was described to assess peritoneal inflammation as an early sign of appendicitis by pressing hands over &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.geocities.com/akramjfr/apt2pic3.jpg" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;McBurney's point&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;*. Sign was first described by a german surgeon and gynaecologist, Jacob Moritz Blumberg (1873 -1955).&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:85%;"&gt;* McBurney's point is located one third of the distance along a line from the front of the right pelvic bone and the belly button (click to see image).&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114893146440094873?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114893146440094873'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114893146440094873'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/blumbergs-sign.html' title='Blumberg&apos;s sign'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114884781425528785</id><published>2006-05-28T14:22:00.000-06:00</published><updated>2006-05-28T14:24:33.376-06:00</updated><title type='text'>MEDiC Bill</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Sunday May 28, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;MEDiC bill&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Senators Hillary Rodham Clinton and Barack Obama have coauthored the proposed MEDiC bill. (National Medical Error Disclosure and Compensation Bill).&lt;br /&gt;&lt;br /&gt;Main ideas of the bill:&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;1.&lt;/span&gt; &lt;span style="font-size:85%;"&gt;This legislation would create an Office of Patient Safety and Health Care Quality within the Department of Health and Human Services. The director of this office will be responsible for establishing a National Patient Safety Database, conducting data analyses to inform policy and practice recommendations, establishing and administering the National Medical Error Disclosure and Compensation (MEDiC) program, and supporting studies related to MEDiC and the medical liability system.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;2.&lt;/span&gt; The MEDiC program would provide federal grant support and technical assistance for doctors, hospitals, and health systems that disclose medical errors and problems with patient safety and offer fair compensation for injuries or harm. Participants would submit a safety plan and designate a patient-safety officer, to whom these disclosures and notices of related legal action would be reported.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;3.&lt;/span&gt; If a patient was injured or harmed as a result of medical error or a failure to adhere to the standard of care, the participant would disclose the matter to the patient and offer to enter into negotiations for fair compensation. The terms of negotiation for compensation ensure confidentiality, protection for any disclosure made by a health care provider to the patient in the confines of the MEDiC program, and a patient's right to seek legal counsel; they also allow for the use of a neutral third-party mediator to facilitate the negotiation.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;4.&lt;/span&gt; Any apology offered by a health care provider during negotiations shall be kept confidential and could not be used in any subsequent legal proceedings as an admission of guilt if those negotiations ended without mutually acceptable compensation.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Is it a fantasy land OR another bureaucratic hurdle ?. OR a real geniune workable idea as argued by senators by citing experiences and studies from University of Michigan Health System and Veterans Affairs (VA) Hospital in Lexington, Kentucky ?. Read by yourself the full article (available free by clicking link below) published by senators in The New England Journal of Medicine, Volume 354:2205-2208, Number 21. May 25, 2006&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://content.nejm.org/cgi/content/full/354/21/2205" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Mak&lt;/span&gt;&lt;span style="color:#660000;"&gt;ing Patient Safety the Centerpiece of Medical Liability Reform&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114884781425528785?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114884781425528785'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114884781425528785'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/medic-bill.html' title='MEDiC Bill'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114877357549291288</id><published>2006-05-27T17:44:00.000-06:00</published><updated>2006-09-24T16:23:51.096-06:00</updated><title type='text'>RT or Iced Saline</title><content type='html'>&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Saturday May 27, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Room temperature or Iced Saline ?&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/strong&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;br /&gt;Critical Care literature is not clear, actually controversial, regarding  the suitable temperature of the solution use as injectable to measure cardiac  output via thermodilution. Let see what is the major pro &amp; con of iced saline.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Advantage:&lt;/span&gt;&lt;/em&gt; Iced injectate gives a higher signal/noise ratio and more reliability in the measured cardiac output. Signal-to-noise ratio is an engineering term for the power ratio between a signal (meaningful information) and the background noise.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;Disadvantage:&lt;/em&gt;&lt;/span&gt; Iced  injectate may affect heart rate and cardiodynamics&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;5&lt;/span&gt;&lt;strong&gt;.&lt;br /&gt;&lt;br /&gt;But practically does it matter ?. Also, iced solution may not be as cold as we think after it passes through the operator's hand and long port.&lt;br /&gt;&lt;br /&gt;Overall literature favours room temperature or atleast does not show any major advantage of using iced saline&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;1-4&lt;/span&gt;&lt;strong&gt;&lt;span style="font-size:78%;"&gt;.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Related: &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;a href="http://intranet.unchealthcare.org/site/Nursing/nurspractice/procedures/procedures/procedurec7.pdf" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Thermodilution Cardiac Output Measurement Protocol &lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="font-size:85%;"&gt;(sample from Univ. of Carolina Hospitals)&lt;/span&gt;&lt;/strong&gt;&lt;span style="font-size:85%;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References:&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://jap.physiology.org/cgi/content/abstract/16/2/271" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Cardiac output measured by thermal dilution of room temperature injectate&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;. - Evonuk E, Imig CJ, Greenfield W, et al:  J Appl Physiol 1961; 16:271-275&lt;br /&gt;&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://www.chestjournal.org/cgi/content/abstract/84/4/418" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Cardiac output by thermodilution technique. Effect of injectate's volume and temperature on accuracy and reproducibility in the critically Ill patient&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Chest, Vol 84, 418-422, 1983&lt;br /&gt;&lt;br /&gt;3. &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=3717644&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Effect of injectate volume and temperature on thermodilution cardiac output determination&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Anesthesiology.1986 Jun;64(6):798-801.&lt;br /&gt;&lt;br /&gt;4. &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=15236143&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Iced versus room temperature injectate for assessment of cardiac output, intrathoracic blood volume, and extravascular lung water by single transpulmonary thermodilution&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - J Crit Care. 2004 Jun;19(2):103-7.&lt;br /&gt;&lt;br /&gt;5. The slowing of sinus rhythm during thermodilution cardiac output determination and the effect of altering injectate temperature. Anesthesiology 1985; 63:540-541&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114877357549291288?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114877357549291288'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114877357549291288'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/rt-or-iced-saline.html' title='RT or Iced Saline'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114868565347170449</id><published>2006-05-26T17:19:00.000-06:00</published><updated>2006-05-26T17:20:53.490-06:00</updated><title type='text'>CO Pitfalls</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Friday May 26, 2006 &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Cardiac Output Pitfalls&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Determination of cardiac output by thermodilution has several technical pitfalls. Any deviation in technique can produce inaccurate and inconsistent results.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#660000;"&gt;Basis of thermodilutional cardiac output:&lt;/span&gt;&lt;/em&gt;  The method relies on an injection of a known volume of fluid (5-10 mL) into the right atrium. This fluid, either normal saline or D5W is at room (or iced at known *) temperature and therefore cooler than blood. The cooler injectate mixes with blood, thus lowering its temperature. The cooled blood is ejected into the pulmonary artery and flows past a thermistor located in the distal end of the PA catheter. The thermistor generates a change in temperature to time curve. The area under this curve is calculated by integration and is inversely proportional to the flow past the thermistor. In other words, the longer it takes for this change in temperature to “wash out,” the slower the flow past the thermistor. The converse is also true. The greater the flow, the faster the temperature “wash out,” and therefore the smaller the area under the curve. Anything that can disrupt the “washout” of this temperature change can affect the accuracy of this measurement.&lt;br /&gt;&lt;br /&gt;* &lt;/strong&gt;&lt;span style="font-size:85%;"&gt; iced saline has been said to provides a better "signal-to-noise" ratio but controversy continues in literature regarding iced vs room temperature solution.&lt;br /&gt;&lt;/span&gt;&lt;strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Clinical pitfalls:&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;1.&lt;/span&gt; Severe tricuspid regurgitation causes the injectate to recycle back and forth across the valve falsely lowering cardiac output.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;2.&lt;/span&gt; An injectate volume that is too large will also falsely lower cardiac output.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;3.&lt;/span&gt; Intracardiac shunts can falsely elevate cardiac output.  In a right-to-left shunt, part of the injectate escapes through the shunt and decreases the amount of time required for washout of the temperature change. An injectate volume that is too small will cause an abbreviated washout and therefore falsely elevate the cardiac output.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Also see &lt;/strong&gt;&lt;/span&gt;&lt;a href="http://www.thoracic.org/sections/clinical-information/critical-care/hemodynamic-monitoring/pulmonary-artery-catheter-primer/index.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Pulmonary Artery Catheter Primer&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt; from American Thoracic Society (About 100 MCQ questions covering almost all aspects of PAC).&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Related previous pearl: &lt;/strong&gt;&lt;/span&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/01/sunday-january-22-2006-arterial.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Arterial pressure-based continuous cardiac output&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114868565347170449?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114868565347170449'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114868565347170449'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/co-pitfalls.html' title='CO Pitfalls'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114861115776094514</id><published>2006-05-25T20:37:00.000-06:00</published><updated>2006-05-25T20:40:41.286-06:00</updated><title type='text'>open abdomen</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Thursday May 25, 2006&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;Q;&lt;/span&gt; &lt;span style="color:#003333;"&gt;&lt;em&gt;What is the antibiotic of choice for prophylaxis in "abdomen left open"?&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A;&lt;/span&gt; The open abdomen (or abdomen left open after damage control) does not require antibiotic prophylaxis (unless there is an evidence of infection).&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Keep as reference, nice bedside management review article:&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.indianjsurg.com/article.asp?issn=0972-2068;year=2004;volume=66;issue=4;spage=203;epage=208;aulast=Kapadia" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Role of ICU in the management of the acute abdomen.&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="font-size:85%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="font-size:85%;"&gt;Kapadia F. Indian J Surg 2004;66:203-208&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference:&lt;br /&gt;&lt;br /&gt;Management of the patient with an open abdomen: techniques in temporary and definitive closure. Curr Probl Surg. 2004;41:815-876.&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114861115776094514?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114861115776094514'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114861115776094514'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/open-abdomen.html' title='open abdomen'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114847834102013226</id><published>2006-05-24T07:43:00.000-06:00</published><updated>2006-05-24T10:30:13.403-06:00</updated><title type='text'>Hydrocortisone and  Dexamethasone</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Wednesday May 24, 2006 &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;&lt;span style="color:#990000;"&gt;Hydrocortisone and Dexamethasone&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;&lt;br /&gt;What are the 3 major differences between Hydrocortisone and Dexamethasone ?&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;1.&lt;/span&gt; Potency of Hydrocortisone and Dexamethasone is 20:1 (precisely 20 : 0.75) - &lt;span style="color:#000000;"&gt;means .75 mg of dexamethasone is equal to 20 mg of hydrocortisone.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;2.&lt;/span&gt; &lt;em&gt;Mineralocorticoid : Glucocorticoid activity&lt;/em&gt; is 1:1 in hydrocotisone but dexamethasone has negligible mineralocorticoid activity as well it does not effect cortisol level.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;3.&lt;/span&gt; Half life of Hydrocortisone is 8-12 hrs and of dexametasone is 36-54 hrs.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;See nice review &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijen/vol1n2/adrenal.xml" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Relative Adrenal Insufficiency: Case Examples &amp;amp; Review&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; from Bradley J. Phillips, M.D. , Boston Medical Center, Boston Univ. Schl of Med. &lt;/span&gt;&lt;span style="font-size:85%;"&gt;(ref: The Internet Journal of Endocrinology. 2005. Volume 1 Number 2)&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114847834102013226?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114847834102013226'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114847834102013226'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/hydrocortisone-and-dexamethasone.html' title='Hydrocortisone and  Dexamethasone'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114835820231823807</id><published>2006-05-22T22:21:00.000-06:00</published><updated>2006-05-23T06:34:46.186-06:00</updated><title type='text'>Acute Liver Failure</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Tuesday May 23, 2006 &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#990000;"&gt;Acute Liver Failure &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;Q;&lt;/span&gt; The chances of survival with medical management in acute liver failure is 26%. How much difference liver transplant can make ?&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A;&lt;/span&gt; It goes upto 90% !! &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;Please see / keep in file video lecture&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://webcast.ucsd.edu:8080/ramgen/UCSD_TV/8320.rm" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Acute Liver Failure: The Critical Team Approach&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Dr. Lorenzo Rossaro, Chief of Gastroenterology and Hepatology and Head of the Liver Transplant Program at University of California Davis Medical Center.&lt;br /&gt;&lt;em&gt;&lt;br /&gt;(Total time: 42 minutes). &lt;/em&gt;Please click on above link.&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:85%;"&gt;You will need &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.real.com/" target="_blank"&gt;&lt;strong&gt;&lt;span style="font-size:85%;color:#000000;"&gt;Real Player&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="font-size:85%;color:#000000;"&gt; to see the lecture&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114835820231823807?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114835820231823807'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114835820231823807'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/acute-liver-failure.html' title='Acute Liver Failure'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114830234806759488</id><published>2006-05-22T06:49:00.000-06:00</published><updated>2006-05-22T06:52:28.090-06:00</updated><title type='text'>PACT</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Monday May 22, 2006&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;PACT - Critical Care distant learning course&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;The European Society of Intensive Care Medicine (ESICM) has  designed a multidisciplinary distance-learning programme PACT, Patient-centred Acute Care Training.&lt;br /&gt;&lt;br /&gt;Eventually, the whole programme will have 45 modules divided into 4 major areas - &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;ul&gt;&lt;li&gt;CLINICAL PROBLEMS,&lt;/li&gt;&lt;li&gt; SKILLS AND TECHNIQUES, &lt;/li&gt;&lt;li&gt;ORGAN SPECIFIC PROBLEM and&lt;/li&gt;&lt;li&gt; PROFESSIONALISM.&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;The content of each module is based on real life in the ICU. Each module describes a clinical scenario in which the user is asked to interpret the nature of problems and make management decisions. At the end of each module there are self-assessment multiple-choice questions (MCQs). 12 modules are already available &lt;/p&gt;&lt;ol&gt;&lt;li&gt;ACUTE RENAL FAILURE&lt;/li&gt;&lt;li&gt;ALTERED CONSCIOUSNESS&lt;/li&gt;&lt;li&gt;ARRHYTHMIA&lt;/li&gt;&lt;li&gt;BASIC CLINICAL EXAMINATION&lt;/li&gt;&lt;li&gt;CLINICAL IMAGING&lt;/li&gt;&lt;li&gt;COPD and ASTHMA&lt;/li&gt;&lt;li&gt;HOMEOSTASTIS &lt;/li&gt;&lt;li&gt;MAJOR INTOXICATION&lt;/li&gt;&lt;li&gt;NUTRITION&lt;/li&gt;&lt;li&gt;PYREXIA&lt;/li&gt;&lt;li&gt;QUALITY ASSURANCE AND COST EFFECTIVENESS&lt;/li&gt;&lt;li&gt;TRAUMATIC BRAIN INJURY &lt;/li&gt;&lt;/ol&gt;&lt;p&gt;Click &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.esicm.org/PAGE_pactprogramme?5n6r" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;here&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; to get more info.&lt;br /&gt;&lt;br /&gt;For USA intensivists, it carries CME via SCCM. See the&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.sccm.org/education/online_education/Documents/PACTNewsletterMar04.pdf" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; &lt;/span&gt;&lt;span style="color:#660000;"&gt;PACT Newsletter&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.icuroom.net/" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;icuroom.net&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; or its editors have no relationship with PACT and introduction provided here is solely for educational purpose.&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114830234806759488?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114830234806759488'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114830234806759488'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/pact.html' title='PACT'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114818881135023571</id><published>2006-05-20T23:18:00.000-06:00</published><updated>2006-05-21T10:24:39.816-06:00</updated><title type='text'>Intrahospital transport and VAP</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Sunday May 21, 2006&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Intrahospital transport - a risk factor for VAP ?&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Interesting study published about 6 months ago in Critical Care Medicine1 from france where 118 ventilated patients who were transported out of the ICU were matched with 118 ventilated patients who did not undergo intrahospital transport. Adjusting all variables, the ventilator-associated pneumonia (VAP) was 26% in transported patients compared with 10% in the matched untransported patients.&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:85%;"&gt;&lt;em&gt;Please read full article to see all inclusion criteria, methods and measurements.&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;The following interventions were recommended by the group to minimize VAP before transportation:&lt;br /&gt;&lt;br /&gt;1. a written protocol focusing on the prevention of aspiration during transport of intubated patients.&lt;br /&gt;&lt;br /&gt;2. check material and devices necessary for transport for normal working status,&lt;br /&gt;&lt;br /&gt;3. aspirate the endotracheal tube,&lt;br /&gt;&lt;br /&gt;4. verify endotracheal tube adequate position,&lt;br /&gt;&lt;br /&gt;5. check the endotracheal cuff pressure,&lt;br /&gt;&lt;br /&gt;6. fit the ventilatory circuit with a filter,&lt;br /&gt;&lt;br /&gt;7. stop enteral nutrition,&lt;br /&gt;&lt;br /&gt;8. aspirate gastric contents before and sometimes during transport,&lt;br /&gt;&lt;br /&gt;9. if possible, transport the patient in semirecumbent position,&lt;br /&gt;&lt;br /&gt;10. if necessary, sedation to obtain a &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.urop.uci.edu/journal/journal98/SusanKhera/table1.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Ramsay score&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; less than 4,&lt;br /&gt;&lt;br /&gt;11. verify the availability of the area to which the patient has to be transported.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: click to get abstract/article&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://www.ccmjournal.com/pt/re/ccm/abstract.00003246-200511000-00004.htm;jsessionid=GnBVj8gQVWxG6S2hvDG4t8FVXwkqBLcV1p2nJ5VwnGdrgLYwCqkG!-1132766741!-949856145!8091!-1" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Intrahospital transport of critically ill ventilated patients: A risk factor for ventilator-associated pneumonia-A matched cohort study Critical Care Medicine&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;. 33(11):2471-2478, November 2005.&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114818881135023571?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114818881135023571'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114818881135023571'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/intrahospital-transport-and-vap.html' title='Intrahospital transport and VAP'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114813062804361529</id><published>2006-05-20T07:08:00.000-06:00</published><updated>2006-05-20T15:36:19.193-06:00</updated><title type='text'>Hypoproteinemia and cosyntropin test</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Saturday May 20, 2006&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Hypoproteinemia and cosyntropin test&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;43 year old malnourished patient admitted with septic shock. You started early goal directed therapy protocol. Patient blood pressure remained low despite showing signs of clinical improvement. You suspected adrenal insufficiency and ordered cosyntropin test. Patient failed to respond. You started low dose hydrocortisone. Next day you received call from lab that they also performed 'free cortisol' response to cosyntropin and found it appropriate to label patient as responder ?&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;Severe hypoproteinemia (as in this malnourished patient) may give false results and responders may get wrongly labelled as non-responders. In blood, about 90 percent of cortisol is bound to protiens (20 percent of cortisol is loosely bound to albumin and 70 percent is tightly bound to cortisol-binding globulin). Only 10 percent cortisol is in the free state.  This is a major pittfall and deception to fall in  while prescribing steroids in septic and hypoproteinemic patient under presumption of 'nonresponder'.&lt;br /&gt;&lt;br /&gt;An important study reported about  2 years ago from Cleveland 1, looked into 66 critically ill patients with 36/66 had  hypoproteinemia (albumin 2.5 g/dl or less) and 30/66 had near-normal serum albumin concentrations (above 2.5 g/dl). Baseline and cosyntropin stimulated serum total cortisol level as well as baseline and cosyntropin stimulated serum free cortisol level were measured. Study found that, nearly 40 percent of critically ill patients with hypoproteinemia had subnormal serum total cortisol levels, even though their adrenal function was normal as measured by free cortisol level.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Related previous pearl: &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/01/wednesday-january-4-2006-low-dose.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Low dose steroid, yes or no ? - responder or non-responder ? - low-dose corticotropin stimulation test or high dose?&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: click to get abstract/article&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://content.nejm.org/cgi/content/abstract/350/16/1629" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Measurements of Serum Free Cortisol in Critically Ill Patients&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Volume 350:1629-1638, April 15, 2004, NEJM&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://jcem.endojournals.org/cgi/content/abstract/91/1/105" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Septic Shock and Sepsis: A Comparison of Total and Free Plasma Cortisol Levels&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;  - The Journal of Clinical Endocrinology &amp; Metabolism Vol. 91, No. 1 105-114&lt;br /&gt;3. &lt;/span&gt;&lt;a href="http://jama.ama-assn.org/cgi/content/abstract/294/19/2481" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Adrenal Insufficiency&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; -  Roberto Salvatori, MD JAMA. 2005;294:2481-2488&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114813062804361529?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114813062804361529'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114813062804361529'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/hypoproteinemia-and-cosyntropin-test.html' title='Hypoproteinemia and cosyntropin test'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114801458054605816</id><published>2006-05-18T22:54:00.000-06:00</published><updated>2006-05-18T22:56:20.560-06:00</updated><title type='text'>HIDA, DISIDA and BRIDA scan</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Friday May 19, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;HIDA, DISIDA and BRIDA scan&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Hepatic 2,6-dimethyliminodiacetic acid (HIDA) and Diisopropyl iminodiacetic acid (DISIDA) are nuclear studies to assess the function of the gallbladder and obstruction of the Common Bile Duct (CBD) in cholecystitis, cholangitis, billiary leak and atresia. These tests are ordered when ultrasound is equivocal. When you will order HIDA Scan or DISIDA scan ?&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;Nuclear Medicine literature is vast in this regard but to be short and simple, HIDA scan is used when serum bilirubin is less than 5-7 mg/dl and DISIDA scan is used when serum bilirubin is more than 7 mg/dl. DISIDA scan is now largely used instead of HIDA scan. The basis of this difference is relatively higher hepatic extraction. HIDA scan can be falsely positive when the gallbladder is not filling despite absence of cholecystitis like in severe liver disease (hyperbilirubinemia), patients on TPN or patient NPO for more than 24 hours, alcohol and opiate abuse. In case, serum bilirubin is extremely high (&gt; 30 mg/dl), you can call for Mebrofenin (BRIDA) scan. Mebrofenin has even higher hepatic extraction than DISIDA scan. &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;Related Previous pearl: &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2005/11/friday-november-25-2005-acute.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Acute acalculous cholecystitis in ICU&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114801458054605816?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114801458054605816'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114801458054605816'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/hida-disida-and-brida-scan_18.html' title='HIDA, DISIDA and BRIDA scan'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114797747276512503</id><published>2006-05-18T12:35:00.000-06:00</published><updated>2006-05-18T12:40:14.013-06:00</updated><title type='text'>RSBI Rate</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Thursday May 18, 2006&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;RSBI Rate - Not only RSBI !&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000000;"&gt;The Rapid Shallow Breathing Index (RSBI) remained an integral part of ventilator weaning parameter. Dr. Segal and coll. from Morristown Memorial Hospital, NJ went one step forward and looked into "RSBI Rate" (rate of change in the RSBI) with the question that as respiratory failure is a dynamic phenomenon - should serial followup of RSBI would be a more accurate predictor of weaning outcome, instead of one RSBI at a given time ?. In a prospective cohort study, patients with following criteria has been included: &lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;ul&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;requiring mechanical ventilation for more than 48hrs, &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;ET tube size no smaller than 7.5 in the ICU, &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;cleared by an intensivist (independent of study investigators) as an appropriate candidate to undergo weaning, &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;on hospital respiratory therapist driven weaning protocol.&lt;br /&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Spontaneous Breathing Trial (SBT) for up to two hours given and parameters were measured periodically at SBT. The RSBI Rate was calculated by the formula:&lt;/p&gt;&lt;p&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;RSBI rate: (RSBI2 - RSBI1)/ RSBI1 × 100&lt;/span&gt;&lt;/em&gt; &lt;/p&gt;&lt;p&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;Out of 30 patients, 21 were successfully extubated, 3 were re-intubated within 24 hours and six were intolerants to the SBT. The RSBI on the failure plus Intolerance group was 40.2 (SD 14.7) but RSBI rate on every patient that failed or had intolerance to SBT had a RSBI Rate greater that 20%. It was concluded that the RSBI Rate less that 20% has a sensitivity of 90.4% and specificity of 100% in predicting weaning success.&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference:&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;br /&gt;USE OF THE RATE OF CHANGE OF THE RSBI DURING SPONTANEOUS BREATHING TRIAL AS AN ACCURATE PREDICTOR OF WEANING OUTCOME - Critical Care Medicine: Volume 33(12) Abstract Supplement December 2005 p A20&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114797747276512503?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114797747276512503'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114797747276512503'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/rsbi-rate.html' title='RSBI Rate'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114787556546465112</id><published>2006-05-17T08:17:00.000-06:00</published><updated>2006-05-17T14:37:57.786-06:00</updated><title type='text'>Calcium in Dig toxicity</title><content type='html'>&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Wednesday May 17, 2006&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Treating Digoxin toxicity&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Case: &lt;em&gt;&lt;span style="color:#003333;"&gt;74 year old male has been found to have arrhythmia with runs of wide complex ventricular tachycardia. Patient so far remained hemodynamically stable. You request crash cart near bed, applied pads to chest and send STAT labs and start reviewing patient's chart. You noticed 4 days ago digoxin level was 1.9 and since then his serum creatinine is steadily rising from 1.6 to 2.8. You suspected "Dig. toxicity" and called lab to run STAT dig. level. Indeed Dig. level is back with 3.4 and accompanying labs showed K+ level of 6.9. You ordered "Digi-bind" (Digoxin Immune Fab). Pharmacy informed you, "it will take time before Digi-bind gets to ICU". Interim you started treating hyperkalemia with IV insulin, D-50, IV bicarb., IV calcium and albuterol neb. treatments.&lt;br /&gt;&lt;br /&gt;Where did you go wrong ?&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;&lt;br /&gt;Answer:&lt;/span&gt; Calcium has shown to make digoxin toxicity worse. It may be more wise to avoid calcium in management of hyperkalemia from digoxin toxicity. Some literature has shown the similar membrane stabalizing effect from magnesium and may be used instead of calcium.&lt;br /&gt;&lt;br /&gt;Caution should be taken not to go very aggressive in treating hyperkalemia, or atleast potassium should be followed very closely if DigiFab is planned. With administration of DigiFab (Digibind), potassium shifts back into the cell and life threatening hypokalemia may develop rapidly. Digoxin causes a shift of potassium from inside to outside of the cell and may cause severe hyperkalemia but overall there is a whole body deficit of potassium. With administration of Digi-bind, actual hypokalemia may manifest which could be equally life threatening.&lt;br /&gt;&lt;br /&gt;Read related interesting review: &lt;/strong&gt;&lt;/span&gt;&lt;a href="http://emj.bmjjournals.com/cgi/content/full/19/1/74" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Recognising signs of danger: ECG changes resulting from an abnormal serum potassium concentration&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;:&lt;/span&gt; &lt;span style="font-size:85%;"&gt;A Webster, W Brady and F Morris (reference: Emerg Med J 2002; 19:74-77)&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: click to get abstract/article&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://emj.bmjjournals.com/cgi/content/full/19/2/183" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Calcium for hyperkalaemia in digoxin toxicity&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Emerg Med J 2002; 19:183&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://ndt.oxfordjournals.org/cgi/content/full/19/5/1333-a" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Using calcium salts for hyperkalaemia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Nephrol Dial Transplant (2004) 19: 1333-1334&lt;br /&gt;3. Slow-release potassium overdose: Is there a role for magnesium? Emergency Medicine 1999;11:263–71&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114787556546465112?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114787556546465112'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114787556546465112'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/calcium-in-dig-toxicity.html' title='Calcium in Dig toxicity'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114778704594982900</id><published>2006-05-16T07:42:00.000-06:00</published><updated>2006-05-16T07:44:05.966-06:00</updated><title type='text'>K level via A-line</title><content type='html'>&lt;strong&gt;&lt;span style="color:#003333;"&gt;Tuesday May 16, 2006&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;&lt;span style="color:#990000;"&gt;Potassium level via A-line&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;Potassium level via arterial line may not be as reliable as through peripheral venous punture. See this interesting case report (click reference) published in British Journal of Anaesthesia, where radial arterial line consistently showed K level of 7.4 - 9.3 mEq/L without any clinical signs. Simultaneous venous sample level was 4.4 mEq/L. When cannula was slightly withdrawn, arterial potassium level came back as 4.1 mEq/L (c/w venous sample).&lt;br /&gt;&lt;br /&gt;It was postulated that the tip of the cannula could have impinged against the vessel wall so that during withdrawal of the sample a high shear rate could have caused haemolysis of red blood cells leading to an increased potassium concentration in the blood samples.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: click to get abstract/article&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://bja.oxfordjournals.org/cgi/content/full/93/3/456" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Apparent hyperkalaemia from blood sampled from an arterial cannula&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - British Journal of Anaesthesia 2004 93(3):456-458&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114778704594982900?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114778704594982900'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114778704594982900'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/k-level-via-line.html' title='K level via A-line'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114769929815108169</id><published>2006-05-15T07:20:00.000-06:00</published><updated>2006-05-15T07:23:03.546-06:00</updated><title type='text'>Pseudothrombocytopenia</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Monday May 15, 2006&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/03/cuff-leak-test.html" target="_blank"&gt;&lt;/a&gt;&lt;br /&gt;&lt;strong&gt;Case: &lt;span style="color:#003333;"&gt;&lt;em&gt;52 year old male is back from cardiac angioplasty with abciximab (ReoPro) infusion. Pre-cath labs were normal. CBC was send per protocol after 4 hours of abciximab infusion and lab call with critical platelet level of 62. Abciximab was stopped and hematology consulted. Hematology advised to restart abciximab !!&lt;br /&gt;&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Pseudothrombocytopenia:&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;Pseudothrombocytopenia is a common phenomenon with patients on abciximab (ReoPro). It is a benign condition and is not a real thrombocytopenia as platelets actually clump in collecting tubes containg EDTA. It is an important diagnosis to make as it may leave patient without an appropriate treatment. Diagnosis can be made by reviewing peripheral blood film or drawing blood in citrated or heparinized tube. It is not clear why abciximab cause more EDTA-induced platelet clumping.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:85%;"&gt;* EDTA (Ethylenediaminetetraacetic acid) is a commonly used anticoagulant in sampling tubes for blood counts.&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: click to get abstract/article&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;list_uids=10898416&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; J Am Coll Cardiol. 2000 Jul;36(1):75-83. &lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;2. &lt;/span&gt;&lt;a href="http://circ.ahajournals.org/cgi/content/full/101/8/938" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Abciximab-Associated Pseudothrombocytopenia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Circulation. 2000;101:938&lt;br /&gt;3. &lt;/span&gt;&lt;a href="http://jcp.bmjjournals.com/cgi/content/abstract/47/7/625" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Journal of Clinical Pathology 1994;47:625-630&lt;br /&gt;4.&lt;/span&gt;&lt;a href="http://content.nejm.org/cgi/content/short/329/20/1467" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt; Pseudothrombocytopenia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; Volume 329:1467 Nov. 11, 1993&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114769929815108169?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114769929815108169'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114769929815108169'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/pseudothrombocytopenia.html' title='Pseudothrombocytopenia'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114764495228940673</id><published>2006-05-14T16:13:00.000-06:00</published><updated>2006-05-14T16:16:01.656-06:00</updated><title type='text'>In Hyperkalemia</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Sunday May 14, 2006&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;In Hyperkalemia !!&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Q;&lt;/span&gt; &lt;em&gt;&lt;span style="color:#003333;"&gt;Nurse call you with K+ level of 7.8 (lab confirmed - no hemolysis). You ordered 10 units of IV insulin with 2 ampules of D-50, 1 ampule of calcium gluconate and 2 ampules of sodium bicarbonate in series. RT was requested to give 2 nebulizer treatments of albuterol. The final order set is followed ultimately by PO Kayexalate/sorbitol.&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;What is wrong in above orders for the management of hyperkalemia?&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A;&lt;/span&gt; In the management of hyperkalemia, sodium bicarbonate should be given before calcium. Administrating bicarbonate after calcium will bind calcium and will render it ineffective. This is another reason, we don't prepare "bicarb drip" in LR (Lactated Ringer’s) as it contains calcium which will bind bicarbonate and will make the whole management ineffective.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Related previous pearls:&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/02/dblranss.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Difference between Lactate Ringer's and Normal Saline solutions&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/02/cnucofks.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Colonic Necrosis - unusual complication of Kayexalate-Sorbitol&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114764495228940673?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114764495228940673'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114764495228940673'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/in-hyperkalemia.html' title='In Hyperkalemia'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114749340710113102</id><published>2006-05-12T22:07:00.000-06:00</published><updated>2006-05-13T16:45:30.606-06:00</updated><title type='text'>Hyperbaric oxygen in CO poisoning</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Saturday May 13, 2006&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#990000;"&gt;Hyperbaric oxygen in CO poisoning&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Q;&lt;/span&gt; &lt;em&gt;&lt;span style="color:#003333;"&gt;What is the role of hyberbaric oxygen in the management of lethal Carbon-monoxide (CO) poisoning ?&lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;A;&lt;/span&gt; It decreases the half life of CO from 5 hours to half hour and so the possible complications. It prevents lipid peroxidation in the brain and preserve ATP levels in tissue exposed to carbon monoxide. It has shown to decrease the cognitive sequelae by 46 % when compared with 'normobaric' group at 6 weeks&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;2.&lt;br /&gt;&lt;/span&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Limitations:&lt;/span&gt; Hyperbaric oxygen in CO poisoning has its own limitations. It may induce "hyperoxic" &lt;/strong&gt;&lt;/span&gt;&lt;a name="4"&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;seizures&lt;/strong&gt;&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt; (rare)&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;3&lt;/span&gt;&lt;strong&gt;. Other adverse effects of hyperbaric oxygen includes reversible myopia, rupture of the middle ear, barotrauma to lungs&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;4.&lt;/span&gt; &lt;strong&gt;Hyperbaric oxygen should be reserved for lethal cases of CO poisoning. &lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#000066;"&gt;Alternate:&lt;/span&gt; If hyperbaric oxygen is not available, apply 100% oxygen, high PEEP and if needed high-frequency ventilation. 100% O2 reduces half life of CO effectively to about one and half hour.&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference: (click to get abstract)&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&amp;amp;db=pubmed&amp;list_uids=10333448&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Diagnosis and treatment of carbon monoxide poisoning&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Respir Care Clin N Am. 1999 Jun;5(2):183-202.&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://content.nejm.org/cgi/content/abstract/347/14/1057" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Hyperbaric Oxygen for Acute Carbon Monoxide Poisoning&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Volume 347:1057-1067, oct. 3, 2002&lt;br /&gt;3. Central nervous system oxygen toxicity during hyperbaric treatment of patients with carbon monoxide poisoning - Hampson NB, Simonson SG, Kramer CC, Piantadosi CA - UNDERSEA &amp;amp; HYPERBARIC MEDICINE 23 (4): 215-219 DEC 1996&lt;br /&gt;4. &lt;/span&gt;&lt;a href="http://content.nejm.org/cgi/content/abstract/334/25/1642" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Hyperbaric-Oxygen Therapy&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Volume 334:1642-1648, june 20, 1996&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114749340710113102?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114749340710113102'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114749340710113102'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/hyperbaric-oxygen-in-co-poisoning.html' title='Hyperbaric oxygen in CO poisoning'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114744095311749912</id><published>2006-05-12T07:32:00.000-06:00</published><updated>2006-05-12T07:35:53.143-06:00</updated><title type='text'>vasopressin/norepinephrine ratio</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Friday May 12, 2006&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#990000;"&gt;vasopressin/norepinephrine ratio in septic shock&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;p&gt;&lt;br /&gt;Role of vasopressin in septic shock seems promising but we don't have enough data yet to support its regular use. Interesting study in Taiwan was done by Lin and co. and published 6 months ago in Am J Emerg Med. 182 patients &lt;span style="font-size:85%;"&gt;(consecutive patients visiting the emergency department),&lt;/span&gt;  who met  the inclusive criteria were divided into 3 groups (per standard guidelines):&lt;/p&gt;&lt;ul&gt;&lt;li&gt;septic shock, &lt;/li&gt;&lt;li&gt;severe sepsis, and &lt;/li&gt;&lt;li&gt;sepsis. &lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span style="font-size:85%;"&gt;30 healthy subjects were included as control.&lt;/span&gt; &lt;/p&gt;&lt;p&gt;&lt;br /&gt;The plasma vasopressin level at baseline was drawn early in course in emergency department.  The plasma vasopressin level was significantly lower for those who finally developed septic shock (3.6 +/- 2.5 pg/mL) than severe sepsis (21.8 +/- 4.1 pg/mL) and sepsis group (10.6 +/- 6.5 pg/mL) - kind of bell curve.&lt;/p&gt;&lt;p&gt;&lt;br /&gt;Simultaneouly norepinephrine level was measured in the same groups. Norepinephrine level was highest for septic shock group, (3650 +/- 980 pg/mL) in comparion to severe sepsis (3600 +/- 1000 pg/mL) and sepsis group (1720 +/- 320 pg/mL).&lt;br /&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;&lt;span style="color:#660000;"&gt;The vasopressin/norepinephrine ratio&lt;/span&gt;&lt;/em&gt; (very early in the course) was significantly lower for the patients with final diagnosis of septic shock (P less than .001). &lt;/p&gt;&lt;p&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;This study lead us to logical question:&lt;/span&gt; Should we use vasopressin early in septic shock instead later ? but probably it is still early to jump on vasopressin, atleast till we get results from evidence based studies such as pending VASST (Vasopressin Vs. Norepinephrine in Septic Shock) study.&lt;br /&gt;&lt;/p&gt;&lt;p&gt;*&lt;span style="font-size:85%;"&gt;VASST is an ongoing multi-centre triple-blind randomized controlled trial being conducted in Canada and Australia to determine the effectiveness of Vasopressin compared to Norepinephrine (28-day and 90-day survival).&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;Previous related pearl: &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2005/12/saturday-december-10-2005-vasopressin.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Vasopressin .07 units/min ?&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference: (click to get abstract)&lt;br /&gt;&lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=16182977&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Low plasma vasopressin/norepinephrine ratio predicts septic shock.&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;  Am J Emerg Med. 2005 Oct;23(6):718-24.&lt;/span&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114744095311749912?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114744095311749912'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114744095311749912'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/vasopressinnorepinephrine-ratio.html' title='vasopressin/norepinephrine ratio'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114739344589809216</id><published>2006-05-11T18:20:00.000-06:00</published><updated>2006-05-11T18:25:53.460-06:00</updated><title type='text'>Auto-PEEP</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Thursday May 11, 2006&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#cc0000;"&gt;Auto-Peep&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;p&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Q;&lt;/span&gt; What level of extrinsic PEEP should be applied to counter act (intrinsic) auto-PEEP?&lt;/p&gt;&lt;p&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A;&lt;/span&gt; 75 - 85% of auto-PEEP.&lt;/p&gt;&lt;p&gt;&lt;br /&gt;Keeping extrinsic PEEP lower than auto-PEEP not only effectively counter acts auto-PEEP but also any ciruclatory depression or lung hyperinflation is unlikely to occur at extrinsic PEEP slightly lower than intrinsic PEEP value.&lt;br /&gt;&lt;br /&gt;Read precise review on auto-peep:&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;a href="http://www.ccjm.org/PDFFILES/Mughal9_05.pdf" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#cc0000;"&gt;Auto-positive end-expiratory pressure: Mechanisms and treatment &lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#cc0000;"&gt;&lt;br /&gt;&lt;/span&gt;M.M. MUGHAL, D.A. CULVER, O.A. MINAI, and A.C. ARROLIGA - CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 72 • NUMBER 9 SEPTEMBER 2005&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114739344589809216?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114739344589809216'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114739344589809216'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/auto-peep.html' title='Auto-PEEP'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114728340571946450</id><published>2006-05-10T11:48:00.000-06:00</published><updated>2006-05-10T11:50:25.726-06:00</updated><title type='text'>TTKG</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#003333;"&gt;Wednesday May 10, 2006&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;The TransTubular Potassium Gradient - TTKG&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;TTKG is an index reflecting conservation of potassium by Kidney.&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:85%;color:#000066;"&gt;TTKG = (Urine-K / Plasma-K) / (Urine-Osm / Plasma-Osm)&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Normal value is 8-9 in normokalemic patient and should be 10-11 in hyperkalemic patient.&lt;br /&gt;&lt;em&gt;&lt;span style="color:#660000;"&gt;&lt;br /&gt;Clinical significance:&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;1. In hyperkalemia if TTKG remains less than 7, most probable cause is hypoaldosteronism. Diagnosis can be confirmed by challenging patient with 0.05 mg of fludrocortisone, which should increase the TTKG. (Mineralcorticoid increases TTKG).&lt;br /&gt;&lt;br /&gt;2. In hypokalemia - kidney try to conserve potassium and TTKG should fall to less than 2 (like in GI source). If TTKG remains higher, it suggests renal loss of potassium (like in diuretics).&lt;br /&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#660000;"&gt;Limitations:&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;1. Always check urine sodium simultaneouly. TTKG is unreliable if urine sodium is less than 25 mmol/l.&lt;br /&gt;2. TTKG is unreliable if urine osmolality is less than the serum osmolality.&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: click to get abstracts/articles&lt;br /&gt;1.&lt;/span&gt;&lt;a href="http://qjmed.oxfordjournals.org/cgi/content/full/93/5/318" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Potassium excretion indices in the diagnostic approach to hypokalaemia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Q J Med 2000; 93: 318-319&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;list_uids=10858974&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Transtubular potassium concentration gradient (TTKG) and urine ammonium in differential diagnosis of hypokalemia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - J Nephrol. 2000 Mar =Apr;13(2):120-5&lt;br /&gt;3. &lt;/span&gt;&lt;a href="http://cnserver0.nkf.med.ualberta.ca/cn/Schrier/Volume1/Chapt3/ADK1_3_13-15.PDF" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Diseases of Potassium metabolism&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;: &lt;/span&gt;&lt;a href="http://www.kidneyatlas.org/" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Atlas of disease of the kidney&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; by Robert W. Schrier, Professor and Chairman, Department of Medicine, University of Colorado School of Medicine, Denver, Colorado&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114728340571946450?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114728340571946450'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114728340571946450'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/ttkg.html' title='TTKG'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114714859640320249</id><published>2006-05-08T22:21:00.000-06:00</published><updated>2006-05-08T22:23:42.630-06:00</updated><title type='text'>Contrast induced Nephropathy</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Tuesday May 09, 2006&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Contrast induced Nephropathy&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Q:&lt;/span&gt; &lt;span style="color:#000000;"&gt;What is the cut off point to suspect Contrast induced Nephropathy ?&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A;&lt;/span&gt; &lt;span style="color:#000000;"&gt;Unfortunately there is no consensus defination yet to define Contrast Induced Nephropathy but its better to be safer than sorry. The most conservative general rule is to suspect some component of contrast induced nephropathy whenever there is a 25% increase in serum creatinine concentration from the baseline, or an increase of at least 0.3 mg/dL within 48-72 hours, when no other cause could be find.&lt;br /&gt;&lt;br /&gt;We found 2 good review articles for further reading :&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;1. &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.medscape.com/viewarticle/494060" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Contrast-Induced Nephropathy&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;, Tadhg G. Gleeson; Sudi Bulugahapitiya, dublin, Ireland. (ref.: Am J Roentgenol 183(6):1673-1689, 2004). This article is available with free registration at &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.medscape.com/" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#003300;"&gt;medscape.com&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;2. &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://intmedweb.wfubmc.edu/grand_rounds/2004/radiocondoc.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Radiocontrast-Induced Nephropathy&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;, Resident Grand Rounds by Jeff S. Rose, MD at Wake Forest University School of Medicine, Winston-Salem, NC&lt;br /&gt;&lt;br /&gt;Previous related Pearl: &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2005/10/preventingcontrastinducednephropathy.html"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Preventing contrast-Induced Nephropathy&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114714859640320249?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114714859640320249'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114714859640320249'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/contrast-induced-nephropathy.html' title='Contrast induced Nephropathy'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114709859575047549</id><published>2006-05-08T08:27:00.000-06:00</published><updated>2006-05-08T08:29:55.780-06:00</updated><title type='text'>Heparin Induced HyperKalemia</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Monday May 08, 2006&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Heparin Induced HyperKalemia&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;strong&gt;Hyperkalemia from Heparin is a well know phenomenon and has been  detected particularly on geriatric, renal insufficient and diabetic  patients. Hyperkalemia can be anywhere from .3 to 1.7 mEq/Litre. It usually occurs around on day 3 with SQ heparin (as for DVT prophylaxis) but can  occur early with IV heparin&lt;/strong&gt;&lt;span style="font-size:78%;"&gt; 1,2,3,4.&lt;/span&gt;&lt;strong&gt; Hyperkalemia has been reported with low- molecular weight heparins too but risk is low&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;5, 6, 7&lt;/span&gt;&lt;strong&gt;.&lt;br /&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Mechanism of action:&lt;/span&gt; Heparin induce hypoaldosteronism and can subsequently lead to hyperkalemia&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;6.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Treatment:&lt;/span&gt; Best thing is to discontinue the culprit but if heparin is  absolutely required, fludrocortisone (.1 mg/day) has been reported to be effective in heparin-induced hyperkalemia&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;8.&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: Click to get abstracts/articles&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://ats.ctsnetjournals.org/cgi/content/full/74/5/1698" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Case report - Heparin-induced hyperkalemia after cardiac surgery&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Ann Thorac Surg 2002;74:1698-1700&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://www.theannals.com/cgi/content/abstract/24/3/244" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Heparin-induced hyperkalemia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; -The Annals of Pharmacotherapy: Vol. 24, No. 3, pp. 244-246.&lt;br /&gt;3. &lt;/span&gt;&lt;a href="http://www.endocrine-abstracts.org/ea/0004/ea0004p26.htm" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Heparin Induced HyperKalemia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Endocrine Abstracts (2002) 4 P26&lt;br /&gt; 4. &lt;/span&gt;&lt;a href="http://www.amjphysmedrehab.com/pt/re/ajpmr/abstract.00002060-200001000-00019.htm;jsessionid=EeI2wAT53phP4F3U0EMxZzYELAgaICWOuTNGLK1o3hzIEPFmWCha!-839643570!-949856144!9001!-1" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Heparin-Induced Hyperkalemia Confirmed by Drug Rechallenge&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;. American Journal of Physical Medicine &amp; Rehabilitation. 79(1):93-96, January/February 2000.&lt;br /&gt;5. &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;amp;db=PubMed&amp;amp;list_uids=15133781&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Early onset of hyperkalemia in patients treated with low molecular weight heparin: a prospective study &lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;- Pharmacoepidemiol Drug Saf.2004 May;13(5):299-302.&lt;br /&gt;6. Effect of Low-Molecular-Weight Heparin on Potassium Homeostasis - Pathophysiology of Haemostasis and Thrombosis 2002;32:107-110&lt;br /&gt;7. &lt;/span&gt;&lt;a href="http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijgg/vol2n2/heparin.xml" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Low Molecular Weight Heparins Can Lead To Hyperkalaemia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;  The Internet Journal of Geriatrics and Gerontology . 2005. Volume 2 Number 2.&lt;br /&gt;8. &lt;/span&gt;&lt;a href="http://www.theannals.com/cgi/content/abstract/34/5/606" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Fludrocortisone for the treatment of heparin-induced hyperkalemia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - The Annals of Pharmacotherapy: Vol. 34, No. 5, pp. 606-610&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114709859575047549?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114709859575047549'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114709859575047549'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/heparin-induced-hyperkalemia.html' title='Heparin Induced HyperKalemia'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114697378143986421</id><published>2006-05-06T21:46:00.000-06:00</published><updated>2006-05-07T13:02:30.876-06:00</updated><title type='text'>Our failures !!!</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Sunday May 07, 2006&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Our failures !!!&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;p&gt;&lt;span style="color:#000000;"&gt;Some big gurus from Critical Care Medicine (all names below in reference) have penned a cumulative article on progress of Intensive Care and Emergency Medicine over the past 25 Years in recent issue of chest 1. The whole article is worth reading but the most interesting part is where authors have pointed out "Our Failures" with following mentions:&lt;/span&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Excessive antibiotic use&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Iatrogenic IV fluid overload&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Excessive administration of inotropic agents&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Ventilation with unnecessarily large tidal volumes&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Excessive, continuous IV sedation&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Unnecessary use of antiarrhythmic agents&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Excessive caloric intake&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Liberal blood transfusions&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Traumatic effects of endotracheal intubation and airway management&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;Excessive ventilation in low flow states&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;Frequent interruption of chest compressions during CPR&lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference: Click to get abstract&lt;br /&gt;&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://www.chestjournal.org/cgi/content/abstract/129/4/1061" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Intensive Care and Emergency Medicine - Progress Over the Past 25 Years: &lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Jean-Louis Vincent, MD, PhD; Mitchell P. Fink, MD, FCCP; John J. Marini, MD; Michael R. Pinsky, MD, FCCP; William J. Sibbald, MD, FCCP; Mervyn Singer, MD; Peter M. Suter, MD; Deborah Cook, MD; Paul E. Pepe, MD and Timothy Evans, MD Chest. 2006;129:1061-1067&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114697378143986421?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114697378143986421'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114697378143986421'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/our-failures.html' title='Our failures !!!'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114692838827389827</id><published>2006-05-06T09:11:00.000-06:00</published><updated>2006-05-06T21:43:50.056-06:00</updated><title type='text'>ABCDEF of CXR</title><content type='html'>&lt;strong&gt;&lt;span style="color:#003333;"&gt;Saturday May 06, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;ABCDEF of CXR&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;There are many mnemoics we use in medicine. One mnemonic easy to teach house staff so they don't miss things on chest x-ray is&lt;/strong&gt;&lt;br /&gt;&lt;/span&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;A&lt;/span&gt; (Abnormal) Air and Aqua -&lt;span style="font-size:85%;"&gt; (like pneumothorax, pulmonary edema, pleural effusions or even free air below right diaphragm).&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000066;"&gt;B&lt;/span&gt; Bone&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000066;"&gt;C&lt;/span&gt; Cardia &lt;span style="font-size:85%;"&gt;(like pericardial effusion, vena cavae, aortic knob and other cardiac contours)&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000066;"&gt;D&lt;/span&gt; Densities &lt;span style="font-size:85%;"&gt;(infiltrates, masses and lesions - also include hilar area)&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000066;"&gt;E&lt;/span&gt; Elevation of diaphragm &lt;span style="font-size:85%;"&gt;(should also take care of atelactasis)&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000066;"&gt;F&lt;/span&gt; Foreign bodies &lt;span style="font-size:85%;"&gt;(lines, tubes, devices etc).&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114692838827389827?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114692838827389827'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114692838827389827'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/abcdef-of-cxr.html' title='ABCDEF of CXR'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114683823917530552</id><published>2006-05-05T08:09:00.000-06:00</published><updated>2006-05-05T08:12:28.843-06:00</updated><title type='text'>Dialysis disequilibrium syndrome</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#003333;"&gt;Friday May 05, 2006&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;Case:&lt;/span&gt; &lt;/span&gt;&lt;span style="color:#000066;"&gt;&lt;em&gt;57 year old female, newly hemodialysis patient, transferred from floor to ICU after she developed seizure at the end of her dialysis session. No significant risk factor could be find otherwise. Nurse reports patient appear irritable and restless before episode and complain of headache, nausea and blurred vision. While resident was called to evaluate as patient also noticed to have muscular twitching and confusion, symptoms progressed and seizure was witnessed.&lt;/em&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Answer:&lt;/span&gt; Dialysis disequilibrium syndrome.&lt;br /&gt;&lt;br /&gt;Dialysis disequilibrium syndrome is common during hemodialysis particularly patient’s first few dialysis sessions. It is characterized by neurologic symptoms of varying severity and actually may lead to herniation and death. The rapid reduction in BUN lowers the plasma osmolality, creating a transient osmotic gradient that promotes water movement into the cells, causing cerebral edema and consequently acute neurologic dysfunction. With better understanding of the process and newer dialysis techniques, severe form of syndrome is now not commonly seen. This not only explains that why our nephrology colleagues start with gentle but frequent sessions but also explains one of the several benefits of mannitol during dialysis. Read interesting article from University of Calgary, Alberta, Canada :&lt;/span&gt;&lt;span style="color:#000000;"&gt; &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.biomedcentral.com/content/1471-2369/5/9" target="_blank"&gt;&lt;span style="color:#660000;"&gt;&lt;strong&gt;Dialysis Disequilibrium Syndrome: Brain death following hemodialysis for metabolic acidosis and acute renal failure&lt;/strong&gt;&lt;/span&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; &lt;/span&gt;&lt;span style="color:#000000;"&gt;- A case report followed with discussion and different management modalities  &lt;span style="font-size:85%;"&gt;(Ref.: BMC Nephrol. 2004; 5: 9.)&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114683823917530552?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114683823917530552'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114683823917530552'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/dialysis-disequilibrium-syndrome.html' title='Dialysis disequilibrium syndrome'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114675316090145820</id><published>2006-05-04T08:31:00.000-06:00</published><updated>2006-05-04T20:37:34.020-06:00</updated><title type='text'>Swan in Amniotic fluid embolism</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#003333;"&gt;Thursday May 04, 2006&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Pulmonary Artery Catheter in Amniotic fluid embolism !!&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;20 years ago it was suggested by Mason that probable diagnosis of Amniotic fluid embolism can be made by analyzing pulmonary artery blood with the logic that amniotic fluid does not ordinarily enter the maternal circulation, and the identification of large numbers of fetal squamous in the postpartum pulmonary microvasculature is of clinical significance. (He applied similar argument for other similar diseases such as fat embolism). Diagnosis becomes more probable if other fetal debris such as mucin or hair is present.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000066;"&gt;Technique described:&lt;/span&gt; &lt;em&gt;Obtain blood from the distal lumen of a pulmonary artery catheter (in wedged position). After discarding the first 10 ml of blood, draw an additional 10 ml, heparinize and analyze utilizing Papanicolaou's method.&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;Above technique is only suggestive of amniotic fluid embolism and not a gold standard.&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: Click to get abstract/article&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://www.chestjournal.org/cgi/content/abstract/88/6/908" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Pulmonary microvascular cytology. A new diagnostic application of the pulmonary artery catheter&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Chest, V. 88, 908-14&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&amp;db=pubmed&amp;amp;list_uids=1478025&amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Amniotic fluid embolism&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Masson RG - Clin Chest Med.1992 Dec;13(4):657-65.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114675316090145820?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114675316090145820'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114675316090145820'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/swan-in-amniotic-fluid-embolism.html' title='Swan in Amniotic fluid embolism'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114668731054335129</id><published>2006-05-03T14:13:00.000-06:00</published><updated>2006-05-03T14:15:10.563-06:00</updated><title type='text'>Massive PE</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#003333;"&gt;Wednesday May 03, 2006&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;What if even thrombolysis fails in massive PE ?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;For intensivists massive pulmonary Embolism (PE) is a dreaded situation, especially when even thrombolysis fails.  Meneveau and coll. from france have studied such group of 40 patients who did not respond to thrombolysis. Results were published recently in chest.&lt;br /&gt;&lt;br /&gt;14/40 patients who were treated by rescue surgical embolectomy were compared with 26/40 patients who were treated by repeat thrombolysis.&lt;br /&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;There was a trend for higher mortality in the medical group than in the surgical group (10 vs 1 deaths). &lt;/li&gt;&lt;li&gt;Also, there were significantly more recurrent PEs in the repeat thrombolysis (35% vs 0%). &lt;/li&gt;&lt;li&gt;While no significant difference was observed in number of major bleed, all bleeding events in the repeat-thrombolysis group were fatal.&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Study concluded that rescue surgical embolectomy led to a better in-hospital course when compared with repeat thrombolysis in patients with massive PE who have not responded to thrombolysis.&lt;br /&gt;&lt;br /&gt;See comprehensive review, &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.emedicine.com/emerg/topic490.htm" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Pulmonary Embolism&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; just updated 2 days ago at emedicine.com by Craig Feied M.D.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: Click to get abstract/article&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://www.chestjournal.org/cgi/content/abstract/129/4/1043" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Management of Unsuccessful Thrombolysis in Acute Massive Pulmonary Embolism&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Chest. 2006;129:1043-1050&lt;/span&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114668731054335129?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114668731054335129'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114668731054335129'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/massive-pe.html' title='Massive PE'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114659508338456958</id><published>2006-05-02T12:36:00.000-06:00</published><updated>2006-05-02T15:03:42.366-06:00</updated><title type='text'>Phosphate level in Tylenol toxicity</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;Tuesday May 02, 2006&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Is serum phosphate level better than King’s College Hospital criteria ?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;br /&gt;One study of 125 patients published in 'Hepatology' in 2002 looked into relation of serum phosphate level and survival in Acetaminophen-induced hepatotoxicity 1. Study found that Phosphate concentrations were significantly higher in nonsurvivors than in survivors at 48 to 72 hours after overdose as well as at 72 to 96 hours after overdose.&lt;br /&gt;&lt;br /&gt;A threshold phosphate concentration of 3.71 mg/dL (1.2 mmol/L) at 48 to 96 hours after overdose had sensitivity of 89%, specificity of 100%, accuracy of 98%, positive predictive value of 100%, and negative predictive value of 98%. The serum phosphate level had higher sensitivity, accuracy, and positive and negative predictive values than the King’s College Hospital criteria, and it identified patients significantly earlier.&lt;/strong&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: Click to get abstract/article&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://www3.interscience.wiley.com/cgi-bin/abstract/106597833/ABSTRACT" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Serum Phosphate Is an Early Predictor of Outcome in severe Acetaminophen-Induced Hepatotoxicity&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;"&gt;&lt;span style="color:#003333;"&gt; Hepatology - 2002;36:659-665&lt;/span&gt; -&lt;span style="font-size:85%;color:#003333;"&gt;Full article available with free registration&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114659508338456958?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114659508338456958'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114659508338456958'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/phosphate-level-in-tylenol-toxicity.html' title='Phosphate level in Tylenol toxicity'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114654089254188865</id><published>2006-05-01T21:32:00.000-06:00</published><updated>2006-05-04T08:39:56.043-06:00</updated><title type='text'>IVF Bolus</title><content type='html'>&lt;strong&gt;&lt;span style="color:#003333;"&gt;Monday May 01, 2006&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;How to write order for IVF bolus !!&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;What we have learnt from guru and professor Jean-Louis Vincent is that the most important thing in Critical care Medicine is to master the 'basic and simple things'. Few months back he taught us the art of everyday rounding in ICUs with simple mnemonic of "Fast Hug"&lt;/strong&gt;&lt;span style="font-size:78%;"&gt; 1&lt;/span&gt;.&lt;strong&gt; In this month issue of Critical Care Medicine he precisely explains the art of fluid challenge. First he busted 5 myths about fluid bolus. Enjoy !!&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;* Fluid should be withheld because the CVP is high (myth).&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;* Fluid should be withheld because there is lung edema on the CXR (myth).&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;* Fluid should be withheld because the patient has already received a large volume in a short time interval (myth).&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;* Tachycardia is due to fluid deficit and should prompt fluid(myth).&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;* I gave fluids to increase the central venous pressure to 12 mm Hg to exclude an underlying hypovolemia (myth).&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;&lt;em&gt;(Read full article to read details on each).&lt;/em&gt;&lt;/span&gt; &lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;And now 4 parameters need to be written for IVF bolus order:&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;ol&gt;&lt;li&gt;Type of Fluid. &lt;/li&gt;&lt;li&gt;Rate of Fluid Administration. &lt;/li&gt;&lt;li&gt;Goal to be Achieved. &lt;/li&gt;&lt;li&gt;Safety Limits.&lt;/li&gt;&lt;/ol&gt;&lt;br /&gt;Like NS 500 cc over 30 minutes with clinical goal of MAP of 70 mm Hg. Hold if CVP is 15 with assessment every 10 minutes !!&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References:&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Click to get abstract&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;1. &lt;/span&gt;&lt;a href="http://www.ccmjournal.com/pt/re/ccm/abstract.00003246-200506000-00005.htm;jsessionid=EUNbhDEOUAHx32B5spgHanbge84rQlNZGK3BtNGvPgYaksVVwBba!-642208954!-949856145!9001!-1" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Give your patient a fast hug (at least) once a day&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Critical Care Medicine. 33(6):1225-1229, June 2005. - Vincent, Jean-Louis MD, PhD, FCCM&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;2. &lt;/span&gt;&lt;a href="http://www.ccmjournal.com/pt/re/ccm/abstract.00003246-200605000-00005.htm;jsessionid=EUNbhDEOUAHx32B5spgHanbge84rQlNZGK3BtNGvPgYaksVVwBba!-642208954!-949856145!9001!-1" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Fluid challenge revisited.&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; Critical Care Medicine. 34(5):1333-1337, May 2006. Vincent, Jean-Louis MD, PhD, FCCM; Weil, Max Harry MD, PhD, ScD (Hon), FCCM&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114654089254188865?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114654089254188865'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114654089254188865'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/05/ivf-bolus_01.html' title='IVF Bolus'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114640767815922082</id><published>2006-04-30T08:32:00.000-06:00</published><updated>2006-05-01T20:48:21.253-06:00</updated><title type='text'>Post fellowship shock syndrome</title><content type='html'>&lt;strong&gt;&lt;span style="color:#003333;"&gt;Sunday April 30, 2006&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Post fellowship shock syndrome&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Q;&lt;/span&gt; &lt;span style="color:#000000;"&gt;What is Post fellowship shock syndrome ?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A;&lt;/span&gt; &lt;span style="color:#000000;"&gt;Post fellowship shock syndrome is a kind of culture shock for young graduates when they transit from big tertiary care academic centers to regular community based medical practice. Transit from high tech, literature oriented, academic based and superior nursing quality to business oriented, "thats how we do things here" practice, no house staff support, no billing experience and wide spectrum of nursing quality - caught unprepared young graduates with mental and culture shock and may leave them frustrated with present situation. Its important to prepare graduating residents and fellows for future practice of medicine.&lt;br /&gt;&lt;br /&gt;Read related article &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.nejmjobs.org/career-resources/first-year-of-practice.aspx" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;The Realities of the First Year of Practice&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; ( &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.nejmjobs.org/career-resources/rc_index.aspx" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#330033;"&gt;NEJM CareerCenter&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; )&lt;br /&gt;&lt;br /&gt;(Post fellowship shock syndrome is a term invented by editors of this web-site)&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114640767815922082?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114640767815922082'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114640767815922082'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/04/post-fellowship-shock-syndrome.html' title='Post fellowship shock syndrome'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114631863025148790</id><published>2006-04-29T07:48:00.000-06:00</published><updated>2006-04-29T17:53:48.220-06:00</updated><title type='text'>Nasogastric tube syndrome</title><content type='html'>&lt;strong&gt;&lt;span style="color:#003333;"&gt;Saturday April 29, 2006&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Nasogastric tube syndrome&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/03/cuff-leak-test.html" target="_blank"&gt;&lt;/a&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Q;&lt;/span&gt; &lt;span style="color:#003333;"&gt;&lt;em&gt;65 year old female admitted to ICU 9 days ago with small bowel obstruction. Pt. is now stable and actually is about to get transferred out of unit. Patient suddenly start complaining of choking sensation with two hands on neck. Monitor shows oxygen desaturation. Patient intubated emergently. No laryngeal or vocal edema seen on laryngoscope but vocal cord paralysis noted.&lt;/em&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;A;&lt;/span&gt; &lt;span style="color:#000066;"&gt;Nasogastric tube syndrome&lt;/span&gt; : &lt;span style="color:#000000;"&gt;Nasogastric tube syndrome was described about 25 years ago by Sofferman and coll. It is a life-threatening complication of an indwelling (more than a week) nasogastric tube. The syndrome may present as complete vocal cord abductor paralysis. The syndrome is thought to result from perforation of the NG tube-induced esophageal ulcer and infection of the posterior cricoid region (postcricoid chondritis) with subsequent dysfunction of vocal cord abduction. Unilateral paralysis of cord is also described. Treatment is protection of airway, removal of NG tube and antibiotics. Some advocates antireflux therapy too. Another variant is described with no esophageal ulcer but possibly because of ischemia of the laryngeal abductor muscle secondary to physical compression of the postcricoid blood vessels by NG tube .&lt;/span&gt;&lt;/strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: Please click to get abstract&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;list_uids=11190859&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;The nasogastric tube syndrome: two case reports and review of the literature&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;. Head Neck. 2001 Jan;23(1):59-63.&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;list_uids=16415551&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;A variant form of nasogastric tube syndrome.&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; Intern Med. 2005 Dec;44(12):1286-90.&lt;br /&gt;3. &lt;/span&gt;&lt;a href="http://content.karger.com/ProdukteDB/produkte.asp?Doi=68162" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Case Report - Nasogastric Tube Syndrome: The Unilateral Variant&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Medical Principles and Practice Vol. 12, No. 1, 2003&lt;br /&gt;4. Sofferman, R.A. and Hubbell, R.N., "Laryngeal Complications of Nasogastric Tubes," ANNALS OTOLOGY, RHINOLOGY, AND LARYNGOLOGY, 90:465-468, 1981.&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114631863025148790?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114631863025148790'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114631863025148790'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/04/nasogastric-tube-syndrome.html' title='Nasogastric tube syndrome'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114628050453238113</id><published>2006-04-28T21:13:00.000-06:00</published><updated>2006-04-28T21:15:04.543-06:00</updated><title type='text'>Iodide in Thyroid Storm</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;&lt;span style="color:#003333;"&gt;Friday April 28, 2006&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Iodide in Thyroid Storm&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/03/cuff-leak-test.html" target="_blank"&gt;&lt;/a&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Q;&lt;/span&gt; &lt;span style="color:#000000;"&gt;How long should you wait to administer iodide after giving antithyroid medication in the management of thyroid storm ?&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;A;&lt;/span&gt; &lt;span style="color:#000000;"&gt;Atleast one hour.&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Oral or rectal iodide compounds block release of thyroid hormones after starting antithyroid drug therapy. But if given early in management  (before antithyroid medication become effective) it can get utilize in the synthesis of new thyroid hormone. Read nicely written review on &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.emedmag.com/html/pre/cov/covers/021503.asp" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;Thyroid Storm&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;(and Myxedema coma) by Nikolaos Stathatos, MD, and Leonard Wartofsky, MD from Washington Hospital Center in Washington, D.C.  - ref.: emedmag.com, 02/15/2003 issue.&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114628050453238113?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114628050453238113'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114628050453238113'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/04/iodide-in-thyroid-storm.html' title='Iodide in Thyroid Storm'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114611210898224606</id><published>2006-04-26T22:16:00.000-06:00</published><updated>2006-04-26T22:28:43.163-06:00</updated><title type='text'>IV steroid in postextubation stridor</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#003333;"&gt;Thursday April 27, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;IV steroid to reduces postextubation stridor&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;Interesting study came out in May' 2006 issue of Critical Care Medicine regarding intravenous injection of methylprednisolone to reduce the incidence of postextubation stridor in intensive care unit patients. 128 patients who were intubated for more than 24 hrs with a cuff leak volume less than 24% of tidal volume but met weaning criteria were studied. 128 patients were divided into 3 groups.&lt;br /&gt;&lt;ul&gt;&lt;li&gt;placebo group (n = 43) with four injections of normal saline every 6 hrs,&lt;br /&gt;&lt;/li&gt;&lt;li&gt;4 INJ group (n = 42) with four injections of methylprednisolone (40 mg every 6 hours)&lt;br /&gt;&lt;/li&gt;&lt;li&gt;1 INJ group (n = 42) with one injection of the methylprednisolone (40 mg) followed by three injections of normal saline.&lt;/li&gt;&lt;/ul&gt;&lt;br /&gt;Extubation done one hour after last injection. Postextubation stridor was confirmed by examination using bronchoscopy or laryngoscopy.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000066;"&gt;Results shows that:&lt;br /&gt;&lt;/span&gt;The incidences of postextubation stridor were lower both in the 1 injection (11.1%) and the 4 injections groups (7.1%) than in the control group (30.2%,). The side effects of steroids over 24 hrs were minimal with no obvious complications such as GI bleed, hyperglycemia, or increased risk of infection.&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:85%;"&gt;Please read full study for inclusion exclusion criteria, all outcomes, comparision with non-intervention group of 193 patients and discussion of study by authors.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;Related previous pearl: &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/03/cuff-leak-test.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Cuff leak tests&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: click to get abstract&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://www.ccmjournal.com/pt/re/ccm/abstract.00003246-200605000-00008.htm;jsessionid=EPUmSaNzhie0wf1VycQJ8qoGYRDvubwDgPn2lEsq2ZW5bfmGwbNL!389595325!-949856144!9001!-1" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Intravenous injection of methylprednisolone reduces the incidence of postextubation stridor in intensive care unit patients -&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; Critical Care Medicine. 34(5):1345-1350, May 2006&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114611210898224606?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114611210898224606'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114611210898224606'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/04/iv-steroid-in-postextubation-stridor.html' title='IV steroid in postextubation stridor'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114602493380912775</id><published>2006-04-25T22:13:00.000-06:00</published><updated>2006-04-25T22:18:27.310-06:00</updated><title type='text'>LaSRS</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;Wednesday April 26, 2006&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#990000;"&gt;LATE STERIOD RESCUE STUDY (LaSRS): The Efficacy of Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;Finally the results of ARDSnet's LaSRS trial are published. Out of 180 patients with ARDS of atleast 7 days, 91 were randomly assigned to the placebo group and 89 to the methylprednisolone group. Some outcomes are very unexpected : &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;1. There was no significant difference in the 60-day hospital mortality rate, with 26 deaths in each group.&lt;br /&gt;&lt;br /&gt;2. At 180 days, 29 patients had died in the placebo group and 28 had died in the methylprednisolone group.&lt;br /&gt;&lt;br /&gt;3. The methylprednisolone group had significantly more ventilator-free days than the placebo group during the first 28 days as well as at 180 days.&lt;br /&gt;&lt;br /&gt;4. As compared with the placebo group, the methylprednisolone group also had significantly fewer days in the ICU during the first 28 days but not at day 180 !!.&lt;br /&gt;&lt;br /&gt;5. Ventilatory assistance was resumed: 6 in the placebo group and 20 in the methylprednisolone group. Also 8 of the 20 methylprednisolone-treated patients who resumed receiving assisted ventilation died, as compared with 3 of 6 patients in the placebo group.&lt;br /&gt;&lt;br /&gt;6. The mean serum glucose level was not significantly different between groups at baseline but was significantly higher in the methylprednisolone group than the placebo group on days 1, 2, and 4.&lt;br /&gt;&lt;br /&gt;7. Forty-three serious infections were diagnosed in 30 patients in the placebo group, as compared with 25 serious infections in 20 patients in the methylprednisolone group.&lt;br /&gt;&lt;br /&gt;8. There were 17 episodes of septic shock among 15 patients in the placebo group and 6 episodes among 5 patients in the methylprednisolone group.&lt;br /&gt;&lt;br /&gt;9. Prospectively, serious neuromyopathy were reported in nine patients, all of whom were in the methylprednisolone group but interestingly retrospective chart review found no significant difference in the incidence of neuromyopathy: 21 in the placebo group and 27 in the methylprednisolone group. Also, Exposure to neuromuscular-blocking agents was not significantly more common among patients who were identified as having neuromyopathy.&lt;br /&gt;&lt;br /&gt;10. Patients who were enrolled at least 14 days after the onset of ARDS and who were randomly assigned to receive methylprednisolone had a significantly higher case fatality rate than similar patients who were assigned to receive placebo. &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Study conclusion:&lt;/span&gt; &lt;span style="color:#000066;"&gt;These results do not support the routine use of methylprednisolone for persistent ARDS despite the improvement in cardiopulmonary physiology. In addition, starting steroid therapy more than two weeks after the onset of ARDS may increase the risk of death.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:85%;"&gt;&lt;span style="color:#660000;"&gt;Editor note:&lt;/span&gt; Please read whole article to be aware of limitations of study.&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;span style="font-size:85%;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References:&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://content.nejm.org/cgi/content/abstract/354/16/1671" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Efficacy and Safety of Corticosteroids for Persistent Acute Respiratory Distress Syndrome&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Volume 354:1671-1684, Number 16, April 20,2006&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://www.ardsnet.org/protocols_tex/lasrsProtocolV5_2000-06.pdf" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Protocol of study&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;: ARDSnet.org&lt;br /&gt;3. &lt;/span&gt;&lt;a href="http://clinicaltrials.gov/show/NCT00295269" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Late Steroid Rescue Study (LaSRS): The Efficacy of Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - clinicaltrials.gov&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114602493380912775?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114602493380912775'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114602493380912775'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/04/lasrs.html' title='LaSRS'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114596044435202677</id><published>2006-04-25T04:12:00.000-06:00</published><updated>2006-04-25T04:23:52.250-06:00</updated><title type='text'>Esophageal Pressure Measurements and compliance</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#003333;"&gt;Tuesday April 25, 2006&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Esophageal Pressure Measurements and compliance&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;At bedside compliance is measured as&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;span style="color:#000066;"&gt;Cs = Vt / Ppl - (PEEP + autoPEEP)&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:85%;"&gt;Where Cs = compliance of static thorax, Vt = tidal volume, Ppl = plateau pressure and PEEP is postive-end-expiratory pressure&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;or in more precise terms&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000066;"&gt;C stat = Vt / (Pao end'inhalation - Pao end'exhalation)&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:85%;"&gt;Where Pao = pressure at the airway opening. Pao end'inhalation is same as Ppl. and Pao end'exhalation is same as TotalPEEP.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;This compliance measures the whole thorax including chest wall and lungs. Normal Cs is ideally 100 ml/cm H2O or practically 50 to 80 ml/cm H2O is acceptable.&lt;br /&gt;&lt;br /&gt;Placement of esophageal catheter can give lung compliance (CL) and chest wall compliance (Ccw) separately. Formulae are&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000066;"&gt;CL = Vt / (Pao - Pes) end'inhalation - (Pao - Pes) end'exhalation&lt;br /&gt;&lt;/span&gt;and&lt;br /&gt;&lt;span style="color:#000066;"&gt;Ccw = Vt / (Pes - Patm) end'inhalation - (Pes - Patm) end'exhalation&lt;br /&gt;or practically done simply as Ccw = Vt / Pes end'inhalation&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000066;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="font-size:85%;"&gt;Where Pes = Esophageal pressure and P atm = Atmospheric pressure&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="font-size:85%;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;Normal CL and Ccw is 200 ml/cm H2O.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Read article&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;a class="l" href="http://www.rcjournal.com/contents/01.05/01.05.0068.pdf" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Esophageal and Gastric Pressure Measurements&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; , including all the basics of how to insert and measure the esophageal catheter pressures by Dr. Joshua O Benditt (ref: Resp. Care, Jan. 2005, vol 50, no. 1)&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114596044435202677?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114596044435202677'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114596044435202677'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/04/esophageal-pressure-measurements-and.html' title='Esophageal Pressure Measurements and compliance'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114585473551232905</id><published>2006-04-23T22:52:00.000-06:00</published><updated>2006-04-23T23:00:23.476-06:00</updated><title type='text'>CURB-65 Score</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#003333;"&gt;Monday April 24, 2006&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;CURB-65 Score&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;Lim and colleagues have designed a score called CURB-65 to rate mortality in community acquired pneumonia (CAP) - based on information available at initial hospital assessment. Give one point each for following values&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;C = Confusion&lt;br /&gt;U = Urea (BUN) if more than 20 mg/dl (7 mmol/l)&lt;br /&gt;R = Respiratory rate if more than / = 30/min,&lt;br /&gt;B = BP if syst. less than 90 mm Hg or diast. less than/= 60 mm Hg, &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000000;"&gt;65 = If age more than / = 65 years &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000000;"&gt;With score 0 expected mortality is 0.7%, &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000000;"&gt;With score 1 expected mortality is 3.2%, &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000000;"&gt;With score 2 expected mortality is 13%, &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000000;"&gt;With score 3 expected mortality is 17%, &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000000;"&gt;With score 4 expected mortality is 41.5% and &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000000;"&gt;With score 5 expected mortality is 57% &lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References:&lt;br /&gt;1.&lt;/span&gt;&lt;a href="http://thorax.bmjjournals.com/cgi/content/full/58/5/377" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - W S Lim, M M van der Eerden, R Laing, W G Boersma, N Karalus, G I Town, S A Lewis and J T Macfarlane - Thorax 2003;58:377-382&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114585473551232905?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114585473551232905'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114585473551232905'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/04/curb-65-score.html' title='CURB-65 Score'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114582073284659884</id><published>2006-04-23T13:30:00.000-06:00</published><updated>2006-04-23T17:37:34.393-06:00</updated><title type='text'>Hemodynamic variables in septic shock</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#003333;"&gt;Sunday April 23, 2006&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Hemodynamic variables to watch in septic shock&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;Dr Varpula and coll. from Helsinki, Finland tried to identify the most related hemodynamic variables in 111 septic shock patients. Data from 6 hours and 48 hours were analyzed separately. Primary endpoint was 30-day mortality. Following results were found:&lt;br /&gt;&lt;br /&gt;1. Univariate analysis showed that lactate level on arrival and MAP-derived variables (average of all MAP values, hypotension time) during the first 6 hours correlated with the 30-day mortality.&lt;br /&gt;&lt;br /&gt;2. The best cutoff values for hypotension and hypoperfusion times were found to be MAP of 65 mmHg and SvO2 of 70%, respectively.&lt;br /&gt;&lt;br /&gt;In conclusion, data suggest that time spent with low BP and with inadequate CO (decrease SvO2) are the most important hemodynamic variables related to outcome. This study find threshold values in synchrony with values published in recent guidelines.&lt;br /&gt;&lt;br /&gt;Related Sites: &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.survivingsepsis.org/get_software.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;survivingsepsis.org&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Related Previous pearls: &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/02/sasb_21.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Shock alert&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt; , &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/04/scvo2-and-svo2.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;ScvO2 or SvO2 ?&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt; &lt;span style="color:#000000;"&gt;and&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/04/egdt-and-need-for-pac.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;EGDT and PAC need&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References:&lt;br /&gt;1.&lt;/span&gt;&lt;a href="http://www.springerlink.com/(nfmzzszdkaagwk2zbawag545)/app/home/contribution.asp?referrer=parent&amp;backto=issue,10,29;journal,10,295;linkingpublicationresults,1:100428,1" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Hemodynamic variables related to outcome in septic shock&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Intensive Care Medicine, Volume 31, Number 8 , August 2005, Pages: 1066 - 1071&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114582073284659884?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114582073284659884'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114582073284659884'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/04/hemodynamic-variables-in-septic-shock.html' title='Hemodynamic variables in septic shock'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114572282515040489</id><published>2006-04-22T10:18:00.000-06:00</published><updated>2006-04-29T15:49:37.953-06:00</updated><title type='text'>Law of LaPlace</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#003333;"&gt;Saturday April 22, 2006&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Law of LaPlace, PEEP and surfactant&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;div align="left"&gt;&lt;br /&gt;Law of LaPlace tells us that "Pressure is always greater in smaller radius".&lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#000066;"&gt;P = 2T/r&lt;/span&gt; &lt;/div&gt;&lt;div align="left"&gt;&lt;br /&gt;&lt;span style="font-size:85%;"&gt;where P = pressure, T = tension and r = radius&lt;/span&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;So in lungs, smaller alveoli will have greater resistance for air to flow during inspiration because of higher pressure. We use PEEP to keep alveoli open during expiration (prevent derecruitment), as name says positive end-expiratory pressure. High tidal volume cause more shear force damage to smaller alveoli with each breath to overcome this pressure. Thats why, our present approach to ventilator management in ARDS is low tidal volume and optimum PEEP (See ARDSnet&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;a href="http://www.ardsnet.org/vent-w_hipeepcard.pdf" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#330033;"&gt;Lower Tidal Volume/ Higher PEEP Reference Card&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;).&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; &lt;div align="left"&gt;&lt;br /&gt;Looking at same formula, other approach is to decrease Tension, by nature's method of applying surfactant. One study published in August 2004 looked into 'Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress Syndrome' and found no significant difference in terms of 28 days mortality or the need for mechanical ventilation but also showed that 'Patients receiving surfactant had a significant greater improvement in blood oxygenation during the first 24 hours of treatment than patients receiving standard therapy'. Actually literature suggests that "..&lt;em&gt;Sufficient levels of PEEP will also help to prevent further loss of surfactant in still ‘healthy’ alveoli&lt;/em&gt;," &lt;/div&gt;&lt;div align="left"&gt;&lt;/div&gt;&lt;div align="left"&gt;Read &lt;span style="color:#000000;"&gt;Professor Lachmann's lecture&lt;/span&gt; - &lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;a href="http://www.eacta.org/cgi-bin/index.pl?page-05-00-20030425.htm" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Current status of lung protective ventilation in ARDS&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;, discussing Law of LaPlace, surfactant and PEEP. (source: eacta.org - European Association of Cardiothoracic Anaesthesiologists)&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References:&lt;br /&gt;1.&lt;/span&gt;&lt;a href="http://content.nejm.org/cgi/content/abstract/351/9/884" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress Syndrome&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Volume 351:884-892, Number 9, NEJM Aug. 26, 2004&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://content.nejm.org/cgi/content/abstract/351/4/327" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Higher versus Lower Positive End-Expiratory Pressures in Patients with the Acute Respiratory Distress Syndrome&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - The National Heart, Lung, and Blood Institute ARDS Clinical Trials Network ,Volume 351:327-336, Number 4, NEJM, july 22, 2004&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114572282515040489?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114572282515040489'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114572282515040489'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/04/law-of-laplace.html' title='Law of LaPlace'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114564013450628926</id><published>2006-04-21T11:21:00.000-06:00</published><updated>2006-04-21T11:23:23.483-06:00</updated><title type='text'>ketek</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#003333;"&gt;Friday April 21, 2006&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Case:&lt;/span&gt; &lt;em&gt;&lt;span style="color:#003333;"&gt;74 year old male resident of assisted living facility, admitted to ICU with exacerbation of his myasthenia gravis. He also reports newly devloped symptoms of blurred vision, difficulty focusing, and diplopia which according to him is not typical of his symptoms but you assume it as part of exacerbation of myasthenia gravis. Patient denies stopping his medicine. 3 days ago he was seen by his primary care physician for cough and was given samples of a new strong antibiotic. His neurologist has been consulted who requests you to change his antibiotic. Patient symptoms resolved within 24 hours.&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Answer:&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://ketek.com/home.do" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Ketek&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; (Talithromycin) is a first ketolide (cousin of macrolide), indicated for mild to moderate acute exacerbation of chronic bronchitis, acute bacterial sinusitis and in mild to moderate CAP, atypical and multi-drug resistant strains of S pneumoniae. Talithromycin unlike the macrolides has 2 strong binding sites on the bacterial ribosome and this strong dual binding helps provide coverage against resistant strains of S pneumoniae. Exacerbations of myasthenia gravis have been reported in patients with myasthenia gravis treated with Talithromycin. It cause visual disturbances like blurred vision, difficulty focusing, and diplopia by slowing the ability to accommodate and the ability to release accommodation. Other major side effects include hepatic dysfunction and potential to prolong the QTc interval.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References:&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://www.fda.gov/cder/drug/advisory/telithromycin.htm" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;FDA Public Health Advisory Ketek (telithromycin) Tablets&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - fda.gov&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://www.fda.gov/cder/consumerinfo/druginfo/Ketek.HTM" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;FDA consumer info&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;. - fda.gov&lt;br /&gt;3. &lt;/span&gt;&lt;a href="http://ketek.com/home.do" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;www.ketek.com&lt;/span&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114564013450628926?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114564013450628926'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114564013450628926'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/04/ketek_21.html' title='ketek'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114546508868173413</id><published>2006-04-19T10:43:00.000-06:00</published><updated>2006-08-28T03:40:02.900-06:00</updated><title type='text'>Ambien</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Thursday April 20, 2006&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Zolpidem-Induced Delirium&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;Relatively Zolpidem (Ambien) is a safe medicine and recently has been the drug of choice in critical care units to induce sleep. But it is important to be aware of reported cases of Ambien related psychosis, delirium and mania. Atleast one case is reported with visual perception distortion after a single dose of zolpidem. One way to combat the problem is to decrease the prescribing dose particularly in elderly population and in hypoalbuminemia (5 mg instead of 10 mg). Also, female population has been reported to have more plasma level with same dose. Also note that Zolpidem metabolized through liver so it may be necessary to decrease the dose in liver insufficiency.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;strong&gt;Related previous pearls: &lt;a href="http://icuroom-pearls.blogspot.com/2005/12/ss.html"&gt;SEROTONIN SYNDROME&lt;/a&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References:&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://www.theannals.com/cgi/content/abstract/35/12/1562" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Delirium associated with zolpidem&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - The Annals of Pharmacotherapy: Vol. 35, No. 12, pp. 1562-1564&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://psy.psychiatryonline.org/cgi/content/full/45/1/88" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Zolpidem-Induced Delirium With Mania in an Elderly Woman&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Psychosomatics 45:88-89, February 2004&lt;br /&gt;3. &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&amp;db=pubmed&amp;amp;list_uids=8937915&amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Zolpidem-induced agitation and disorganization&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;. - Gen Hosp Psychiatry. 1996 Nov;18(6):452-3. (pubmed)&lt;br /&gt;4. &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&amp;db=pubmed&amp;amp;list_uids=8807033&amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Zolpidem-induced psychosis&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;. - Ann Clin Psychiatry.1996 Jun;8(2):89-91. (pubmed)&lt;br /&gt;5. Clinical pharmacokinetics of zolpidem in various physiological and pathological conditions, in Imidazopyridines in Sleep Disorders. Edited by Sauvanet JP, Langer SZ, Morselli PL. New York, Raven Press, 1988, pp 155–163&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;span style="font-size:78%;color:#003333;"&gt;6. &lt;/span&gt;&lt;a href="http://www.theannals.com/cgi/content/abstract/37/5/683" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Zolpidem-Induced Distortion in Visual Perception&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - The Annals of Pharmacotherapy: Vol. 37, No. 5, pp. 683-686&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114546508868173413?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114546508868173413'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114546508868173413'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/04/ambien.html' title='Ambien'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114545326606660414</id><published>2006-04-19T07:25:00.000-06:00</published><updated>2006-04-22T10:23:12.960-06:00</updated><title type='text'>US guided radial artery</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#003333;"&gt;Wednesday April 19, 2006&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Ultrasound guided insertion of radial artery catheters&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;strong&gt;Role of ultrasound guidance in central venous catheter (particularly internal jugular vessel) is well known&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;1&lt;/span&gt;&lt;strong&gt; but literature on its efficacy in arterial line insertion is very scant. Levin and coll. from Hadassah University Hospital, Jerusalem, Israel has done a simple but interesting study on the use of ultrasound guidance in the insertion of radial artery catheters&lt;/strong&gt; &lt;span style="font-size:78%;"&gt;2&lt;/span&gt;&lt;strong&gt;. A total of 69 patients were randomized - 34 to the ultrasound group and 35 to the palpation group. The following results were found:&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;*&lt;/span&gt; The arterial cannula was inserted on the first attempt in 21 of the 34 patients (62%) in the ultrasound group vs. 12 of the 35 patients (34%) in the palpation group.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;*&lt;/span&gt; Overall, there were 55 total attempts (1.6 per patient) at arterial catheter insertion in the ultrasound group vs. 110 (3.1 per patient) in the palpation group.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;*&lt;/span&gt; The mean overall time taken per patient for catheter insertion was 55.5 secs in the ultrasound group vs. 111.5 secs in the palpation group.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;*&lt;/span&gt; In the ultrasound group, a total of 39 cannulae were used vs. 60 in the palpation group (cost effectiveness).&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References:&lt;br /&gt;1 &lt;/span&gt;&lt;a href="http://www.chestjournal.org/cgi/content/abstract/128/3/1766" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Bedside Ultrasonography in the ICU Part 2&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Chest. 2005;128:1766-1781&lt;br /&gt;2. &lt;/span&gt;&lt;a href="http://www.ccmjournal.com/pt/re/ccm/abstract.00003246-200302000-00021.htm;jsessionid=EE8oj75G6mVVH0JeYBQxM2zqPdPtIMORSpYnAbnzXylTYOQXhH3k!329698451!-949856144!9001!-1" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Use of ultrasound guidance in the insertion of radial artery catheters&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Critical Care Medicine: Volume 31(2) February 2003 pp 481-484&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114545326606660414?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114545326606660414'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114545326606660414'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/04/us-guided-radial-artery.html' title='US guided radial artery'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114539856326082438</id><published>2006-04-18T16:14:00.000-06:00</published><updated>2006-04-18T16:16:03.300-06:00</updated><title type='text'>Wernicke's Encephalopathy</title><content type='html'>&lt;strong&gt;&lt;span style="color:#003333;"&gt;Tuesday April 18, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Wernicke's Encephalopathy in ICU&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;br /&gt;&lt;/strong&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Q:&lt;/span&gt; &lt;span style="color:#000000;"&gt;Can Wernicke's Encephalopathy  be iatrogenic in ICU ?&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;A:&lt;/span&gt;  Yes, it can be precipitated in any patient by glucose (like D-5, D-10 or D-50)  administration who is thiamine deficient. It is not limited to alcoholics and can happen in any nutritionally deficient patient. It is always a good idea to add thiamine in D-5 drip in patients who are at risk of  Wernicke's  Encephalopathy.&lt;br /&gt;Disorder was described about 25 years ago by Carl Wernicke as a triad of &lt;/span&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;acute mental confusion &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;ataxia &lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;opthalmoplegia &lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;Read a case of Wernicke's encephalopathy. in a non-alcoholic patient with MRI findings &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://content.nejm.org/cgi/content/full/352/19/e18" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;here&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; (Ref.: The New England Journal of Medicine, Kaineg and Hudgins 352 (19): e18, May 12, 2005)&lt;br /&gt;&lt;br /&gt;Also full review article &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://www.emedicine.com/EMERG/topic642.htm" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Wernicke's encephalopathy&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt; from Philip Salen, MD at emedicine.com&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114539856326082438?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114539856326082438'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114539856326082438'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/04/wernickes-encephalopathy.html' title='Wernicke&apos;s Encephalopathy'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114525146399363996</id><published>2006-04-16T23:21:00.000-06:00</published><updated>2006-04-16T23:25:39.310-06:00</updated><title type='text'>Rule of 20s</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Monday April 17, 2006&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Progressive rule of 20s&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;p&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Q:&lt;/span&gt; What is "progressive rule of 20s" during Pulmonary Artery Catheter insertion ?&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A:&lt;/span&gt; During Pulmonary Artery catheter insertion from Right Internal Jugular approach: &lt;/p&gt;&lt;ol&gt;&lt;li&gt;Right atrium (or SVC) should be entered within 20 cm from skin&lt;/li&gt;&lt;li&gt;Right ventricle should be entered within 40 cm from skin &lt;/li&gt;&lt;li&gt;Pulmonary artery should be entered within 60 cm from skin&lt;br /&gt;&lt;/li&gt;&lt;/ol&gt;&lt;p&gt;Related Previous Pearl: &lt;/span&gt;&lt;/strong&gt;&lt;a href="http://icuroom-pearls.blogspot.com/2006/01/tuesday-january-3-2006-procedure-tip.html" target="_blank"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Procedure Tip - Does that waveform look ‘wedged’?&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114525146399363996?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114525146399363996'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114525146399363996'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/04/rule-of-20s.html' title='Rule of 20s'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-17315753.post-114515990788854690</id><published>2006-04-15T21:55:00.000-06:00</published><updated>2006-04-15T21:58:27.903-06:00</updated><title type='text'>Tacrolimus</title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#003333;"&gt;Sunday April 16, 2006&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000066;"&gt;Case:&lt;/span&gt; &lt;span style="color:#000066;"&gt;&lt;em&gt;34 year old male with recent kidney transplant admitted to your unit with mental status change and family reports witnessed seizure. While evaluating patient, nurse hand over critical lab to you with magnesium of 0.2 mg/dl, your first response is to ask potassium level but it is actually on hyperkalemic side with 5.5 meq/l. As you call his renal transplant physician and reports severe hypomagnesemia and seizure but normal BUN/Cr level, his first question is to read patient's medication list. Why ?&lt;br /&gt;&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;Tacrolimus (FK-506 or Prograf) is a macrolide, an immunosuppressive drug, use in organ transplant to reduce the risk of organ rejection. It causes hyperkalemia due to renal tubular acidosis, Type 4 (RTA-IV) but simultaneously cause hypomagnesemia, unusual to find both together. Other side effects of tacrolimus includes seizures, tremors, hypertension, confusion, calciuria, hyperglycemia, weakness, depression, cramps, and neuropathy. Apart fron side effect of severe hypomagnesemia, seizure and other neural are direct effects of tacrolimus too.&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References:&lt;br /&gt;1. &lt;/span&gt;&lt;a href="http://jasn.asnjournals.org/cgi/content/full/15/3/549" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Downregulation of Ca2+ and Mg2+ Transport Proteins in the Kidney Explains Tacrolimus (FK506)-Induced Hypercalciuria and Hypomagnesemia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;  - J Am Soc Nephrol 15:549-557, 2004&lt;br /&gt;2. FK 506-induced neurotoxicity in liver transplantation. - Wijdicks EF, Wiesner RH, Dahlke LJ, Krom RA.  -  Ann Neurol 1994;35:498–501.&lt;br /&gt;3. &lt;/span&gt;&lt;a class="l" href="http://www.fda.gov/cder/warn/2004/12327Prograf.pdf"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Prograf Warning Letter&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - fda.gov&lt;br /&gt;4. Tacrolimus leukoencephalopathy: A neuropathologic confirmation Lavigne et al. Neurology.2004; 63: 1132-1133&lt;br /&gt;5. &lt;/span&gt;&lt;a href="http://www.biomedcentral.com/1471-2369/7/7" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Progressive neurological disease induced by tacrolimus in a renal transplant recipient: Case presentation&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - BMC Nephrology 2006, 7:7&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/17315753-114515990788854690?l=icuroom-pearls.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114515990788854690'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/17315753/posts/default/114515990788854690'/><link rel='alternate' type='text/html' href='http://icuroom-pearls.blogspot.com/2006/04/tacrolimus.html' title='Tacrolimus'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry></feed>
